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ABSTRACT
Erythrocyte invasion is a process essential to the survival of malaria 
parasites. An understanding of the mechanism of erythrocyte invasion by 
malarial merozoites is important, since interruption of any of these events . 
would halt the parasites asexual cycle and prevent disease. Much work has 
focused on the human malaria Plasmodium falciparum, however it is 
expensive to maintain in the laboratory. The research described here 
concentrates on the rodent malaria Plasmodium berghei, which in many 
ways is similar to P. falciparum, but is more convenient to obtain, cheaper to 
maintain and remains relatively uninvestigated.
A percoll density gradient centrifugation step was developed to purify 
mature parasite-infected erythrocytes from other infected and uninfected 
erythrocytes. This purification step allowed the development of in vitro 
invasion assays and erythrocyte receptor binding assays for P. berghei. The 
invasion assays confirmed in vitro, the invasion specificities observed in 
vivo for P. berghei, in particular the preference of P. berghei merozoites for 
invasion of immature erythrocytes, the reticulocytes. The binding assays 
identified a 130 kDa P. berghei molecule that bound exclusively to murine 
erythrocytes, and which undoubtedly has a role in merozoite invasion of 
erythrocytes.
Polyclonal antisera was raised to various protein preparations of P. 
berghei, and these were used to screen a cDNA expression library of P. 
berghei constructed in gt11. This cDNA library was also screened with 
radiolabelled oligonucleotide probes corresponding to fragments of a gene 
encoding an erythrocyte binding protein of the human malaria 
Plasmodium falciparum.
A cDNA library constructed in gt11 from the sexual stages of P. 
falciparum was screened with an antisera specific for sexual stage 
antigens. Isolated clones were characterised and (3-galactosidase fusion 
proteins prepared. Antisera was raised to these fusion proteins.
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ABBREVIATIONS
BCIP 5’-bromo-4-chloro-3-indoyl phosphate
bp base pairs
BSA Bovine serum albumin
CS Circumsporozoite
DAP Duffy adhesion protein
DEPC Diethyl pyrocarbonate
EBA Erythrocyte binding antigen
EBP Erythrocyte binding protein
EDTA Ethylenediaminetetraacetic acid disodium salt
EE Exoerythrocytic stage
E-64 trans-epoxysuccinyl-L-leucylamido (4-guanidino)
butane
FCS Foetal calf serum
HEPES N-[2-hydroxyethyl] piperazine-N’[2-ethanesulfonic acid]
i.p. intra-peritoneal
IPTG Isopropyl-S-D-Thiogalactopyranoside
kDa kilodalton
NBT Nitro blue tétrazolium
PAGE Polyacrylamide gel electrophoresis
PBS Phosphate buffered saline
PMSF Phenylmethylsulfonyl fluoride
RBP Reticulocyte binding protein
SDS Sodium dodecyl sulphate
STI Soybean Trypsin inhibitor
TPCK N-Tosyl-L-Phenylalanine chloromethyl ketone
Tris Tris (hydroxymethyl) aminomethane
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CHAPTER 1
INTRODUCTION
MALARIA
Throughout the tropics and subtropics, over 2000 million people are 
at risk from infection with malaria. Of these, between 200 and 400 million 
are infected and between one and two million, mainly children, die each 
year. The disease is caused by a protozoan parasite of the genus 
Plasmodium, which is transmitted to man by the anopheline mosquito. Four 
species of the parasite affect man: Plasmodium falciparum and 
Plasmodium vivaxare the most common, with the former being the most 
dangerous and responsible for nearly all malaria related deaths. 
Plasmodium malariae and Plasmodium ovale are much less prevalent.
Traditional methods of malaria control involve the use of insecticides 
against the mosquito vector and drugs for the prevention and cure of 
infection. However these methods have merely contained the disease, and 
have had little impact on its eradication. Even these control measures are 
now becoming less effective with the worldwide spread of insecticide- 
resistant mosquitoes and the emergence of malaria parasites that are 
resistant to the available antimalarial drugs. In addition, factors such as the 
growth in world population, the destabilisation of developing regions of the 
world and the problems of administering control programs all increase the 
threat of malaria.
Most malariologists agree that a vaccine will have to be an essential 
component of a future control and eradication scheme and consequently 
great resources have been put Into developing one. However the task has 
been much more difficult than had been envisaged, due both to the 
parasites ability to avoid or adapt to immune pressure and to our 
incomplete understanding of man’s immune system.
Although the Plasmodium species attacking man have been the 
most extensively studied, considerable research use has been made of 
malarial species which infect laboratory animals, especially Plasmodium 
knowlesi in monkeys, Plasmodium gallinaceum in birds and Plasmodium 
berghei in rodents. The problem with these model host-parasite systems 
are that they can provide only indirect information about what might happen 
in a human infected with malaria, though several important leads have 
come from studies on owl monkeys (Aotus trivirgatus) and Squirrel 
monkeys (Saimirí sciureus), both of which can be experimentally infected 
with P. falciparum. However the number of these monkeys available for
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experimental purposes is limited and they are now only used to a 
significant extent in their native South America. A murine model has now 
also been developed for P. falciparum, which is hoped will aid research into 
certain stages of the malarial life cycle (Sacci et al., 1992). It remains likely 
that the rodent and avian malarias like will continue to be provide useful 
information on the parasite and the disease it causes for some time as they 
remain easier and cheaper to maintain in the laboratory, and may 
themselves be evolutionarily closer to Plasmodium falciparum than the 
monkey malarias are (McCutchan et al., 1984). However in the light of past 
mistakes, and failed vaccine candidates, greater care is being taken in the 
inferences drawn from immunological data provided by animal malarias.
All malarial plasmodia that infect animals, spend a part of their life in 
a vertebrate host and part in a mosquito host. Their life cycle is therefore 
complex, comprising several stages, each of which is structurally, 
biochemically and antigenically distinct. Despite the large number of 
species and the range of hosts affected by the malaria parasite, they share 
a common life-cycle and a similarity in the morphology of the various 
developmental stages.
THE LIFE CYCLE OF THE MALARIA PARASITE
The life cycle of malaria in the vertebrate and invertebrate hosts is 
shown in Fig. 1.1. Infection is initiated by the injection of the sporozoite form 
of the parasite into the victim by the female Anopheline mosquito during 
feeding. Since the mosquito usually feels about with its proboscis until it 
strikes a capillary, the sporozoites are introduced directly into the 
bloodstream. Injected sporozoites released from the mosquito salivary 
gland circulate in the blood and are carried to the liver where they invade 
the hepatocytes and begin to replicate. This stage of the life cycle is termed 
the exoerythrocytic (EE) stage. In the case of P. falciparum , the sporozoite 
develops into merozoites over the course of 5-7 days and up to 40,000 
merozoites are released from each infected cell.
The merozoite initiates the asexual erythrocytic cycle of the parasite, 
rapidly invading erythrocytes where it develops from ring-form to schizont, 
the stage which undergoes nuclear division. In P. falciparum nuclear 
division gives rise to 10-20 new merozoites each capable of invading a
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FIG. 1.1. The life cycle of the malaria parasite
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new erythrocyte.The process of merozoite formation is known as 
schizogony and the mature schizont containing individual merozoites is 
known as a segmentor. These segmentors rupture, releasing the 
merozoites which
invade new erythrocytes, initiating a new round of the erythrocytic cycle. It Is 
the erythrocytic cycle which is responsible for the clinical manifestations of 
the disease, including fever, anaemia and spleenomegaly. In addition, P. 
falciparum infected erythrocytes bind to the vascular endothelium and 
block blood flow in the brain and kidneys, which can prove fatal. Not all 
invading merozoites proliferate asexually in erythrocytes. Some ring-forms 
differentiate into sexual forms called gametocytes, which are ingested by 
mosquitoes during a blood meal. Male gametocytes are termed 
microgametocytes, and female gametocytes, macrogametocytes. In the 
mosquito midgut, a microgametocyte fertilises a macrogametocyte, 
resulting in a motile ookinete which penetrates the mosquito gut wall and 
multiplies into an enlarging oocyst. Development of the oocyst takes 10-20 
days, and results in the production of enormous quantities of threadlike 
sporozoites. Rupture of the cyst allows release of the sporozoites which 
migrate to, and accumulate in the salivary gland of the mosquito, thus 
completing the sexual cycle of the parasite which is referred to as 
sporogony. In P. vivax malaria of man, but not P. falciparum, latent EE forms 
reside in the liver as hypnozoites for months or even years before initiating 
a relapse clinical infection in the blood.
RODENT MALARIA - PLASMODIUM BERGHEI
Plasmodium bergheiwas first isolated as sporozoites from the 
Anopheles dureni mosquito. The engorged blood In the gut of this mosquito 
was sourced back to the tree rat Thamnomys surdaster surdaster (Vincke & 
Lips, 1948). The discovery of P. berghei has proven to be one of great 
significance, as it was found possible to transmit this species of malaria to a 
number of laboratory rodents, enabling much research on malaria. A wide 
range of laboratory hosts have been tested for susceptibity to P. berghei. 
Rats, mice and hamsters are easily infected, however the response to 
infection may differ between different mouse strains, some showing 100% 
death rate while others rarely die (Garnham, 1967). Squirrels are infected
7
to a lesser degree, while birds and man have proved resistant to infection. 
The characteristics of P. berghei may be summarised as
(a) The exoerythrocytic stages occur in the parenchymal cells of the liver 
and mature 48 hours after the introduction of sporozoites
(b) The erythrocytic cycle takes 22-24 hours, is asynchronous, and 
commences with uninucleate rings. The mature schizont contains 10-18 
nuclei
(c) The merozoites show a strong preference for reticulocytes. Early in 
infection, the reticulocytes are parasitised almost exclusively, with 
increasing parasitism of mature erythrocytes as the reticulocyte numbers 
drop due to cell destruction (Ott, 1968). Gametocytes seem to develop in 
mature erythrocytes exclusively.
After the discovery of P. berghei, other malarial species - P. yoelii 
(closely related to P. berghei), P. vinckei, and P. chabaudi were isolated in 
African rodents and adapted to laboratory animals. These rodent malarias 
differ somewhat in morphology but also in host-erythrocyte preference, and 
in outcome of infection. P. berghei and P. yoe///have a preference for 
invasion of reticulocytes, while reports indicate that P. vinckei prefers 
mature erythrocytes (Garnham, 1967 and Ramakrishnan & Prakash, 1950). 
McNally etal. (1992) demonstrate that in vitro, P. chabaudi shows a 
preference for reticulocytes. The outcome of infection differs between 
mouse strains, however generally P. chabaudi produces an infection which 
resolves spontaneously while P. berghei infection results in a fulminating 
lethal parasltaemia. In addition two variants of P. yoelii have been isolated, 
one of which is non-lethal (strain 17X); the other, lethal (strain XL) (Yoelii et 
al., 1975)
Researchers have tried to establish evolutionary relatedness of 
species of Plasmodia. McCutchan etal. (1984) examined the base 
composition of various plasmodial species. Three different rodent parasites 
displayed a dG-dC content of approximately 18%. In contrast, P. vivax, and 
a number of monkey malarial plasmodia were reported to have a dG-dC 
content of about 30%. P. falciparum however was found to have a base 
composition more like that of the rodent and avian parasites than the other 
primate parasites. McCutchan postulated that the rodent malarias bore a 
closer evolutionary relatedness to P. falciparum, than the other primate
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malarias did. Therefore research on the rodent malarias would provide 
valuable insights into the major human malaria. Indeed, in immunological 
research the extensive immunobiological and genetic knowledge available 
on inbred strains of mice and rats allows experimental manipulation of the 
host immune system, and a more detailed understanding of the range of 
host defence mechanisms. Sacci etal. (1992) have reported the growth of 
mature exoerythrocytic stages of P. falciparum in human hepatocytes 
transplanted into a severe combined immunodeficient (SCID) mouse strain, 
after intravenous injection of sporozoites. This murine model should 
facilitate the characterisation of EE-stage antigens, and the assessment of 
stage specific anti-malarial agents.
VACCINE DEVELOPMENT
Each developmental stage of the malarial life-cycle has adapted so 
well to its particular environment that they can almost be regarded as 
separate parasites. As well as having different antigenic determinants, the 
sporozoite, exoerythrocytic, erythrocytic and sexual forms of the parasite 
also have different growth requirements and metabolism. Much recent 
vaccine development work has centred on the exoerythrocytic stage of the 
life cycle. The aim of such a vaccine would be to prevent the release of 
blood stage parasites from the liver. The impetus for much of this work came 
from the observation that solid immunity could be achieved following 
immunisation with large numbers of radiation attenuated sporozoites via 
mosquito bites (reviewed in Nussenzweig and Nussenzweig, 1986). 
However vaccines based on the sporozoite surface protein - the 
circumsporozoite (CS) protein have failed to provide adequate protection 
upon challenge (reviewed in Greenwood, 1990). Further definition of the 
immunoreactive and immunosuppressive epitopes of the CS protein may 
result in its use as part of a vaccine. However exoerythrocytic immunity is 
unlikely to be effective in preventing disease as it would theoretically take 
only one sporozoite or infected hepatocyte to bypass this immunity in order 
to establish infection.
Research into the sexual stages of the parasite have centred on the 
genetic signals that initiate the development of macrogametocytes and 
microgametocytes and on the specific sexual stage antigens of the parasite. 
Vaccines based on the sexual stages would aim to exert a transmission
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blocking effect, that would arrest the development of the parasite in the 
mosquito and reduce or abolish the transmission of the disease in an 
endemic area. Development of such vaccines has been facilitated by the 
observations that antibody alone can mediate functional immunity in 
mosquito feeding experiments (Carter & Chen, 1976), and that the surface 
antigens of sexual stages under investigation as vaccine candidates show 
limited antigenic diversity (Kochen, etal., 1993). The greatest impact of 
such vaccines is likely to be in regions of low to moderate endemicity, and 
would probably only be useful in areas of high endemicity when used in 
conjunction with other control methods.
It is the asexual erythrocytic stage of the parasite that causes the 
clinical manifestations of the disease. The maximum benefit of vaccines in 
reducing morbidity and mortality would thus be achieved by an effective 
immunological response against this stage of the parasite life cycle. The 
relevance of the erythrocytic stage to the disease and also the general 
availability of large quantities of erythrocytic parasite material and culturing 
methods for the erythrocytic stage has facilitated much research into this 
area of vaccine development. The search for candidate molecules for 
inclusion in a vaccine has centred on antigenic regions of molecules that 
are recognised as having a vital role In parasite function and are thus 
unlikely to be subject to significant variation without affecting the viability of 
the parasite. The most obvious of these 'vital' molecules are those of the 
merozoite involved in the invasion of the erythrocyte, but equally vital 
molecules would be those involved in nutrient uptake, and in sequestration 
which are probably accessible on the infected erythrocyte surface. It is the 
molecules involved in invasion however that have received the most 
attention from researchers. The interaction of the merozoite with the 
erythrocyte is now recognised as a complex multistep process involving 
specific receptor molecules on the surface of both the erythrocyte and the 
merozoite. While many of the interactions involved in invasion by P. 
falciparum and P. knowlesi have been partly elucidated very little is known 
about the rodent malarias and this is the focus of our research. We will now 
review the current understanding of the invasion of erythrocytes by 
merozoites, beginning with a description of the merozoite, and going on to 
discuss the molecular interaction involved in invasion.
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ERYTHROCYTE INVASION BY MALARIAL MEROZOITES
1. THE MEROZOITE
Merozoites of mammalian Plasmodium species are small elliptical 
cells, 2-3|im long in P. knowlesi and a little smaller in P. falciparum. They 
have a conical protuberance, the apical prominence, at one end; the other 
pole containing the nucleus is rounded. A 15-20nm-thick bristly coat covers 
the plasma membrane, deep into which (except apically) lie two more 
membranes binding a single flat cisternae, the series of three membranes 
being termed the pellicle. A single acristate mitochondrion and numerous 
ribosomes are present in the cytoplasm. Also located in the cytoplasm are 
three major types of densely granular membranous vesicles. These are : (a) 
the paired rhoptries which converge on a common rhoptry duct, which ends 
blindly beneath the apical membrane; (b) several small fusiform 
micronemes which also appear to connect with the rhoptry duct; (c) up to 20 
rounded structures (microspheres or dense granules) present in all parts of 
the cytoplasm. The existence of dense granules has been reported in P. 
knowlesi merozoites and also in P. falciparum merozoites (Bannister etal., 
1975 and Langreth etal., 1978)
2. THE EVENTS IN ERYTHROCYTE INVASION
Invasion of erythrocytes by P. knowlesi merozoites, at the light 
microscope level, was described by Dvorak (1975). They found that 
merozoites initially attach to erythrocytes by any part of the merozoite 
surface. This adherence induces a marked deformation in erythrocyte 
shape. For penetration to ensue, the more conical, apical end of the 
merozoite must come into contact with the erythrocyte. The apical contact 
causes a rapid deformation in the erythrocyte, which lasts about 10 
seconds, after which the erythrocyte becomes quiescent, and the merozoite 
interiorizes in about another 20 seconds. This is followed by intermittent 
erythrocyte deformations over the next 10-15 minutes until the normal 
biconcave shape returns. The parasite now proceeds to the ring-stage.
Descriptive ultrastructural studies of invasion using electron 
microscopy have generally been performed using P. knowlesi merozoites, 
as viable merozoites are relatively easy to obtain from this species. The
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process appears to be the same for P. falciparum and P. berghei (Langreth 
et al., 1978 and Yan et al., 1986 respectively). The major events are 
summarised in Fig. 1.2. Merozoites are covered with a thick fuzzy coat, by 
which they adhere to the erythrocyte at any part of their surface (Fig. 1.2, A). 
Erythrocytes tend to wrap themselves partly around the merozoite during 
this first stage of attachment as though maximising the area of attachment 
between the two (Fig. 1.2, B). For the sequence of invasion to continue, the 
apical end of the parasite must contact the red cell membrane, leading to 
the formation of the close junctional zone between the two cells, a step 
referred to as reorientation (Fig. 1.2, C). Apical contact triggers the secretion 
of the contents of two sets of membranous vesicles whose ducts open onto 
the apical prominence of the merozoite, the micronemes and the rhoptrles. 
These secretions lead to the invagination of the red cell surface, thus 
forming an invasion pit (Fig. 1.2, D), in through which the parasite moves 
(Fig. 1.2, E). The zone of apical attachment changes from a disc to an 
annulus through which the parasite passes, finally coalescing once more 
into a disc posteriorly as the invasion pit closes to isolate the parasite within 
the parasitophorous vacuole (Fig. 1.2, F) During this process the fuzzy coat 
of the parasite is lost.
During the final phase of invasion, a set of spheroid membranous 
vesicles (dense granules or microspheres) move from positions deep in the 
cytoplasm to the merozoite surface where their contents are discharged into 
the parasitophorous vacuole (Torii et al., 1989)(Fig. 1.2, G). The 
parasitophorous vacuole membrane then increases further in surface area 
to accommodate the rapidly deforming parasite (Fig. 1.2, H). Many 
merozoitic organelles disappear from the parasite and it elongates, then 
flattens to a discoidal form, its early ring-stage condition (Fig. 1.2, I).
3. ADHESION OF MEROZOITES TO ERYTHROCYTES
There are two major stages in merozoite attachment which can be 
described as (a) circumferential, distant and reversible; and (b) apical, 
close and irreversible
(a) Circumferential attachment
This is the first to occur, the parasite adhering by any part of its 
surface to the erythrocyte, at distances between 20 and 40 nm. It is
1 2
FIG 1.2. Diagram depicting the major stages in merozoite invasion of the 
erythrocyte
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probable that the merozoite filaments making up the merozoite fuzzy coat 
are responsible for this attachment., as well as longer merozoite surface 
filaments of up to 40 nm.There are many candidate molecules on the 
erythrocyte and merozoite surface that are believed to be involved in this 
attachment for each malaria species. The malarial molecules will be 
discussed in the next section. It seems likely however that multiple binding 
sites along both the erythrocyte ligand and the merozoite binding molecule 
would maximise the adhesion between the erythrocyte and the merozoite. 
The interactions involved between the molecules are probably charge 
related, this would allow for a wide range of temporary adhesive 
interactions.
(b) Apical adhesion
This is much closer (<5 nm) and involves the formation of a dense 
undercoating to the erythrocyte membrane in the region of contact 
(Bannister et al., 1986). This adhesion step does not occur in the absence 
of specific erythrocyte ligands. The merozoite components involved in this 
close apical attachment may be molecules such as the P. knowlesi 66kDa 
molecule or the P. falciparum AMA-1, which are both believed to be 
apically concentrated (Waters et al., 1990). On the erythrocyte surface, 
'short ‘ molecules such as band 3 or the Duffy blood group antigen may be 
the corresponding erythrocyte ligands. Merozoites of P. knowlesi will 
circumferentially attach to Duffy negative erythrocytes but will not form this 
close apical attachment with formation of the dense undercoating. It Is 
important to consider that the zone of apical adhesion is transformed into 
an annulus during invasion, and therefore the region of close contact 
passes back over the merozoite during this process. How this occurs at the 
molecular level is not understood.
INVESTIGATIONS ON MEROZOITE INVASION OF 
ERYTHROCYTES  
1 .IN VA SIO N  ASSAYS
Elucidation of the molecular intricacies of erythrocyte invasion has 
necessitated the development of methods that allow the examination of the 
invasion process in vitro. Currently two types of in vitro erythrocyte invasion
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assay exist; (1) those that involve mixing schizont-infected erythrocytes with 
target erythrocytes; and (2) those that mix free merozoites with target 
erythrocytes. To examine reagents for their ability to interfere with specific 
steps in invasion, they are added to these assays and their effects 
measured by observing the difference in the number of successful 
invasions compared to appropriate controls.
Invasion assays that use schizont-infected erythrocytes are the 
simplest to perform. Such invasion assays have been developed for P. 
knowlesi, P. falciparum and P. vivax (Miller et al., 1983; Mitchell etal., 1986 
and Barnwell et al., 1989 respectively) and are routinely used for 
investigating inhibitors of invasion, antibody blocking of invasion and the 
erythrocyte and merozoite molecules required for invasion.Purified 
schizont-infected erythrocytes are added to target erythrocytes, and after 
allowing time for rupture, merozoite invasion and development of parasites 
into visible ring forms, giemsa stained smears are prepared from the 
assayed erythrocytes. Invasion is estimated microscopically by counting the 
percentage of erythrocytes containing ring-form parasites. Caution must be 
exercised when testing certain reagents in invasion assays that use 
schizont-infected erythrocytes. Some reagents, such as enzyme inhibitors 
or polysaccharides, may appear to affect the invasion process but may 
actually inhibit cell rupture (Hadley etal., 1986). Indeed, reagents 
demonstrated to inhibit invasion in these assays must be shown to be non­
toxic to schizonts.
Invasion assays using free merozoites circumvent this problem. 
However, of the primate malarias, viable free merozoites for these assays 
can be obtained only for P. knowlesi. Merozoites of P. knowlesi are 
prepared by culturing schizont-infected erythrocytes in the presence of 
leupeptin and chymostatin (which prevent cell rupture), until individual 
merozoites are easily discernable in the infected erythrocyte. The infected 
erythrocytes are agglutinated with anti-rhesus serum and then passed 
several times though a narrow gauge needle, the shear forces rupturing the 
infected erythrocyte and releasing the merozoites. The released 
merozoites are then added to the target cells, and after a period of 6 hours 
smears are prepared and examined.
The difficulty in maintaining rodent malarias in vitro, has hampered 
the development of in vitro invasion assays for these species. P. berghei
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also presents the problems of; (a) the asynchronicity of its asexual stages;
(b) the preference of P. berghei merozoites for invasion of immature 
erythrocytes; and (c) erythrocytes containing mature erythrocytes sequester 
in the deep vasculature. An invasion assay using free P. berghei merozoites 
has been described by Janse et al. (1989). A continuous flow culture 
system was used, with the exit of the chamber covered with a 
polycarbonate filter, through which only free merozoites could pass.
Rupture of the cultured schizont-infected-erythrocytes is caused by the 
shearing forces of a magnetic bar spinning on the filter. Released 
merozoites are mixed with rat reticulocytes and invasion recorded as the 
percentage of ring-stage infected rat reticulocytes. Janse reported invasion 
rates of up to 13% into rat reticulocytes. Braun Breton et al. (1992) have 
described an invasion assay for the rodent malaria P. chabaudi. However 
their techniques involve the use of flow cytometry, and invasion rates are 
low.
We sought to develop an in vitro invasion assay for P. berghei that 
was simple to perform, that didn’t require expensive culturing apparatus or 
Quantitation equipment and enabled a number of tests to be carried out 
simultaneously. The invasion assays outlined and discussed in this thesis 
(also see McNally et al., 1992) meet these requirements and should 
contribute to the understanding of erythrocyte invasion by P. berghei 
merozoites.
2. MOLECULAR INTERACTIONS OF INVASION
The interaction with and entry into erythrocytes by malarial 
merozoites is a crucial yet potentially vulnerable event for the parasite’s 
survival. The complexity of the interaction has evolved so as to minimise the 
effect of the immunological reaction of the host. However through the 
definition of the molecular basis of invasion of erythrocyte by merozoites, it 
may be possible to discover and exploit weaknesses in the merozoite 
machinery of invasion and modulate the host immune system to respond to 
it.
Progress towards the identification of merozoite proteins potentially 
involved in the invasion of erythrocytes has advanced considerably for P. 
falciparum, P. vivaxand P. knowlesi. These molecules have been assigned 
a function in the invasion process for one of the following reasons
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(a) They have been shown to bind to erythrocytes. The specificity of binding 
generally correlates with the erythrocyte invasion preferences of the 
plasmodial species. It is likely that some of these molecules are involved in 
the reversible circumferential attachment of merozoite to erythrocytes while 
other would be involved in the non-reversible apical attachment that 
precedes invasion.
(b) They have been localised on the merozoite surface or in the rhoptries, 
micronemes or dense granules by immunocytological studies. In many 
cases the fate of these molecules during the invasion process has been 
followed.
(c) Monoclonal antibodies against certain molecules have been found to 
block or inhibit invasion. Rarely do such antibodies completely block 
invasion, for the most part their blocking activity is in the range 40-60%. 
This may be either a result of the inaccessibity of molecules such as those 
released from the rhoptries or may be due to the existence of several 
different routes open to the merozoite for attachment and invasion of 
erythrocytes.
BINDING ASSAYS AND BINDING MOLECULES
The most common technique employed in the identification of 
malarial molecules that attach to erythrocytes is the Radiolabel Binding 
Assay. It involves the mixing of erythrocytes with metabolically labelled 
parasite proteins. Molecules that bind to the erythrocytes are then eluted 
with high concentrations of NaCI. Using binding assays, three families of 
erythrocyte binding molecules have been identified for malaria parasites,
(1) the EBA/DAP family, (2) the MSP family and (3) the RBP family
1. THE ERYTHROCYTE BINDING ANTIGEN/DUFFY ADHESION  
PROTEIN FAMILY
Camus and Hadley (1985) were the first to report the binding to intact 
erythrocytes of a P. falciparum protein from in vitro culture supernatants. 
They found a 175 kDa Erythrocyte Binding Antigen (EBA-175) whose 
binding to erythrocytes correlated with the erythrocytes susceptibility to 
invasion by P. falciparum merozoites. It had previously been determined 
that erythrocyte membrane glycophorin, in particular, its sialic acid, was
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required for invasion of erythrocytes by merozoites of P. falciparum (PasvoI 
e ta l., 1982). Camus & Hadley (1985) and Pasvol etal. (1982) have shown 
that human erythrocytes treated with trypsin, which cleaves glycophorin 
from the erythrocyte membrane, or neuraminidase, which removes sialic 
acid, or human TN variant erythrocytes, which lack sialic acid on the o- 
linked oligosaccharides of glycophorin, did not bind the EBA-175, and were 
not invaded by P. falciparum merozoites. Neither did the EBA-175 bind to 
erythrocytes of guinea pig or rhesus erythrocytes which are also refractory 
to invasion. Camus & Hadley (1985) found that the EBA-175 bound to 
merozoites and they postulated that its role was to act as a bridge between 
the erythrocyte and the merozoite. This was consistent with the observation 
that it was released into culture supernatants as schizonts ruptured.
However the presence of the sialic-acid ligand on the erythrocyte 
does not appear to be an absolute requirement for invasion. Several strains 
of P. falciparum differ in their ability to invade sialic-acid deficient 
erythrocytes (Mitchell etal., 1986; Hadley etal., 1987). Hadley 
demonstrated that the P. falciparum strain 7G8 could invade neuraminidase 
treated erythrocytes with 50% of the efficiency that it invaded untreated 
erythrocytes, while the invasion rates of the Camp strain of P. falciparum 
into neuraminidase treated erythrocytes were <3% of invasion rates into 
control erythrocytes. Hadley concluded that the 7G8 strain parasites were 
able to invade by a pathway independent of sialic-acid, and therefore 
independent of the binding of EBA-175. Recently Dolan etal. (1994) 
reported that the binding of EBA-175 was predominantly to Glycophorin A, 
while Glycophorin B and an unknown erythrocyte ligand X, were probably 
the ligands involved in the EBA-175 independent invasion process. Dolan 
etal. (1994) however, was unable to find the merozoite molecule involved 
in binding to these erythrocyte ligands. This indicates one of the 
inadequacies of the binding assays, in that it doesn’t identify all parasite 
molecules involved in invasion. Only those molecules that are soluble and 
binding-competent when released into the culture supernatant are 
identified.The specificity of binding of the EBA-175 indicates nonetheless 
that it has a role in the invasion process.
After the discovery of the P. falciparum EBA-175, many researchers 
sought to identify, using binding assays, molecules from other malarial
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species that could similarly be linked with the invasion process. In 
particular, attention turned to P. vivax and P. knowlesi. It had been well 
documented that invasion of human erythrocytes by the merozoites of P. 
vivax in vivo and by the merozoites of P. knowlesi in vitro was dependent 
on an erythrocyte membrane glycoprotein serologically defined by the Duffy 
blood group determinants (Miller eta!., 1976; Mason etal., 1977). Haynes 
etal. (1988) described a P. knowlesi 135 kDa molecule, present in culture 
supernatants, that bound to Duffy blood group-positive but not to Duffy 
blood group-negative human erythrocytes. They found that specific anti- 
Duffy antibodies blocked the binding of the P. knowlesi 135 kDa Duffy 
Adhesion Protein (PkDAP), and that purified PkDAP bound to the 35-45 
kDa Duffy glycoprotein on a blot of electrophoretically separated membrane 
proteins from Duffy-positive erythrocytes. Cleavage of the Duffy determinant 
by chymotrypsin-treatment of erythrocytes abrogated the binding of the DAP 
and also inhibited invasion of the erythrocytes by merozoites of P. 
knowlesi. The correlations between binding of the 135 kDa molecule and 
invasion of erythrocytes led Haynes etal. (1988) to conclude that the 
PkDAP had a role in the invasion of Duffy-positive erythrocytes by P. 
knowlesi merozoites. Dalton etal. (1991) demonstrated that the binding of 
the 135 kDa molecule to the Duffy determinant could be inhibited and 
reversed by the sulphated polysaccharide fucoidan and the 
glycoaminoglycan dextran sulphate. These sulphated molecules also 
inhibited the in vitro invasion of susceptible erythrocytes by P. knowlesi 
merozoites. It Is likely that it is involved in the apical adhesion events of 
invasion rather than in the initial circumferential attachment, as P. knowlesi 
merozoites attach to both Duffy-negative erythrocytes and Duffy-positives 
erythrocytes but only with Duffy-positive erythrocytes does apical junction 
formation occur and invasion proceed.
Wertheimer & Barnwell (1989) identified a P. vivax 135-140 kDa 
protein that bound with similar specificity as the PkDAP to Duffy-positive 
erythrocytes. This P. vivax Duffy adhesion protein (PvDAP) bound only to 
Duffy-positive human and Aotus monkey erythrocytes which were 
susceptible to invasion by P. vivax, but not to Duffy negative human 
erythrocytes or erythrocytes from Macaca or Cebus erythrocytes that are not 
susceptible to P. vivax. As with the PkDAP, treatment of susceptible 
erythrocytes with chymotrypsin abrogated binding of the PvDAP, and
19
inhibited invasion of these erythrocytes by P. wVaxmerozoites. The 
interaction of the PvDAP with Duffy-positive erythrocytes could be 
specifically inhibited with purified Duffy glycoprotein (Wertheimer & 
Barnwell, 1989). The Duffy glycoprotein has recently been defined as the 
erythrocyte receptor for interleukin-8 (IL-8)(Horuk etal., 1993).
While the PvDAP and PkDAP are related in their specificity for the 
Duffy glycoprotein, their interactions seem to be with different determinants 
on that glycoprotein (Wertheimer & Barnwell, 1989). Despite this both 
proteins were shown by Wertheimer to be antigenically related, in that an 
antiserum raised against P. knowlesi proteins which binds to Saimiri 
erythrocytes ( including PkDAP), also recognise the P. vivax PvDAP. The 
relatedness of the two proteins however only became apparent after the 
cloning of their respective genes. Adams etal. (1990) reported the cloning 
of the 3’ part of the cDNA of the P. knowlesi DAP using antibodies affinity 
purified on the 135 kDa molecule. Antibodies to multiple regions derived 
from the the deduced amino acid sequence of the P. knowlesi gene 
immunopreciplted the soluble 135 kDa molecule,indicating that the cloned 
gene Indeed encoded the Duffy receptor. When southern blots of P. 
knowlesi were probed with the cDNA, it hybridised to 3 regions in the 
genome, indicating the existence of a family of P. knowlesi Duffy adhesion 
proteins. The cloning of the P. vivax DAP was reported by Fang etal. 
(1991), using as a probe a cDNA clone from the identified P. knowlesi gene. 
There appeared to be only one locus for this gene in the P. vivax genome. 
Adams etal. (1992) reports the completion of this Duffy Adhesion Protein 
cloning work. He cloned and sequenced all 3 P. knowlesi DAP’s, and 
completed the sequencing of the PvDAP gene. When these sequences 
were compared, the gene structure and predicted amino acid sequence of 
the cloned PvDAP and PkDAP’s were, as expected, very similar, and 
placed as part of the same gene family. However based on the same 
criteria, namely gene structure and amino acid homology the gene 
encoding the P. falciparum EBA-175 was placed in the same gene family 
(Adams etal., 1992). Exon 2 of the P. knowlesi/P. vivax genes is known to 
encode the erythrocyte binding domain of the proteins, and contains a 3’ 
cysteine-rich region and a 5’ cysteine-rich region that is highly conserved 
between these two species. The P. falciparum protein differs from the Duffy 
binding proteins in that it has two copies (F1 and F2) of the 5’ cysteine-rich
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region. However twelve cysteine residues are present in roughly the same 
position in the F1 and F2 motifs and in the P. wVaxand P. knowlesi proteins. 
There is a similar degree of alignment between the tryptophan and 
tyrosine/phenylalanine residues. In the 3’ cysteine-rich region the 
homology encompasses 104 amino acids, again with alignment of most of 
the cysteine and tyrosine/phenylalanine residues. The genes for the DAP’s 
and the EBA-175 also have the same intron/exon division. This would 
indicate a common origin of the genes, as introns are generally rare in 
malarial genes.
The DAPs and the EBA-175 do not seem to be located on the 
surface of invasive merozoites, but internally in the micronemes or dense 
granules (Adams etal., 1990; Sim e ta i, 1992). Therefore they probably 
function after initial attachment of the merozoite to the erythrocyte, and 
apical reorientation.
Similarities in localisation of the DAPs’ and EBA-175, and regions of 
homology between the P. falciparum, P. wVaxand P. knowlesi genes are 
interesting because of the wide evolutionary separation of these species as 
outlined by Waters etal. (1991) and McCutchan etal. (1984). Since these 
molecules are under immune pressure it is likely that the conserved motifs 
are necessary for function. Whether the regions of homology are conserved 
for binding function and how they account for the different binding 
specificities of the DAP’s and the EBA-175 however isn’t known. The 
presence of a similar protein in P. berghei, which is considered the most 
evolutionary divergent from P. falciparum, would be very significant as it 
would emphasise the importance of this molecule to the malarial species.
2. THE MAJOR MEROZOITE SURFACE PROTEIN-1
The second P. falciparum merozoite protein that has been shown to bind in 
a specific manner to human and certain primate erythrocytes was first 
identified and it’s gene characterised by Holder & Freeman (1982), and 
since then has been termed gp195, p190, pf200, PMMSA, and more 
definitively MSP-1 (Merozoite Surface Protein 1) due to its localisation on 
the merozoite surface. Since its discovery by Holder and Freeman (1982), 
the P. falciparum MSP-1 has been well characterised immunologically 
(Pirson & Perkins, 1985), and in terms of its primary structure (Holder etal., 
1985). However it was not until the report of Perkins and Rocco (1988) that
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its binding specificity to human erythrocytes was realised. Like EBA-175, 
the binding of MSP-1 to human erythrocytes is dependent on the sialic acid 
of the glycophorin glycoproteins, soluble glycophorin and neuraminidase 
treatment both inhibit the binding, and it binds only to those cells that are 
susceptible to infection by P. falciparum.
A major question raised by the research carried out on MSP-1 
concerns the nature of the actual molecular structure of the MSP-1 on the 
merozoite surface. Several studies suggest that the large molecular weight 
form of the MSP-1 is a precursor molecule and that at, or about, the time of 
merozoite release is proteolytically processed to form three fragments (83 
kDa, 38 kDa and 42 kDa) that remain attached to the merozoite membrane 
presumably as a complex (Holder etal., 1987). Upon invasion the 42 kDa 
appears to be cleaved to a 33 KDa polypeptide, which is shed as a soluble 
complex with the other products of MSA-1 processing, and a 19 kDa 
fragment which is carried on the surface of the merozoite into the new 
erythrocyte (Blackman etal., 1990). Chappel & Holder (1993) have defined 
monoclonal antibodies that inhibit P. falciparum invasion in vitro as reacting 
with one of two growth factor-like domains in this 19 kDa MSA-1 fragment. 
However none of the processed fragments have been shown to bind to 
erythrocytes, the only molecule that does so is the intact MSP-1. This may 
in itself indicate the limitations of the binding assays as currently performed, 
but also may indicate that the MSP-1 has indeed a functional role as an 
intact molecule in the initial attachment of merozoites to erythrocytes, 
interacting with sialic acid residues of the erythrocyte glycophorin.The fact 
that intact MSP-1 can be immunoprecipitated from P. falciparum culture 
supernatants indicates that this is the form of the protein on the merozoite 
surface and the fragments seen may be an effect of the radioiodination 
procedure used to identify them. This however does not rule out the 
biological significance of the fragments seen.Several specific proteases 
have been described for merozoites (Schrevel etal., 1990), one of which 
may be activated then to cleave MSP-1 after initial attachment to 
erythrocytes, which may then have a further role in invasion. Szarfman 
(1988) reported the expression of the MSP-1 in the exoerythrocytlc (EE) 
stages of P. falciparum. Therefore a vaccine incorporating this protein could 
also be effective against the EE-stage parasites.
The discovery of the MSP-1 of P. falciparum led to the
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characterisation of molecules in other species of malaria that had similar 
characteristics. They are all synthesised late in schizogony, are localised on 
the merozoite surface, are of high molecular weight and appear to be 
processed to smaller fragments. The MSP-1 of P. yoelii was identified as a 
230 kDa molecule (Holder & Freeman, 1984). When animals were 
immunised with the purified 230 kDa molecule, they were found to be 
protected against challenge infection with P. yoelii, with fulminating 
infections being converted to self-limiting reticulocyte-restricted infections 
(Holder & Freeman, 1981). The protection induced could not be transferred 
by passive immunisation so it is likely that cell mediated immunity was 
involved in protection. A polyvalent antiserum raised to the purified P. yoelii 
230 kDa molecule cross reacted with schizonts of P. chabaudi, P.vinckei, P. 
falciparum and other strains of P. yoelii in indirect immunofluoresence tests 
(Holder & Freeman, 1984). The equivalent MSP-1 in P. chabaudi is of size 
250 kDa, and monoclonal antibodies recognising this antigen injected into 
mice reduced the parasitaemia of P. chabaudi challenge infections (Bates 
etal., 1988). David etal. (1984) described a MSP type molecule of P. 
knowlesi of 230 kDa, which had processed fragments of 200,145 and 110 
kDa and possible breakdown of these into 75, 57, 50 and 43 kDa 
fragments. Monoclonal antibodies against the 230 kDa molecule of P. 
knowlesi inhibited in vitro invasion of rhesus erythrocytes by P. knowlesi 
merozoites (Epstein etal., 1981) , and its derived 75 kDa fragment, which 
was found present in the membranes of infected erythrocytes induced 
partial protection in rhesus monkeys (Schmidt-Ullrich et al., 1983). The P. 
vivax MSP-1 gene was completely sequenced by del Portillo etal. (1991) 
and was found to be a 200 kDa protein. When the MSP-1 genes of P. 
yoelii, P.vivax, and P. falciparum were compared, a number of homologous 
regions were found. The P. falciparum and P. vivax proteins showed greater 
similarity in amino acid composition and the overall distribution of the 
shared amino acid was more highly conserved than when P. falciparum and 
P. yoelii were compared (del Portillo etal., 1991). From the work of 
McCutchan etal. (1984), P. vivax and P. falciparum are predicted to be 
evolutionary diverse. This is confirmed by the comparisons of the small- 
subunit ribosomal RNA sequences from various malarial species as 
determined by Waters et al. (1991). That a higher similarity exist in the MSA 
of these two species, than between the MSP-1 of P. falciparum and P.
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yoelii, which McCutchan described as evolutionary close may reflect the 
effect of positive selection in the human host. The conserved regions 
between the MSP-1 of the two human malaria species are also the regions 
conserved between the different alleles of the P. falciparum MSP-1.
From the data presented, the potential of the MSP-1 as a vaccine 
candidate was obvious. Not only were its analogous molecules in other 
malarial species shown to be effective in reducing or preventing infection, 
but regions of homology between different strains of P. falciparum had also 
been identified. Promising results came from immunisation of Aotus 
monkeys with preparations of the P. falciparum MSP-1, and the complete 
protection it afforded them (Siddiqui etal., 1987). Peptides derived from the 
83 kDa fragment of the P. falciparum MSP-1 are constituents in the Spf66 
vaccine formulated by Patarroyo and described in the next section.
3. RETICULOCYTE BINDING PROTEINS OF P. VIVAX
No erythrocyte binding protein similar to the EBA/DAP or MSP-1 
family of proteins have been described in P. berghei. Indeed very little is 
known about the specificity of invasion of P. berghei merozoites except that 
they appear to have a preference for invasion of immature erythrocytes in 
vivo (Ramakrishnan & Prakash, 1950). The work presented by us confirms 
this observation in vitro. P. vivax, in addition to being dependent on the 
Duffy glycoprotein/PvDAP interaction for invasion, is also dependent on the 
host erythrocyte being immature (reticulocyte) instead of a normocyte.
While in vivo P. berghei appears to invade both reticulocytes and 
normocytes, despite its preference for reticulocytes, the P. wVax merozoite 
will exclusively invade only reticulocytes (Kitchen, 1938). It was suggested 
that this very strong preference for invading reticulocytes may occur 
because P. vivax merozoites are incapable of invading normocytes due to a 
mature cytosketetal protein network that makes the normocyte membrane 
less pliable, whereas, the reticulocyte membrane with its less mature 
cytoskeleton is more readily invaginated by the merozoite during invasion 
(Mons, 1990). This would imply that the merozoite would go from cell to cell, 
testing each cell at each contact, until it finds a cell with a membrane pliable 
enough for it to successfully Invade. In a human, reticulocytes make up 0.2- 
1% of the erythrocyte population (Rapoport, 1986). Such a random invasion 
strategy would be detrimental to the survival of the parasite, and it is more
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likely that P. vivax and the other reticulocyte preferring species P, 
cynomolgi (a simian malaria) and P. berghei would have a receptor/ligand 
interaction for identifying reticulocytes.
Galinski et al., (1992) identified and cloned the genes encoding two 
P. vivax merozoite proteins that could be involved in a mechanism for 
selecting reticulocytes. Two proteins of approximately 250 kDa bind 
preferentially to reticulocytes of humans and other primates, except for 
rhesus erythrocytes which are refractory to invasion by P. vivax merozoites. 
These two proteins have been termed reticulocyte binding proteins -1 and - 
2 (RBP-1 and RBP-2) and their deduced secondary structure seems to be 
similar. By indirect immunofluoresence assays these two proteins were 
localised to the apical pole of merozoites of P. vivax. Using the same 
antisera a similar localisation was observed on merozoites of P. cynomolgi, 
but there was no reaction with merozoites of P. knowlesi or P. falciparum. 
The exact role, binding domains and reticulocyte ligand for these RBP is not 
known, but their specificity of binding indicates some interaction with 
reticulocytes. In southern blot analysis, gene probes from the P. vivax RBP 
hybridised to genomic DNA from P. cynomolgi, but not to DNA from P. 
knowlesi, P. falciparum or P. berghei, indicating that the reticulocyte 
preference of P. berghei may have its basis in another receptor or in 
another aspect of the parasite/host relationship (Galinski et al., 1992).
The MSP-1, EBA, DAP and RBP molecules described are all considered to 
be involved in erythrocyte invasion due to their erythrocyte-binding 
properties and specificities. There are undoubtably many other molecules 
involved in invasion, which are not detected by the binding assays, either 
because of the nature of the binding assays or because the function in 
some other area of erythrocyte invasion other than direct erythrocyte 
attachment. The PK66 cloned by Waters etal. (1990), which Is shed from 
the merozoite at, or behind the invasion Interface, and the ring infected 
erythrocyte surface antigen (RESA) which is thought to facilitate invasion by 
interfering with the erythrocyte cytoskeleton (Foley etal., 1990) are 
examples of two such molecules. Many of the molecules described have 
been investigated for their potential in asexual stage vaccines against P. 
falciparum (reviewed in Cox, 1991). However the only vaccine developed 
so far that has had any degree of success in preventing malaria is that of
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Patarroyo (Valero etal., 1993).
THE SPF66 VACCINE OF PATARROYO
A pragmatic approach to the development of a malaria vaccine was 
adopted by M. E. Patarroyo and coworkers at the National University of 
Colombia. Fractions of mature asexual parasites separated by gel 
electrophoresis were used to vaccinate Aotus monkeys against challenge 
P. falciparum infection. Protein was then purified from the relevant fractions 
and confirmed as able to give either total or partial protection in the 
monkeys (Patarroyo etal., 1987). Animals immunised with a 155 kDa or a 
55 kDa protein showed delayed onset of parasitaemias by 5 to 7 days 
compared to controls, suggesting partial protective immunity. Monkeys 
immunised with a 83 kDa or a 35 kDa fragment were completely protected, 
showing either no detectable blood infection or very low parasitaemia with 
spontaneous recovery. The 155 kDa and the 83 kDa proteins were 
identified as the RESA and the N-terminal processed fragment of the MSP- 
1, for which the peptide sequences had already been determined (Cowman 
etal., 1985 and Holder etal., 1985 respectively). Protein sequences were 
determined for the smaller proteins by N-terminal sequencing. Eighteen 
peptides were then synthesised corresponding to different fragments of 
these four proteins and after complexing to bovine serum albumin were 
used to vaccinate the monkeys, which were subsequently challenged with 
P. falciparum sporozoites. Fifteen elicited antibodies against schizonts, but 
while no peptide provided complete protection individually, a combination 
of 3 gave complete or almost complete protection. The most effective 
combination derived from the 83, 55 and 35 kDa molecules. For a human 
trial, two polymeric hybrid proteins were synthesised, termed SPf(66)30 
and SPf(105)20 (Patarroyo et al., 1988). The SPf(66)30 contained 
sequences from the 83, 55 and 35 kDa proteins and also the Asn-Ala-Asn- 
Pro repeat from the P. falciparum circumsporozoite protein (CS). These 
peptide sequences were then polymerised into a 30-mer. SPf(105)30 was a 
20-mer polymer of a 58 amino acid peptide which included sequences from 
the 83 kDa fragment and the CS. Both these peptides were then tested in 
human volunteers. In half the individuals immunised the SPf(105)20 gave a 
significant delay in infection after challenge with P. falciparum sporozoites,
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while the SPf(66)30 gave strong protection to 3 of the 5 volunteers who 
received it, compared to controls. The three volunteers who were protected 
with SPf(66)30 had mild infections with steady decrease in parasite counts 
and total recovery by day 21 after infection. The SPf(66)30 was the first 
vaccine against to afford this degree of protection in humans. However 
many scientist were skeptical about this work and when an American team 
sought to repeat the success of Patarroyos group in immunising Aotus 
monkeys, they failed to get any protection at all (Ruebush et at., 1990). 
Other researchers expressed concern that some of the peptide sequences 
used in SPf(66)30 were from the variable domains of the proteins, and 
could therefore select very rapidly for variants that would be unaffected by 
the induced immunity. Patarroyo continued his work, upgrading his 
production facility to achieve F. D. A. approval and completed a vaccine trial 
with SPf(66)30 (now termed SPf66) In La Tola, Columbia, involving greater 
than 1500 volunteers, receiving either 3 doses of the vaccine or the 
placebo. In a one year follow-up, the vaccine group reported 38.8% fewer 
clinical episodes of malaria than the placebo group (Valero eta!., 1993). 
Further trials are in progress, with greater numbers of vaccinees both in 
South America and Africa which should demonstrate the usefulness of the 
SPf66 vaccine. Advantages of such a chemically synthesised vaccine 
would be the inexpensiveness of each dose (estimated at 20p) and 
elimination of the necessity for a cold-chaln distribution system.
How exactly the SPf66 works isn’t clear. Patarroyo suggests that it 
blocks merozoite invasion of erythrocytes (BSP, spring 1994). Patarroyo 
has not been able to establish a correlation between antibodies titres 
against the SPf66 and the protection it confers. However sera from SPf66- 
immunised volunteers had a greater capacity to inhibit in-vitro parasite 
growth than control sera, irrespective of the titres of anti-SPf66 IgG 
antibodies (Salcedo etal., 1991). Molano et al. (1992) found that the 
predominant antibodies in serum from protected individuals were directed 
against Lysine-Glutamic acid-Lysine (KEK) motifs. The KEK motif is part of 
the 83 kDa-fragment derived peptide of the vaccine, but is also present in 
the EBA-175 native protein. Molano etal. (1994) suggests that highly 
charged motifs of this type may be involved in determining the 3- 
dimensional structure of the erythrocyte binding proteins EBA-175 and 
MSP-1, and the synthetic peptide may focus the immune response toward
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this critical epitope, which may be seldom or only transiently exposed 
during the natural infection. In addition other serum factors may be 
responsible for protection, whether these factors are other Ig class 
antibodies not detected so far, or some other constituent of the immune 
system isn’t known. The most plausible explanation for protection is that 
there are multiple factors involved in the immune response against the 
SPf66 vaccine and the P. falciparum parasite.
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MATERIALS AND METHODS
CHAPTER 2
29
1. METHODS
Parasites and animals
The P. berghei (ANKA strain ) line was maintained in 6 to 8 week- 
old Balb/c mice by passage of infected blood from one animal, with 
parasitaemia between 15% and 20%, to another animal by intra-peritoneal 
injection. A cloned line of P. c. chabaudiAS was maintained in CD-1 mice 
and was passaged similarly. These CD-1 mice were adapted to lighting for 
7 days prior to, and during infection, artificial daylight beginning at 12 
midnight and ending at 12 noon. Parasitaemia was determined by 
examination of giemsa stained blood smears, (taken from the tail of an 
Infected animal), and recorded as the percentage of erythrocytes which 
contained parasites.
Induction of reticulocytosis
Solutions of 0.4% phenylhydrazine were prepared, immediately 
before use in PBS, from a 97% stock solution. Mice were injected 
intraperitoneally with 100 |il of this solution per 15 g body weight on day 1 
and every alternate day up to day 9. Erythrocytes from these mice were 
used when the reticulocytes number accounted for greater than 50% of the 
total erythrocyte population, as determined by methylene blue staining.
Preparation of sera for culture media
FCS was bought commercially, aliquoted into 50 ml sterile
containers and heated to 56°C for 30 min to inactivate complement The
heat inactivated sera was then stored at -20°C until used .
Rat sera was collected from the animal facility in DCU. Adult Wistar 
rats were bled by cardiac puncture into syringes, which was allowed to clot
overnight at 4°C. The clots were then centrifuged at 500 x g for 20 min and 
the serum (supernatant) removed. The serum was then filter sterilised,
through a 0.22 |j,m filter, before being heat-inactivated at 56°C for 30 min
and stored in aliquots at -20°C.
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Purification of parasite infected erythrocytes
(a) P. berghei
P. berghei is an asynchronous malaria species, all stages of the 
erythrocytic cycle except sequestering schizont being present in the blood 
at any given time. A Percoll density gradient centrifugation step was 
developed to separate mature-trophozoite infected erythrocytes from 
¡mmature-trophozoite infected erythrocytes and uninfected erythrocytes.
The purified trophozoites were then considered synchronous and could be 
used in invasion assays. This percoll gradient was termed the P. berghei 
65-75-85 Percoll Step.
A second Percoll gradient was developed which separated infected 
erythrocytes from uninfected erythrocytes. The resulting parasite 
preparation wasn’t synchronous, but resulted in a higher recovery of 
parasite material per ml of infected mouse blood than the 65-75-85 step. 
This percoll step was termed the P. berghei 80 Percoll Step.
1. P berghei 65-75-85 Percoll Step
Approximately 1 ml of blood was removed from a P. berghei infected 
mouse by cardiac puncture into a heparinised syringe. After passage over a 
1 ml CF11 column , to remove lymphocytes, the cells were washed in PBS, 
and resuspended in 0.5 ml PBS. The 65-75-85 stepwise gradient was then 
prepared by first loading 4 ml of a 65% Percoll solution (see BUFFERS 
AND SOLUTIONS) into a Corex centrifuge tube. This was then underlaid 
with 4 ml of the 75% solution which in turn was underlaid with 2 ml of the 
85% solution. The resuspended cells were then layered onto the gradient, 
and it was centrifuged at 5000 x g for 20 min at room temperature.
Following centrifugation the very top layer of cells (showing pigmentation), 
which did not or only slightly penetrated the top Percoll layer, was removed 
, washed in 10 ml PBS and resuspended in 0.5 ml PBS. In this preparation, 
>95% of the erythrocytes contained mature-trophozoites.
2. P. berghei 80 Percoll Step
Infected blood was collected, washed, and resuspended in 0.5 ml 
PBS. These cells were then layered onto 10 ml of a 80% percoll solution
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in a Corex tube and was centrifuged at 5000 x g for 20 mins at room 
temperature. The top layer of cells was removed, washed and resuspended 
in 0.5 ml PBS. This Percoll step resulted in preparations containing >95% 
parasite-infected erythrocytes.
(b) P. c. chabaudi
As the intra-erythrocytic cycle of P. c. chabaudi is synchronous, large 
quantities of mature-trophozoite infected erythrocytes were obtained by 
taking blood from an infected animal at the time of day corresponding to 
that stage of maturation in the cycle (approximately 1pm).The infected 
erythrocytes were separated from uninfected erythrocytes using a Percoll 
gradient modified from that described by Wunderlich etal. (1985). Cells 
were collected, washed, and resuspended as before, then layered onto 10 
ml of a 74% Percoll solution ( see BUFFERS AND SOLUTIONS ) in a Corex 
tube. After centrifugation at 5000 x g for 20 min at room temperature, the 
cells formed 2 bands in the Percoll. The upper band contained >95% 
infected erythrocytes, the lower band contained uninfected erythrocytes. 
This Percoll step was termed the P. c. chabaudi 74 Percoll Step.
Preparation of target erythrocytes
Blood from Balb/c, Schofield and CD-1 mice was obtained by 
cardiac puncture into heparinised syringes, washed in 10 volumes of PBS 
by centrifugation at 450g for 5 min, and resuspended in 0.5 ml PBS. 
Erythrocytes from guinea-pigs, rabbits, and humans (supplied by Dublin 
Transfusion Board) were prepared similarly.
Enzyme treatment of erythrocytes
Erythrocytes were collected from mice by cardiac puncture into 
heparinised syringes. The cells were washed three times in 10 ml RPMI-
1640 and then 1 x 109 cells were treated with chymotrypsin (50 U/mg 
protein), trypsin (10,000 U/mg protein), papain (20U /mg protein) or 
neuraminidase (1 U/ml, Vibrio cholera source) in RPMI 1640, pH 7.4, for 90 
min at room temperature. The cells were then washed three times with 
RPMI 1640, incubated for 10 min at room temperature with a suitable 
enzyme inhibitor (5mM TPCK for chymotrypsin, 1 mg/ml STI for trypsin,
1 mM PMSF for papain), and washed a further three times with RPMI 1640.
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Control cells were treated similarly, with the exception that enzymes were 
omitted.
Invasion assays
(a) P. berghei
There were 3 steps involved in the P. berghei invasion assay,
(1) culturing of purified mature-trophozoite infected erythrocytes.
(2) preparation of target erythrocytes.
(3) incubation of parasite infected erythrocytes with target erythrocytes
(1) Culturing of purified mature-trophozoite infected erythrocytes
P. berghei schizont cannot be obtained by bleeding infected mice as 
this stage of the asexual cycle sequester in the blood vessels of the the liver 
and spleen. Schizont stages were obtained in vitro using culturing 
methods similar to those described by McLean, Dougall, and Phillips 
(1986). Synchronous mature-trophozoite infected erythrocytes, obtained 
using the P. berghei 65-75-85 Percoll Step described, were cultured in 
vitro in a 50% FCS/50% RPMI 1640 based media. The cells, at a density of
2.5 x 107 cells/ml were cultured at 37°C for 5 hours in a tissue culture flask 
placed in a candle jar. During this time the parasites develop into schizont.
(2) Preparation of target erythrocytes
Immediately before use target erythrocytes or enzyme treated target 
erythrocytes were prepared.
(3) Incubation of parasite infected erythrocytes with target erythrocytes
A total of 2 x 107 target cells was added to 0.8 ml of the 50% 
FCS/50% RPMI 1640 media, in wells of a 24-well tissue culture plate. The 
flask containing the cultured parasitised erythrocytes, was removed from 
the candle jar after 5 h incubation, and the cells were gently resuspended.
Two hundred (xl (5x10® infected erythrocytes) of this culture were then 
added to each well containing target erythrocytes. The 24-well plate was 
then gently agitated and placed into the candle jar which was returned to
the 37°C incubator. Nineteen hours later the contents of each well were
removed, dispensed into a microfuge tube and centrifuged at 450 x g for 5
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min. The cell pellet was then resuspended in 50 \i\ FCS, 10 [i\ of which was 
used to make a smear on a glass slide. These smears were giemsa stained 
and examined under a light microscope. The invasion of target erythrocytes 
was estimated by counting the number of erythrocytes infected with ring- 
stage parasites and expressing this as a percentage of total erythrocytes.
(b) P. c. chabaudi
The P. c. chabaudi invasion assay was carried out in 3 stages, 
similar to that of the P. berghei invasion assay.
(1)Culturing of purified parasite infected erythrocytes 
Synchronous mature-trophozoite infected erythrocytes were
obtained using the P. c. chabaudi 74 Percoll Step described. These cells
were then cultured in a RPMI 1640 based media, at 37°C for 5 h in a tissue
culture flask in a candle jar, at a density of 2.5 x 107 cells/ml. After this 
incubation the parasitised cells had developed to schizogony.
(2) Preparation of target erythrocytes
Immediately before use, target erythrocytes or enzyme treated target 
erythrocytes were prepared.
(3) Invasion assays
The invasion assay was carried out exactly as described for P. 
berghei except that the P. c. chabaudi culture medium was used.
Metabolic 3 5 S-labelling of parasite proteins
P. berghei infected mice were bled by cardiac puncture into 
heparinised syringes when parasitaemias were between 15% - 25%. 
Following passage over CF11 column, and washing in PBS, mature- 
trophozoite infected erythrocytes were purified using the P. berghei 65-75-
85 Percoll Step. The parasites were then cultured at 2.5 x 107 cells/ml in a
50% FCS/50% RPMI 1640 based ^ 5S-labelling media, for 6 hours, at
37°C in a culture flask placed in a candle jar. After this incubation, the 
culture was centrifuged at 500 x g for 10 min, the supernatant removed and
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the cell pellet washed once In 50 ml ice-cold PBS, and 3 times in 1 ml ice- 
cold PBS. The cells were then extracted by 3 freeze-thaw cycles in 1 ml 
PBS (containing 1mM iodoacetamide, 1mM PMSF, 1mM EDTA, and 5(iM E-
64). The extract was centrifuged at 10,000 x g for 30 min at 4°C to remove 
cell debris and the supernatant brought up to the original culture volume 
with ice-cold PBS (including protease inhibitors). This extract was termed
P. berghei Hot Pellet Extract and was stored in 1 ml aliquots at -20°C.
A Hot Pellet Extract, from P c. chabaudi trophozoites that had been 
purified on the P c. chabaudi 74 Percoll Step and cultured in the P c. 
chabaudi radiolabelling medium for 6 h was prepared, in exactly the same 
manner as theP berghei extract. This extract was termed the P c. 
chabaudi Hot Pellet Extract.
Binding assays
Erythrocytes (1 x 10®) were mixed with 0.4 ml metabolically ^ S -  
labelled Hot Pellet Extract for 30 min at room temperature in a 1.5 ml 
microfuge tube. The suspension was then layered on 0.5 ml silicone oil and 
centrifuged for 20s at 12,000 x g. The pellet was resuspended in 1 ml cold 
RPMI 1640 and centrifuged. The supernatant was removed and 20 |il of
1.5 M NaCI was mixed with the pellet. After 10 min the suspension was 
centrifuged for 20 s at 12,000 x g. The supernatant was mixed with an equal 
volume of 2X SDS - PAGE reducing sample buffer, placed in a boiling water 
bath for 2 min and electrophoresed on 10% reducing SDS polyacrylamide 
gels in parallel with prestained molecular weight markers. Radioactive
bands were visualised by fluorography using Amplify®.
Preparation of P. berghei extract
P. berghei infected blood was collected in heparinised syringes and 
parasitised erythrocytes were purified using the P. berghei 80 Percoll
Step. These cells were then cultured at 37°C for 6 h at a cell density of 2.5
x 107 cells/ml. The 50% RPMI 1640/50% FCS media was used and the 
culture flask was left in a candle jar for the duration of the incubation. The 
culture was then centrifuged at 500 x g for 10 min and the cell pellet 
washed twice in a hundred volumes of PBS, and twice in ten volumes of
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PBS. The pellet was then resuspended in a volume of PBS (including 1mM 
PMSF, 1mM EDTA, and 5nM iodacetimide), corresponding to 1% of the 
initial culture volume. The resuspended cell pellet was then subjected to 3 
cycles of freeze-thaw lysis and then centrifuged at 10,000 x g for 30 min at
4°C. The supernatant was removed, aliquoted and stored at -20°C and 
used either for immunisations or for separation on SDS-PAGE and blotted 
to nitrocellulose. This extract was termed C1 Extract.
Production of anti-C1 Extract antibodies
The C1 Extract was used to generate antibodies in a rabbit, the sera 
produced was termed anti-C1 antisera. Equal volumes of antigen (100 fig 
protein) and Freunds Complete Adjuvant were mixed and sonicated on ice 
to form an even emulsion. This was then injected subcutaneously at the 
base of the neck of a male rabbit. After 3 weeks the rabbit was injected 
again with an emulsion consisting of equal parts antigen (100 |ig protein) 
and Freunds Incomplete Adjuvant. This injection was repeated 3 times at 
3-week intervals. Ten days after the final injection the rabbit was sacrificed 
and bled by cardiac puncture. Approximately 50 ml of blood was collected
and left to clot overnight at 4°C. The serum was drawn off and heat 
inactivated at 56°C for 30 min, before being aliquoted and stored at -20°C.
Radio-im munoprecipitation
To 200 |il of Hot Pellet Extract was added 5 |il rabbit anti-serum and
the mixture was incubated at 4°C overnight. Protein-A agarose (50 |il) was
added, and the mixture incubated for one hour at 4°C, with occasional 
mixing. The precipitates were then washed at 500 x g in this sequence of 
these buffers-
i) NETT - 0.5% BSA
ii) NETT
iii) NETT - 0.5M NaCI
iv) NETT
The microfuge tube was changed between the third and fourth wash 
and the fourth wash was spun at 10,000 x g for 5 min. The pellet was 
resuspended in 40 |il of 1X SDS PAGE reducing sample buffer and was
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boiled for 2 min. The sample was then spun at 10,000 x g for 20s to pellet 
the Protein-A agarose, and the supernatant was analysed by SDS-PAG or
stored at -20°C. Immunoprecipitated proteins were visualised by 
fluorography. Control immunoprécipitations were carried out with pre- 
immune sera.
If rat sera was used in immunoprécipitations then a rabbit anti-rat 
antibody was added after the first overnight incubation of sera with labelled
proteins, and this was incubated at 4°C for 4 h before proceeding to the 
Protein -A agarose step.
Fluorography
Electrophoresis gels that were performed for the resolution of radio­
labelled proteins, were fixed for 30 min in destain and subsequently 
incubated in Amplify for 30 min. The gels were then dried, and exposed to
X-ray film at -70°C. The film was then developed and fixed according to the 
manufacturers instructions.
SD S -P A G E
Samples were routinely run on 8% or 10% polyacrylamide gels 
according to Laemmli (1970). Gels were prepared fresh each day and run 
at 25mA per gel, with prestained molecular weight markers run in parallel. 
The gel was removed from the apparatus, fixed in destain for 30 min and 
then either stained with 0.1% coomassie blue or silver stained. Gels 
destined for transfer to nitrocellulose were not fixed in destain but incubated 
for 30 min in transfer buffer.
Semi-dry transfer of protein from PAG to nitrocellulose
An ATTO semi-dry transfer apparatus was used. The gel, 
nitrocellulose paper, and 16 pieces of filter paper were incubated in transfer 
buffer for 30 min. The anode was then covered with a thin film of transfer 
buffer, and 8 pieces of soaked filter paper were layered, one on top of 
another, onto the wet anode. The nitrocellulose was laid next, followed by 
the gel, and then the 8 remaining pieces of filter paper completed the 
sandwich. The cathode in the lid of the apparatus was then lowered onto 
the top of the sandwich. For the effective transfer of proteins onto the
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nitrocellulose the operating current (mA) was calculated as 1.5 times the 
area of the gel (cm2). By experience it was found that proteins up to 250 
kDa would transfer in 6 h at this current/area ratio. When transfer was 
complete the current was switched off and the transfer sandwich 
disassembled. Success of transfer could be gauged by the transfer of the 
prestained molecular weight markers, and by coomassie staining the gel 
after transfer.
Western Blotting
After successful transfer of protein to nitrocellulose the blot was 
washed in TBST for 5 min to remove any acrylamide. This was then 
followed by incubation in Blocking Buffer (TBST-1% BSA) for 1 h at room
temperature or overnight at 4°C. The membrane was then incubated with 
shaking in an appropriate dilution of primary antisera in TBST for 1 h, 
followed by 5 x 10 min washes in TBST. The secondary antibody (alkaline 
phosphatase conjugated) was then diluted in TBST (1:10,000) and the blot 
incubated with it for 1 h, followed by washing 5 x 1 0  min in TBST, to 
remove unbound antibody. The blot was then incubated in Alkaline 
Phosphatase Colour Development Solution until reactive areas turned 
purple. The reaction was stopped by rinsing the membrane in distilled 
water. The blot was placed on filter paper, air dried and stored in clingfilm.
Construction of cDNA expression library - Preparation
Several precautions were taken to ensure that this work remained 
RNase free. Micropipette tips and microfuge tubes were washed in 
chloroform and autoclaved before use. All glassware, non disposable 
plastlcware, and electrophoresis apparatus used for RNA work was kept 
separately from other labware. Glassware was soaked and rinsed in a
solution of 0.02% DEPC, autoclaved, and baked for at least 3 h at 250°C 
before use. Solutions to be used with RNA were treated by addition of 
DEPC to 0.02%, followed by thorough mixing of the solution , incubation at
37°C overnight and then autoclaving the solution to remove the DEPC. Tris 
solutions or solutions of substances containing amine or sulfhydryl groups 
which react with DEPC could not be treated directly, and so were made up 
in DEPC treated water and autoclaved. Sterile disposable plastic test-tubes
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and individually wrapped sterile pipettes were used wherever possible, and 
disposable gloves were worn at all times and changed regularly.
Isolation of RNA
P. berghei parasitised erythrocytes (2.5 x 10®) were purified on the
P. berghei 80 Percoll Step and cultured for 6 h at 37°C as described. This 
culturing ensured that the RNA isolated included mRNA from the schizont 
stage of the life cycle. After washing in PBS, the cell pellet was 
resuspended in 1 ml PBS (made up in DEPC water). The resuspended 
pellet was then transferred to a 15 ml corex centrifuge tube and 7 ml of 
RNAzol B was added. This mix was solubilised by passage up and down a 
pipette several times. Then 0.1 volume of chloroform was added to the 
suspension, the corex tube was covered tightly and shaken vigourously for 
15s. Subsequently the mix was let sit on ice for 5 min and then centrifuged
at 12,000 x g for 15 min at 4°C. The colourless upper aqueous phase 
(approx. 5 ml), was removed and transferred to a clean Corex tube. An 
equal volume of cold isopropanol was added and the sample was stored at
4°C for 15 min. Following another centrifugation at 12,000 x g for 15 min at
4°C the RNA had precipitated to form a white-yellow pellet at the bottom 
of the tube. The supernatant was removed and the pellet was washed once 
in 1 ml of 75% ethanol by vortexing and subsequent centrifugation for 8
min at 7,500 x g at 4°C. The pellet was then briefly dried in a vacuum drier 
and resuspended in 100 \i\ of 1mM EDTA. RNA was spectrophotometrically 
quantitated and a sample run on an agarose gel. The RNA was considered 
to be of suitable quality to proceed with mRNA isolation if the ribosomal 
RNA ran as sharp bands.
Isolation of mRNA from total RNA
The BRL mRNA Isolation System was used to purify mRNA from total 
isolated RNA. Total RNA was reprecipitated in ethanol and dissolved in the 
Binding Buffer supplied with the kit. This RNA was passed over a cellulose 
chromatography matrix containing immobilised deoxythymidine oligomers 
(oligo dT). The presence of salt in the Binding Buffer promoted hybridisation 
between the immobilised oligo dT and the poly (A) tails at the 3’ termini of
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mRNA. After the column was washed to remove unbound nucleic acids, the 
mRNA was eluted in a buffer containing no NaCI, (Elution Buffer) which 
destabilised the A-T bonds. NaCI was then added to the Elution Buffer, and 
the mRNA chromatographed a second time. The second eluate was
ethanol precipitated and stored in a 1 mM EDTA solution at -70°C until 
used for cDNA synthesis.
cDNA synthesis
The RiboClone® cDNA Synthesis kit from PROMEGA was used to 
generate double stranded cDNA from mRNA isolated as described. All 
procedures were carried out as outlined in the manufacturers instructions.
In this method, first strand synthesis was carried out with AMV Reverse 
Transcriptase using oligo dT primers in the presence of 4mM sodium 
pyrophosphate, which suppressed the formation of hairpins. Second strand 
synthesis was then carried out using RNase H to create nicks and gaps in 
the hybridised mRNA strand, which provides 3’ -OH priming sites for DNA 
synthesis and repair by DNA polymerase 1. The second strand synthesis 
reaction was allowed to proceed for 4 h to ensure that large size cDNA was 
synthesised. This reaction was then stopped, and incubated briefly with T4 
DNA polymerase to remove any remaining 3’ protruding ends. The cDNA 
was then ready for linker addition.
Ligation of EcoR1 linkers to cDNA
In order to ligate the cDNA into gt11 arms it was first necessary to 
add EcoR1 linkers to the cDNA. All procedures were carried out using the
RiboClone® Linker Ligation Kit according to PROMEGA’s instructions. The 
cDNA was first methylated with an EcoR1 methylase to protect internal 
EcoR1 restriction sites in the cDNA from EcoR1 treatment later in the 
procedure. It was important then to eliminate small size DNA’s from the
linker ligation reaction, and this was done using PROMEGA’s Sephacryl ® 
S-400 spin columns. These columns get rid of double stranded DNA 
fragments less than 270 bp.The EcoR1 linkers (10 mers) were then ligated 
to the size fractionated cDNA using T4 DNA Ligase. Subsequently this 
reaction mix was treated with EcoR1, and the unligated linkers removed by 
another round of Sephacryl
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®S-400 spin column chromatography. The cDNA was then ready for 
ligation and packaging into lambda.
Ligation and Packaging of cDNA into gt11
The cDNA from the linker ligation step was ligated to alkaline
phosphatase treated gt11 arms supplied with the PROMEGA ProtoClone ® 
gt11 system, using T4 DNA Ligase. This was then packaged into lambda
heads using the PROMEGA Packagene® system. A control ligation and 
packaging was carried out in parallel with just the lambda arms and no 
insert DNA. This allowed determination of the background level of religated 
arms, and also provided a supply of wild type gt11. The packaged phage 
was then titred by infecting LE392 bacteria with dilutions of the phage, and 
then plating the bacteria out on LB plates in top agar. The Phage stock was 
then amplified by plating at an appropriate dilution on LB plates.
Preparation and plating of phage competent cells
Two bacterial strains were used.
(a) E. coli LE392 - used for amplification, titration, and screening of phage 
libraries with nucleotide probes. This strain was maintained on LB plates.
(b) E. coli Y1090 - used for screening of expression library with antibody 
probes. Y1090 was always maintained in LB with 100 jig/ml ampicillin and 
15 jig/ml tetracyclin.
One colony from a stock plate of the bacteria was used to inoculate 
10 ml of LB media (with 0.2% maltose, 10mM M gSO^ which was then
cultured overnight at 37°C. Fifty [i\ of this was then used to inoculate 5 ml of 
similar media and the cells grown until AgQOnm was between 0.6 and 0.9.
For each plate to be poured 100 fil of these phage competent cells 
was mixed with 100 |il of the desired dilution of phage in a microfuge tube
and incubated at 37°C for 20 min. This phage/cells mix was then added to
3 ml molten top agar (including 10mM MgSO^ at 48°C and this was 
mixed by very gentle vortexing before pouring onto prewarmed LB plates. 
The plates were allowed to harden at room temperature for 10 min, and
then incubated inverted at 37°C until plaques reached the desired size.
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Titration of phage stock
One hundred |il of phage competent LE392 cells were infected with 
100 \i\ of tenfold increasing dilutions of the packaged phage, by incubation
in a microfuge tube for 20 min at 37°C.This mixture was then added to 3 ml 
molten top agar (with 10 mM MgSO^, and plated out on LB plates. These 
plates were then incubated overnight at 37°C. The efficiency of packaging 
was calculated for both the cDNA and the control as the number of Plaque 
Forming Units (pfu) per (ig DNA packaged.
Ampiification of phage stock
One hundred \i\ of phage competent cells was infected with 5000 pfu
of the packaged phage for 20 min at 37°C. The entire packaged phage 
stock was used in this way. The cells were plated out in 3 ml top agar and 
incubated overnight at 37°C. The top agar was then overlaid with 5 ml SM 
buffer and rocked at room temperature for 2 h. The SM buffer was then 
harvested to a centrifuge tube and chloroform added to 5%. This was then
mixed gently and centrifuged at 3000 x g for 10 min at 4°C. The
supernatant, which contained the amplified phage was removed, leaving 
cell debris and the chloroform in the tube. The amplified stock was then 
aliquoted into microfuge tubes, chloroform added to 0.3% and stored at
4°C until used. The stock was regularly titred.
Preabsorption of the antisera
It was important to remove all antibodies reactive with bacterial 
products from the antisera before commencing screening. This was done 
by mock screening of wild-type phage plaques with the polyclonal sera. 
Phage competent E. coli Y1090 were prepared, infected with 5000 pfu 
wild-type phage, and plated out on LB-ampicillin plates as described. The
plates were incubated at 42°C until the plaques became visible (2 - 3 h). 
Nitrocellulose discs (83mm diameter) were soaked in 10 mM IPTG, briefly 
air-dried, and carefully placed onto the plates to avoid air bubbles. The
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plates were then incubated inverted at 42°C for a further 4h. The 
nitrocellulose discs were then inverted on the plates and the plates were 
returned to the incubator for another 4 h at 42°C (or incubated overnight at 
4°C). The discs were carefully removed from the plates, washed briefly in
TBST, and then blocked overnight in TBST-1% BSA at 4°C. The diluted 
antisera was then incubated with one filter per 4 ml for 4 h at room 
temperature, the filters were then replaced with another and allowed to
incubate with the antisera overnight at 4°C. The second filter was then
removed and the preabsorbed antisera stored at 4°C until used.
Preparation of anti-C1 sera for immunoscreening
The antisera against the C1 extract reacted against a very large 
range of proteins and screening with it would have proved very 
cumbersome. Therefore it was decided to absorb the antibodies reacting 
against high molecular weight proteins ( >100 kDa) from the sera and to 
use only this fraction for immunoscreening.
A 10% reducing SDS-PAG was run with 10 lanes of C1 Extract. This
was then transferred to nitrocellulose for 6 h at 1.5 mA/cm2 . After blotting, 
the strip of nitrocellulose corresponding to proteins >100 kDa, as 
determined by the molecular weight markers was cut from the 
nitrocellulose, and blocked in TBST-1% BSA for 1 h at room temperature. 
Ten ml of a 1/50 dilution of anti-C1 antisera (which had been absorbed 
against wild-type plaques) was then added to the nitrocellulose strip and 
incubated for 1 h at room temperature. Unbound sera was then poured off 
and the strip washed 5 x 1 0  min in TBST-0.05% Triton-X to remove non- 
specifically bound antibody.
The bound antibodies were then removed by incubating the strip in 
10 ml glycine buffer pH 2.6 for 2 min. This elution buffer was then poured 
off the strip and neutralised with a pretitred volume of 2 M Tris base. Azide
was added and the anti -C1 (+100 kDa) sera stored at 4°C.
Immunoscreening of lambda library
Twenty plates with -3000 pfu each were used in primary screening
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with each antisera. Phage competent E. coli Y1090 were prepared, 
infected with -3000 pfu of the library and plated on LB-ampiciHin plates as
described.The plates were incubated at 42°C until the plaques reached 
pinprick size (-3  h). Numbered nitrocellulose discs were soaked in 10 mM 
IPTG, air dried and then placed carefully onto the correspondingly 
numbered plates, avoiding air bubbles. The plates were then either
incubated at 37°C for 4 h or at 4°C overnight. Three asymmetric orientation 
marks were then made on the filter by stabbing through it into the agar with 
a needle. The filters were then removed carefully and blocked by 
incubation in TBST-1% BSA overnight. The plates were wrapped In
parafilm, and stored at 4°C until required. The discs were incubated in 4 ml 
preabsorbed antisera for 2 h at room temperature (The primary antibody 
was not discarded after use, but was used for subsequent screening) and 
then washed 3 x 1 0  min in TBST. They were then incubated in secondary 
antibody (alkaline phosphatase conjugated) for 2 h at room temperature. 
After a further 3 x 1 0  min washes in TBST the discs were developed in 
Alkaline Phosphatase Developing Solution, until purple rings appeared on 
the discs. The reaction was stopped by replacing the AP Developing 
Solution with distilled water. The filters were then air dried.
The marks were then used to orientate the the filters with the original 
plate. Usually the plaques were too confluent to identify the individual 
plaques responsible for the positive signal on the filters and therefore the 
area of the plate corresponding to the positive signal was removed as a 
agar plug using a sterile pasteur pipette. This plug was transferred to 1 ml
of Phage Buffer in a microfuge tube, and was left at 4°C overnight to allow 
the phage to diffuse out. These were called ‘primary positives' .The primary 
positives were then titred and plated out at -200 pfu on Y1090 and 
rescreened as described. As there were less plaques on the plate, it was 
easier to identify individual positive plaques, and these 'secondary 
positives1 were picked and allowed to diffuse into phage buffer as before. 
The phage were then rescreened at -100 pfu per plate and 'tertiary 
positive' plaques picked. On these plates all the plaques were usually 
positive. However, if they were not another screening cycle was performed.
Purified phage was amplified as described, and stored at 4°C until
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required.
Preparation of Lambda lysates and isolation of Lambda DNA
Lambda DNA could be isolated from stocks of amplified phage. 
However if large amounts (-50 (j.g) of DNA was required, the phage was 
amplified using a liquid culture method, and DNA purified from the lysate.
Phage competent E. coli Y1090 were prepared as described.
Twenty |il of phage stock was added to 500 \i\ of cells in a microfuge tube,
mixed, and incubated at 37°C for 20 min. This was then used to inoculate 
100 ml of prewarmed LB (with 10mM MgSO^ 100 (xg/ml ampicillin, 15 
|j.g/ml tetracyclin), which was incubated at 37°C in an orbital shaker. The 
media went cloudy after about 4 h and then clear again after a further hour 
as the phage lysed all the cells. The culture was then centrifuged at 8000 x 
g for 10 min to remove cellular debris. The supernatant containing the
phage was aliquoted to sterile 50 ml tubes and stored at 4°C until used. As 
well as being used for preparation of phage DNA, this lysate could also be 
used as an amplified phage stock.
DNase 1 (1|ig/ml) and RNase A (1|ig/ml) were added to 80 ml of the
lambda lysate supernatant, and it was incubated at 37°C for 30 min. An 
equal volume of Phage Precipitation Buffer was added to the lysate, mixed 
a few times by inversion, and incubated overnight in ice-water. The 
precipitated phage particles were recovered by centrifugation at 10,000 x g
for 20 min at 4°C, and the supernatant discarded. The centrifuge tube was 
allowed to stand inverted on paper towels for at least an hour, to allow the 
fluid to drain away, before the phage particles were resuspended in 5 ml 
Phage Buffer. The resuspended phage was then centrifuged at 8000 x g for 
2 min to remove debris, and then extracted in turn with one volume of TE- 
saturated phenol/chloroform, one volume of TEN-saturated 
phenol/chloroform and finally one volume of chloroform : isoamyl alcohol 
(24:1). The aqueous phase was mixed with an equal volume of isopropanol
in a Corex centrifuge tube and was left at -70°C for 20 min. The solution
was then centrifuged at 12,000 x g for 10 min at 4°C, the supernatant 
carefully drained and the pellet resuspended in 400 |il H20  and transferred 
to a microfuge tube. Eight hundred (il ethanol was added, and the tube
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placed at -20°C for 1 h. The DNA pellet was recovered by centrifugation at
10,000 x g for 10 min at 4°C, washed with 70% ethanol, and dried under 
vacuum.
This preparation was often found to have large amounts of RNA and 
therefore an RNase digestion step necessary. The pellet was resuspended 
in 200 |il sterile water and RNase A added to 100 ng/ml. Following a 30 min
incubation at 37°C, phenol/ chloroform and chloroform extraction, the DNA 
was precipitated with ethanol, washed in 70% ethanol, vacuum dried, and 
resuspended in 50 |xl sterile H20 . This procedure routinely yielded 
between 20 - 50 |ig DNA from 80 ml phage lysate. Phage DNA was 
quantitated spectrophotometrically, and analysed by PCR and EcoR1 
digestion.
PCR analysis of lambda DNA
PCR was used to size and isolate the inserts in the phage library.
The primers used were derived from the sequence flanking the EcoR1 
cloning site of the gt11, and could be used to amplify cloned sequences. In 
the wild-type lacZ gene the distance between the two primer sites was 39 
bp (which includes the EcoR1 site), and since both primers were 24 mers, 
amplification using the wild-type DNA would be expected to give a PCR 
product of 87 bp. This was then subtracted from the PCR fragment size 
generated from phage containing inserts in order to establish the true 
fragment size.
The PCR conditions were for each reaction
L forward primer ( 0.5 jig / \i\ ) 1 |il
L reverse primer (0.5 |ig / | i l ) 1 |xl
dNTP’s (1 mM each ) 5 [i\
10x PCR buffer 5 \l\
MgCI2 (25 mM ) 6 ill
Taq Polymerase ( 5u / | i l ) 0.5 |^ l
Lambda DNA ( -0.5 jig / | i l ) 1 |il
Sterile H2O 30.5 (xl
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Each 50 |il reaction was overlaid with 50 |il mineral oil and placed in the 
Hybaid Omnigene PCR machine, and Program no. 1 was executed.
PROGRAM 1 
Stage 1 94 °C 4min.
Stage 2 94°C 1m in,
55 °C 2min,
74 °C 2min.
stage 2 was run for 40 cycles.
Ten |il of each PCR reaction was removed from below the mineral oil,
mixed with 2 [l\ of 6X DNA electrophoresis sample buffer and run on an
agarose gel in parallel with size markers.
A 200 bp fragment could be PCR amplified from P. berghei 
genomic DNA using primers derived from the known sequence of the P. 
falciparum 175 kDa Erythrocyte Binding Protein (primer 142 and primer 
143). These primers were used to determine whether any of the clones 
picked from the cDNA library by the immunological screening encoded a 
gene homologous to the P. falciparum that encoded an erythrocyte 
binding protein. In this PCR reaction, reagents and volumes were as 
described above, except that primers 142 and 143 were used in place of 
the Lambda forward and reverse primers and a new program was created.
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PROGRAM 2
Stage 1 94°C 4 min.
Stage 2 94°C 30 s,
42°C 2 min,
74 °C 1 min.
stage 2 was run for 5 cycles.
Stage 3 94 °C 30 s,
45°C 30 s,
74°C 1 min.
stage 3 was run for 25 cycles. 
Analysis of PCR products was by agarose gel electrophoresis.
Oligonucleotide probe JA159
A 40 mer oligonucleotide probe (JAI59) was synthesised from the 
200 bp sequence that was amplified using P. berghei genomic DNA as 
template and primer 142 and primer 143. An EcoR1 site was engineered 
into the 5’ end as shown (P. Curley, personal communication).
OLIGO JA159
5' -0H AAGGATCCAATAATCTGATATTGAGCAGCATAATTGTTTC -3'
I I
EcoR1
This oligo was first end-labelled with 32P from gamma labelled ATP.
The reaction mix was
JA 159 (700 ng/|j.l) 0.5 til
10 x T4 polynucleotide kinase buffer 5 |il
L3 2 ATP (5 |iC/|il) 10 |il
T4 polynucleotide kinase (10 u/jj.I) 1 |il
sterile H2O 33.5 }il
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The kinase and the label were added last and the reaction mix was 
incubated for 2 h at room temperature. When the reaction was complete, 
50 |il of 0.2M EDTA and 100 \i\ of 20X SSC were added and the reaction 
tube placed in a boiling water bath for 5 min. The reaction was cooled on 
ice for 5 min, before addition to the Prehybridisation Solution.
Screening of lambda library with radiolabelled JA 159
Phage competent E. coli LE 392 were prepared as described.
Twenty LB plates with -5000 pfu were incubated at 37°C for 6 h. In this 
time small plaques became clearly visible. Numbered nitrocellulose discs 
were then placed carefully onto the plates, avoiding the trapping of air 
bubbles, and left there for 1 min. The discs and plates were then marked 
with orientation marks by stabbing a needle through the disc and into the 
agar in several asymmetrically located points. The discs were then 
removed and washed successively in Denaturing solution, Neutralising 
solution, and 20 X SSC for 5 min each. This was done by placing the disc 
on a pool of the solution (made on tinfoil), always keeping the side of the 
disc which was in contact with the plaques up. The discs were dried on 
filterpaper for 5 min between each wash. Finally the discs were allowed to
dry at room temperature for 20 min and then baked at 80°C for 2 h.
After baking the filters were wet by washing in distilled H20  for 5 min 
and then 6 X SSC for 5 min. The filters were then placed into a heat 
sealable plastic bag, 100 ml of prehybridisation buffer added, the bag
sealed and the filters allowed to prehybridise at 68°C  for 2 h.The labelling 
reaction was then added to the prehybridisation solution, and hybridisation 
carried out at 45°C overnight.
The 200 bp PCR product of the primers 142/143 transferred by 
Southern transfer onto nitrocellulose served as a positive control. After 
hybridisation the discs and control were washed in 6 X SSC 0.2% SDS
3 x 10 min at room temperature,1 x 10 min at 50 °C.
The filters were then touch dried onto filter paper, wrapped in 
clingfilm and exposed to X-Ray film, in a cartridge containing an intensifier
screen, at -70°C overnight. The film was developed and fixed according to
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the manufacturers instructions. The area on the film that showed exposure 
to isotope was aligned with the filter discs, which were then aligned with the 
original agar plates, to identify the plaques which hybridised with the probe.
The areas of the top agar corresponding to the 'primary positive1 
plaques were placed into 1 ml of Phage buffer in a microfuge tube and the 
phage allowed to diffuse out overnight. This was then titred and replated at 
-200 pfu and a more definite identification of the positive phage made by 
another round off hybridisation. If any 'secondary positive' plaques were 
found, the hybridisation procedure was repeated until the positive plaques 
were isolated to purity.
Positive phage were amplified and DNA extracted as described.
PCR was used to check for the 200 bp sequence using primers 142 and 
143. The insert size was determined using the lambda forward and reverse 
primers.
Preparation of fusion Protein
Two different methods were used to make fusion protein from lambda 
clones
(a) Preparation of lysogens
(b) Plate Wash Supernatant method
(a) Preparation of lysogens
Recombinant protein was prepared by creating lysogens of the 
phage in E. coli Y1089. This strain has a mutation which enhances the 
frequency of phage lysogeny, is relatively resistant to lysis and is deficient 
in certain protease systems. These qualities allow for the accumulation of 
large amounts of fusion protein.
Y1089 cells were grown overnight at 37°C in LB medium 
(supplemented with 0.2% maltose, 10mM MgC^, and 100 fig/ml ampicillin). 
The cell concentration was calculated using A6gg (An A6q0 of 1.0 is
equivalent to 8 x 108 cells/ml).
One hundred |il of cells were then infected with 100 |il of phage such
that the multiplicity of infection (phage:cells) was 10. Generally 104 cells
were used and the reaction was incubated at 30°C for 20 min. One ml of LB 
medium (with 10 mM MgS04) was added to the reaction and the infected
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cells plated at a density of 500 cells and 50 cells per plate. These plates 
were then incubated at 32°C overnight. The next day 50 colonies were 
picked in duplicate arrays using sterile toothpicks. One plate was grown at 
42°C, the other at 30°C. Lysogens were identified by growth at 30°C, but
no growth at 42°C. Putative lysogens were tested by another series of
growth on duplicate plates at 30°C and 42°C. Positive lysogens were
picked, grown in LB-ampicillin at 30°C overnight, frozen stocks made in
glycerol, and stored at -70°C until required.
Crude lysates from the lysogens were then prepared. A single colony 
from a fresh plate of the Y1089 recombinant lysogen was used to inoculate
10 ml of SB-ampicillin, which was grown at 30°C overnight. One ml of this 
culture was then used to inoculate 50 ml of SB-ampicillin and the culture 
was incubated shaking at 30°C, until it reached an Aggg = 0.5. The
temperature of the culture was then raised as rapidly as possible to 42°C 
(this temperature elevation was accelerated by the addition of 5 ml SB 
media at 55°C). After 20 min incubation at the elevated temperature, IPTG
was added to the culture to 10mM. The culture was then incubated at 38°C 
for up to 2 h. The lysogens sometimes lysed during this incubation. If lysis 
occured within the first hour of this incubation the procedure was repeated 
with another isolate of the lysogen (as susceptibility to lysis varies for 
different lysogens). If lysis occured after the first hour, then the exact time for 
lysis was determined and the procedure repeated with the same lysogen
isolate, with the 38°C incubation allowed to proceed until just short of this 
lysis time.
When the 38°C culture was complete the cells were centrifuged at
3000 x g for 5 min at 24°C - 37°C, and the cells resuspended in 1 ml TBS 
buffer (including 1 mM EDTA, 1 mM PMSF, 1 mM iodacetimide) in a 
microfuge tube. Lysozyme was added to 1 (ig/ml and the cells incubated for
20 min, before a freeze/thaw lysis step at -70°C. In most cases this was 
insufficient to completely lyse the cells, and in these cases sonication was 
used to complete lysis.
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After sonication , the cell preparation had a very gloopy consistency 
due to the high concentration of DNA. DNase (1 (j.g/ml) was added and the 
lysate incubated at room temperature for 30 min on a rotator. This 
incubation reduced the viscosity of the extract. The extract was then
centrifuged at 10,000 x g for 10 min at 4°C to pellet cell debris.
The supernatant should contain the fusion protein sequestered in 
inclusion bodies. However not all fusion protein are sequestered as such 
and therefore the lysate pellet and the supernatants from all subsequent 
wash steps were retained and checked for partitioning of the fusion protein. 
The supernatant was transferred to a Corex centrifuge tube and
centrifuged at 16,000 x g for 5 min at 4°C. The pellet, containing the 
inclusion bodies was resuspended in 1 ml cold TBS, 10 mM EDTA, 0.5% 
Triton-X and was incubated for 5 min at room temperature. The inclusion
bodies were then pelleted by centrifugation at 16,000 x g for 5 min at 4°C. 
The pellet was resuspended, incubated, and centrifuged once more in the 
TBS-EDTA-Triton-X, followed by resuspension in 100 \x\ TBS.
An aliquot of this as well as samples of the wash supernatants and 
the sonicate supernatant were analysed on an 8% SDS-PAG, under 
reducing conditions and analysed by coomassie staining. If putative fusion 
proteins were identified, they were checked by western blotting with an anti- 
B-galactosidase primary antibody. Wild-type phage lysogen produced (3- 
galactosidase, purified by the method described, was used as a control.
(b) Plate Wash Supernatant method for production of fusion proteins
Phage competent E. coli Y1090 were prepared as described. One 
hundred \i\ of cells was infected with - 10,000 pfu of phage for 20 min at
37°C, before pouring onto LB -ampicillin plates in top agar. The plates were
then incubated at 42°C for 3 h, by which time plaques had appeared. Five 
ml of Phage Buffer (including 1 mM EDTA, 1 mM PMSF, 1 mM lodacetimide, 
and 10 mM IPTG) was then poured onto the plates and they were placed in
a 37°C incubator overnight. There was little bacterial growth left on the 
plate after this incubation due to the growth of the phage plaques. The 
phage buffer was transferred to a centrifuge tube to which was added the 
top agar scraped from the plate. This was vortexed for 20 s before
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centrifugation at 10,000 x g for 10 min at 4°C. The supernatant was 
carefully removed and aliquoted into 1.5 ml microfuge tubes. These tubes 
were centrifuged at 10,000 x g for 10 min at 4°C, and the supernatant
removed to fresh microfuge tubes, which were stored at 4°C until required.
The Plate Wash Supernatants were analysed for presence of fusion 
protein by reducing SDS-PAGE followed by coomassie or silver staining. 
Fusion proteins were also analysed by Western blotting using an anti-13- 
Galactosidase primary antibody.
Purification of Fusion proteins
The PROMEGA Protosorb® lacZ immunoaffinity column was use to 
purify recombinant fusion proteins. The column matrix consists of a pure, 
mouse anti-6-galactosidase monoclonal antibody coupled to cross-linked 
agarose beads. The affinity of the monoclonal is high enough to allow for 
specific binding of fusion proteins from crude extracts, yet low enough to 
allow for efficient elution of the fusion protein under relatively mild 
conditions. The PROMEGA instructions for operation of the column were 
followed and fusion protein purified from Plate Wash Supernatants.
Nine ml of a saturated (NH4)2S04 solution was added to 3 ml of
Plate Wash Supernatant. This was mixed well and chilled at 4°C for 60 
min, before centrifugation at 10,000 x g for 20 min. The supernatant was 
removed and the pellet resuspended in 1 ml cold TEP buffer. The protein 
concentration was then determined and the protein sample diluted to 1 
mg/ml protein with cold TEP buffer, before loading on the equilibrated 
column. After extensive washing the fusion protein was eluted with 3 
successive 1 ml aliquots of the Elution Buffer, pH 10.8, followed by 1 ml of 
TBS. The column was then quickly re-equilibrated in TBS.The eluted 
fractions were analysed by SDS-PAGE and western blots for the presence 
of the fusion protein.The amount of fusion protein in each aliquot was then
determined and then they were stored at 4 °C until used for immunisations.
Immunisation of rats with fusion protein
Equal volumes of fusion protein and Freunds Complete Adjuvant 
were sonicated on ice to form an even emulsion. This was then injected
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subcutaneously into the base of the neck of male Wistar rats. After 3 weeks 
the rats were injected with a similarly produced emulsion of fusion protein 
antigen and Freunds Incomplete Adjuvant. This injection was repeated a 
further 3 times. The rats were then bled and serum collected as described.
DNA and RNA gel electrophoresis
DNA gels were made up with agarose in 1x TAE buffer and RNA gels 
were prepared and run as described in Maniatis (1982).
Determination of protein concentration
The PIERCE BCA Protein Assay kit was used for protein 
determination using BSA as a standard, as outlined by the manufacturers.
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2. BUFFERS AND SOLUTIONS
Giemsa stain
The giemsa solution for staining parasites was a solution of 10% 
giemsa azur-eosin methylene-blue in a solution of 4 mM Na2HP0 4 , 2.5 mM 
NaH2P04.
PB S
NaCI 8 g
KCI 0.2 g
Na2 HP04 1.15 g 
KH2P04 0.2 g
qs to 1L and autoclaved
Percoll Solutions
Solution A ; 10X PBS-alucose
NaCI 8 g
KCI 0.2 g
Na2 HP04 1 g
KH2P 04 0.2 g
NaH2P04 0.15 g 
Glucose monohydrate 22.5 g 
qs to 100 ml and sterile filtered
Solution B : 1X PBS - glucose
Tenfold dilution of solution A in sterile H20.
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Percoli Gradients
% Percoli soin A soin B 
3.8 
2.17 
2
65 9
74 9
75 9
80 9
85 9
1.2
0.58
Media for parasite culture
Three types of media were used for parasite cultivation
(a) P. berghei 50% RPMI 1640/50% FCS culture medium
(b) P. c. chabaudi culture medium
(c) metabolic radio-labelling medium
(a  ^ P. berahei 50% RPMI 1640/50% FCS medium
RPMI 1640 (1 OX) 10 ml
HEPES 0.96 g
Hypoxanthine 0.5 mg
Neomycin (10 mg/ml) 0.5 ml
Glucose monohydrate 0.2 g
qs to 97 ml with sterile H2O, pH adjusted to 7.0 , and sterile filtered. 
Immediately before use, 1 ml of 200 mM glutamine and 2 ml of a 5% 
sodium bicarbonate solution was added. The required amount of medium 
was then made up by mixing equal volumes of the RPMI based medium 
and heat-inactivated FCS
(b) P. c. chabaudi culture medium
RPMI-1640 (10X) 10 ml
HEPES 0.46 g
Hypoxanthine 0.5 mg
Neomycin (10 mg / m l) 0.2 ml
Glucose monohydrate 0.2 g
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qs to 95 ml with sterile H2O , pH adjusted to 7.3 , and sterile filtered.
Before culturing, 1 ml of 200 mM glutamine and 4.2 ml of a 5% sodium 
bicarbonate solution was added. The required amount of medium was then 
made up by mixing 9 parts RPMI based media with 1 part sterile, heat- 
inactivated rat serum.
(c) metabolic radiolabellina medium
The P. berghei radiolabelling media was the same as the 50% 
FCS/50% RPMI based medium except that incomplete RPMI 1640 was 
used. This preparation lacked leucine, lysine and methionine. Leucine and
lysine were added to 5 mg and 4 mg per 100 ml RPMI 1640, and 35S- 
methionine added to the required amount of media at 50 jiC/ml.
The P. c. chabaudi radiolabelling media was the same as the RPMI
1640/10% Rat serum media used for culturing parasites, except that
incomplete RPMI 1640 was used. Leucine, lysine and the 35S-methlonine 
were added as for the P. berghei radiolabelling culture medium.
Electrophoresis solutions
Running buffer : 25 mM Tris, 192 mM Glycine, pH 8.3.
Fixing/detaining solution : 10% methanol, 10% acetic acid in distilled H20. 
Staining soln : 0.1% Coomassie blue R-250 in fixing solution.
Electroblotting solutions
Blotting buffer : 25 mM Tris, 192 mM Glycine, 10% Methanol, pH 8.3. 
Radio-immunoprecipitation solutions
NETT
NaCI
EDTA
100 mM 
1 mM 
20 mM 
0 .1%
Trls-HCI pH 8 
Triton-X
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Western blot solutions and immunoscreening solutions
TBST
Tris-HCI pH 8.0 10 mM
NaCI 150 mM
Tween 20 0.05%
Blocking solution : 1 % BSA in TBST
Alkaline Phosphatase Colour Developing Solution
Tris-HCI pH 9.5 100 mM
NaCI 100 mM
MgCI2 1 mM
To 10 ml of Developing solution was added,
66 |il NBT (50 mg/ml in 70% DMF),
33 |il BCIP (50 mg/ml in DMF)
mRNA isolation and cDNA synthesis
All reagents for mRNA isolation were supplied with the BRL mRNA 
Isolation System. All restriction enzymes, buffers and other reagents were
supplied with the PROMEGA RiboClone® cDNA synthesis kit except TE 
buffer.
TE buffer
Tris-HCI pH 8.0 10 mM
EDTA 1 mM
Linker ligation and lambda packaging reagents
All enzymes, buffers and reagents for linker addition were supplied
with the PROMEGA RiboClone® Linker Ligation Kit and PROMEGA
Sephacryl ® S-400 spin column kit. All enzymes, buffers and reagents for
packaging into gt11 arms were supplied with the PROMEGA Packagene® 
system.
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Media, Buffers and Reagents used in bacterial and phage work
LB medium
Bacto-tryptone 10 g 
Bacto-yeast extract 5 g 
NaCI 5 g
pH to 7.5 , qs to 1 L , and autoclaved.
LB a g a r: 1.5% Bacto-agar in LB media. If antibiotics were to be added the
autoclaved agar solution was allowed to cool to 55°C before addition of 
100 |j.g / ml ampicillln and 15 [ig / ml tetracyclin.
SB medium
Bacto-tryptone 20 g 
Bacto-yeast extract 10 g 
NaCI 5 g
pH to 7.5 , qs to 1 L , and autoclaved.
Top Aaarose
0.6% agarose dissolved in 100 ml LB media and autoclaved.
Phaae Buffer 
Tris-HCI pH 7.4 
NaCI 
MgS04
SM Buffer
This was Phage buffer including 0.01% gelatin.
Phaae Precipitation Buffer 
NaCI 2 M
PEG 8000 20% (w/v)
20 mM 
100 mM 
10 mM
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Reagents for elution of +100 kD reactive fraction of anti-C1
antisera
Glycine buffer
Glycine 200 mM
NaCI 150 mM
pH 2.6
Neutralisation buffer 
2 M Tris
Reagents for labelling of oligonucleotide probe and library 
screening
The T4 Polynucleotide kinase was supplied by PROMEGA along 
with a kinase 10X buffer which contained,
Tris-HCI pH7.6 700 mM
M gC ^ 100 mM
DTT 50 mM
Denaturing solution 
NaCI 1.5 M
NaOH 0.5 M
Neutralising solution 
NaCI 1.5 M
Tris-HCI pH 6.8 0.5 M
20X SSC
NaCI 3.0 M
CgHgNagOy 0.3 M
(sodium citrate) 
pH to 7.0
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Prehybridisation solution 
30 ml 20 X SSC 
10 ml 500 mMNa2HP04 
10 ml 50 X Denhardts solution
0.5 ml SDS
1 ml Salmon sperm DNA (1 mg/ml) 
qs to 100 ml.
50X Denhardts solution
10 mg/ml Ficoll, 10 mg/ml Polyvinylpyrrolidine, 10 mg/ml BSA.
Solutions used in purification of Fusion proteins
TEP Buffer
Tris-HCI pH 7.4 100 mM
EDTA 10 mM
PMSF 1 mM
Tris Buffer
Tris-HCI pH 7.3 50 mM
TN Buffer
Tris buffer with 0.2% NP-40.
High pH Elution Buffer
50 ml 0.1 M NaHC03
50 ml 0.1 M Na2C 03
adjust pH of solution to 10.8 with NaOH.
TBS Buffer
Tris-HCI pH 7.3 50 mM
NaCI 150 mM
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Buffer for DNA gel electrophoresis
50X TAE
Tris 2 M
EDTA (pH 8) 50 mM
Glacial acetic acid 57.1 ml/L
PCR reagents
A 10X PCR reaction buffer and 25 mM MgCl2 were supplied with the Taq 
Polymerase by PROMEGA.
10X PCR buffer 
KCI 500 mM
Tris-HCI pH 9.0 100 mM
Triton-X  1%
A 10X stock of dNTP’s was made such that the concentration of each dNTP 
was 1 mM, giving a working concentration of 0.1 mM.
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3. MATERIALS’ SUPPLIERS
Aldrich Chemical Company 
Phenylhydrazlne-HCI, Triton-X.
Amersham
Amplify.
AMS Biotechnology ltd 
RNAzol B.
Becton - PicKinson
All needles and syringes.
Biological laboratories 
CD -1 mice.
Biotrin research 
Protein - A agarose.
Boehrinaer Mannheim 
Neuraminidase.
PliPQDt
ATP 32PGamma-
Flow Laboratories 
FCS, L - glutamine.
General Electric Company 
Silicone oil.
Gibco -BRL
RPM11640, mRNA isolation kit.
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Griengc
All tissue culture flasks, and sterile disposable plasticware.
ICN
Trans - methionine.
Kodak
X - Omat X-ray film, FX -40 liquid fixer, LX - 24 developer.
Labscan
Methanol, propanol, Ethanol, Chloroform.
Merck 
Acetic acid.
Nunc
24 - well tissue culture plates.
.Qxoid
Bacto-tryptone, Bacto-yeast extract, Bacto-agar no. 3.
Promeaa
RiboClone® cDNA Synthesis System, RiboClone® Linker Ligation System,
Sephacryl®S - 400 Spin Columns, Packagene® Lgt11 Packaging System, 
Taq Polymerase and 10X reaction buffer, T4 Polynucleotide Kinase and 10 
X reaction buffer, EcoR1 and 10 X buffer ( H ), Kpn 1 and Sac 1 and 10 X 
buffer ( J ),
Mouse anti-B-galactosidase monoclonal, Alkaline Phosphatase linked 
secondary antibodies, Protosorb® lacZ Immunoaffinity column dNTP’s, 
Agarose.
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Bflldal=da=Haan
Ammonium persulphate, Bromophenol blue, DMF, Azur-eosin-methylene 
blue,EDTA Glucose monohydrate, Glycerol, Glycine, Hydrochloric acid, 
Magnesium chloride-6-hydrate, Potassium dihydrogen phosphate, Sodium 
chloride, Sodiun hydroxide, Sodium dihydrogen phosphate, Sodium 
hydrogen phosphate, TEMED.
Schleicher and Schull 
Nitrocellulose paper 0.45 |im.
Sigma
Acrylamide, Ammonium sulphate, Bis-acrylamide, BCIP, BSA, 
Chymotrypsin, E-64, Freunds adjuvants, Gentamycin, Neomycin, Heparin, 
Leupeptin, HEPES, Hypoxanthine, Leucine, Lysine, Magnesium sulphate, 
Maltose, NBT, Papain, Percoll, PMSF, RPMI 1640 (incomplete), Sodium 
azide, Sodium bicarbonate solution, Sodium bicarbonate, Sodium 
carbonate, Sodium citrate, SDS, SDS-PAGE molecular weight markers, 
TPCK, Trypsin, Trypsin inhibitor, Tween - 20.
Trinity College Dublin 
New Zealand white rabbits.
Whatman
CF11, 3MM filter paper.
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CHAPTER 3
RESULTS
Development of Plasmodium berghei erythrocyte invasion 
assays
To perform P. berghei invasion assays, specific techniques for 
purification and culturing the parasites were developed.
(a) Percoll purification of parasites
The first requirement of P. berghei invasion assays was 
synchronous mature-trophozoite-infected erythrocytes free from other 
parasitised erythrocytes and uninfected erythrocytes. For P. berghei a 
Percoll density gradient centrifugation step, the 'P. berghei 65-75-85 
Percoll’, was developed. This gradient routinely gave cell preparations 
containing >95% mature-trophozoite infected erythrocytes from a 
preparation of asynchronous infected erythrocytes. (Fig. 3.1 A and 3.1 B).
While this percoll step yielded cells containing the most mature 
trophozoites, they represented only 1-2% of the total number of parasitised 
erythrocytes. A second Percoll centrifugation step was developed therefore 
which yielded much greater amounts of parasite material. This 'P. berghei 
80 Percoll’ step resulted in cell preparations that contained >95% 
asynchronous parasitised erythrocytes and yielded enough parasite 
material for procedures such as RNA preparation.
(b) Culturing of parasites
Successful cultivation of P. berghei was a requirement not only of 
invasion assays, but for RNA preparation and protein extract preparation as 
it was necessary to cultivate the parasites in order to obtain schizonts. A 
culture medium was developed consisting of 50% RPMI 1640/50% FCS. 
When purified mature-trophozoite infected erythrocytes were cultured for 6 
h in this medium, they continued their development to schizogony (Fig 
3.1 C). On being added to target erythrocytes in fresh medium, the parasites 
ruptured their erythrocytes and released merozoites which invaded the new 
erythrocytes. Nineteen hours after adding the parasitised cells to the 
uninfected cells the percentage of newly invaded erythrocytes could be 
estimated by counting the number of erythrocytes containing ring-stage or 
young trophozoite parasites (Fig. 3.1 D). In all experiments, invasion into 
erythrocytes from rabbits or humans acted as controls for background 
invasion. Any parasites observed in these controls were mature
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trophozoites and were therefore introduced with the infected mouse 
erythrocytes as ring-stage parasites.
(a) Invasion of reticulocytes and mature erythrocytes by P. 
berghei merozoites
The preferential invasion of reticulocytes by P. berghei merozoites 
both in vivo and in vitro is well documented (Ramakrishnan & Prakash,
1950; Janse etal., 1984, 1989; Suhrbier etal., 1987). The results from our 
invasion assays, presented in Fig. 3.2, confirm these observations. In the 
in vitro invasion assay using target erythrocytes from 8 to 10-week-old mice 
an invasion rate of 0.5-2% was routinely observed (Fig. 3.2, Exp. 2 and 3). 
Reticulocyte counts in these mice were usually 0.5-1.5%. Only in one case 
was a higher invasion level observed using these erythrocytes (Fig. 3.2,
Exp. 1), however the reticulocyte count in the blood of the animal was 11%, 
which was unusually high for an animal of that age.
In an attempt to improve invasion levels, erythrocyte preparations 
from very young mice were used. These preparations contain higher 
reticulocyte counts than preparations from older animals. In two 
experiments shown (Fig. 3.2, Exp. 1 and 2), the reticulocyte counts of the 2- 
week-old mice were 29% and 17.7% and the respective invasion levels 
were 3.9% and 5.1%, indicating a greater invasion level for reticulocyte-rich 
preparations. The lower level of invasion in Exp. 1 compared to Exp. 2 was 
attributed to variation between experiments.
Phenylhydrazine treatment was used to obtain erythrocyte 
preparations with even higher reticulocyte counts. The reticulocyte count 
was >50% on days 6 , 8 and 10 during phenylhydrazine treatment, using the 
protocol outlined. When these cell preparations were used in invasion 
assays, the observed invasion levels increased greater than 7-fold over that 
obtained with normal erythrocytes (Fig. 3.2, Exp 1, 2 and 3).
(b) P. berghei merozoite invasion into erythrocytes obtained 
from various murine strains.
Three strains of mice (Balb/c, Schofield and CD-1) were treated 
similarly phenylhydrazine and their erythrocytes tested in invasion assays 
and compared to normal erythrocytes of the same strain. In Exp. 3 (Fig. 3.2) 
invasion levels into Balb/c was higher than into the other two strains, this
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was attributed to experimental variation, as in Exp. 2 (Fig. 3.2) the invasion 
levels into Balb/c and Schofield mice were almost identical.
(c) P. berghei merozoite invasion into enzyme treated murine 
erythrocytes
The effect of enzyme treatment of the target erythrocyte preparations 
on the P. berghei merozoite invasion was examined. As P. berghei 
invasion levels into normal erythrocyte preparations were too low to allow 
any significant conclusions to be made, these studies were carried out 
using reticulocyte-rich preparations. As can be seen in Table 1, treatment of 
the erythrocytes with the proteinases chymotrypsin, trypsin and papain (100 
|ig/ml) resulted in significant reduction in invasion levels compared to 
untreated cells; merozoite invasion was 42%, 8% and 28% of controls, 
respectively.
Neuraminidase treatment of target erythrocytes resulted in a slight (82% of 
control), but not significant reduction in P. berghei merozoite invasion 
compared to untreated cells (Table 1).
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TABLE 1.
Invasion of P. berahei merozoites into enzvme t reated murine ervthrocvtes 
in vitro
Treatment Invasion %*
Control (no treatment) 100
Chymotrypsin 100 |ig/ml 42
-(50U/mg) 10 ng/ml 66
Trypsin 100 (ig/ml 8
-(10,000 U/mg) 10 |ig/ml 21
Papain 100 |ig/ml 28
-(20 U/mg) 10 |ig/ml 77
Neuraminidase 50 mU/ml 82
* Invasion is expressed as a percentage of merozoite invasion into 
controls (untreated murine erythrocytes). Typically these controls had 
invasion levels of between 5% and 8% (ring-stage parasitised erythrocytes 
expressed as a percentage of total erythrocytes). Erythrocyte preparations 
used in these invasion assays contained >50% reticulocytes.
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Binding of radiolabelled P. berghei proteins to murine 
erythrocytes
The binding of P. berghei metabolically labelled proteins to 
erythrocytes was investigated by mixing P. berghei 35S-labelled proteins 
with erythrocytes. Molecules that bound to erythrocytes were eluted with 
NaCI and analysed by reducing SDS-PAGE and fluorography.
P. berghei incorporated 35S-methionine into many of its proteins 
during the 6 h labelling culture (Fig. 3.3, lane 1). When these labelled 
proteins were mixed with murine erythrocytes a 130 kDa molecule 
selectively bound to the cells and could be eluted with 1.5 M NaCI (Fig. 3.3, 
lane 2). Erythrocytes from rats, rabbits, or guinea pigs failed to bind any P. 
berghei labelled protein (Fig. 3.3, lane 3, 4 and 5). A similarly sized 
molecule, which also bound selectively to murine erythrocytes had
previously been shown to be 35S-labelled in vitro byP. c. chabaudi (O’ 
Donovan, S., PhD Thesis and Fig. 3.4A, lane 7).
Binding assays were carried out comparing the binding of the P. 
berghei 130 kDa molecule and the P. c. chabaudi 130 kDa to enzyme 
treated murine erythrocytes (Fig. 3.4A). Neither molecule bound to murine 
erythrocytes treated with the proteinases chymotrypsin (100 ^ig/ml), trypsin 
(100 |ig/ml) or papain (100 (ig/ml), (Fig. 3.4A, lanes 3-5 and 8-10). 
Neuraminidase treatment of erythrocytes didn’t affect the binding of the 130 
kDa molecule from either species.The effect of enzyme treatment on the 
binding of the P. berghei 130 kDa was the same with both reticulocyte rich 
and normal erythrocyte preparations.
Binding assays were also carried out examining the binding of the 
P. berghei 130 kDa to erythrocyte preparations containing varying amounts 
of reticulocytes (Fig. 3.4B). Erythrocytes from a phenylhydrazine treated 
mouse were mixed with erythrocytes from a similarly aged and sexed 
untreated-mouse in varying proportions to give 3 preparations of cells with 
differing reticulocyte populations. Preparations A, B and C contained 3.8%, 
23% and 46% reticulocytes respectively. From densitometric analysis of the 
autoradiograph, the amount of the 130 kDa molecule in prep. B (Fig. 3.4B, 
lanes 3) and prep.C (Fig. 3.4B, lane 4) is only 60% and 32% respectively of
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the amount in prep. A (Fig. 3.4B, lane 2). This indicated an inverse 
relationship between the % of reticulocytes in the erythrocyte preparation 
and the binding of the 130 kDa P. berghei molecule.
Immunoprécipitation of 3 5 S-labelled P. berghei proteins with 
various antisera
The antisera used in radio-immunoprecipitations were as follows
(1) Anti-C1 : Rabbit antiserum generated against 'C1 Extract ‘ as described 
in METHODS.
(2) Balb/c 4.3 antiserum : Serum collected from balb/c mouse that had 
cleared P. berghei infection.
(3) Anti-TCS : Antiserum raised by S. O’ Donovan using spent culture 
media from a P.c. chabaudiculture as antigen (S. O’ D., PhD Thesis).
The pattern of the proteins immunoprecipitated by the antisera are 
shown in Fig. 3.5. A sample of the Hot Pellet Extract used in the 
immunoprécipitation and the 130 kDa eluted from murine erythrocytes in a 
binding assay are included on lanes 1 and 8 respectively.
As expected the anti-C1 antisera precipitated a large number of 
labelled proteins (lane 5), the most prominent of which were the pair at -42 
kDa, the single protein at -55 kDa and a doublet at -119 kDa.
The balb/c 4.3 antiserum also precipitated a range of proteins (lane 
6), particularly strongly the ~55kDa protein as well as molecules of -90 kDa 
and 110 kDa. The most interesting molecules precipitated by this sera 
however were the doublet at -130 kDa. The lower band of this doublet 
comigrated to the 130 kDa eluted in binding assays (lane 8). A similar 
doublet appeared in the anti-C1 immunoprecipitated proteins (lane 5), 
although at a much lower intensity. The arced protein bands at -55 kDa in 
lanes 5 and 6 are probably due to presence of large amounts of 
immunoglobulin at this position in the gel.
The anti-TCS sera precipitates a protein of -42 kDa, as well as a 
slightly smaller protein (lane 7). There is a faint doublet, precipitated with 
the anti-TCS, comigrating with the 130 kDa band of the binding assay 
(compare lane 7 and 8). As with the doublet precipitated with balb/c 4.3 
antiserum, the lower band of this doublet corresponds with the 130 kDa 
molecule eluted in the binding assay. No P. berghei protein was 
precipitated by any of the control sera (Fig. 3.5, lanes 2, 3 and 4).
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Preparation of cDNA library
(a) mRNA isolation and cDNA synthesis
The RNAzol B method for RNA isolation yielded approximately 500
|ig RNA from 101® cultured parasitised erythrocytes. The integrity of the 
RNA was assessed by running a sample on a denaturing RNA gel (Fig 
3.6A). The markers used were E. coli rRNA, which contains 16S and 23S 
rRNA (lane 1). This analysis indicates that the P. berghei rRNA bands are 
the 5S, 18S and 28S typical of eukaryotic rRNA (lanes 2 and 3). The 
ribosomal RNA bands of the P. berghei RNA were seen as sharp bands 
indicating no RNase activity (lanes 2 and 3). There was a diffuse 
background of mRNA spread throughout the entire gel. The A260/28O 
this RNA was 1.9.
Passage of all 500 |ig RNA over the oligo dT column yielded 5 ng
poly(A)+ mRNA. This was used in first and second strand synthesis. A 
fraction of the reaction from the completed second strand synthesis was run 
on an agarose gel alongside 0X174 x Haelll markers (Fig. 3.6B, lanes 3 
and 1 respectively). A very diffuse smear of cDNA, up to approximately 
1500 bp, can be seen in lane 3. Larger cDNA may have been synthesised, 
but was too diffuse to visualise.
This cDNA was also analysed by PCR, using primers 142 and 143, 
which were constructed from the known sequence of the P. falciparum EBA- 
175 (Fig 3.6C). Both P. berghei genomic DNA and the synthesised cDNA 
gave a 200 bp PCR product when amplified using primers 142 and 143 
(lanes 5 and 3 respectively).
(b) Ligation and packaging of cDNA into gt11 arms
After methylatlon and linker addition, 200 ng of cDNA was ligated to 
500 ng gt11 arms and packaged. The efficiency of packaging for the cDNA
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library was calculated as 1 x 105 recombinants per |ig packaged DNA. A 
control ligation reaction was carried out with just the gt11 arms and no 
insert DNA. This was packaged and the efficiency of packaging calculated
as 1 x 102 recombinants per (ig DNA. The cDNA library was amplified to
10™ pfu/ml and the control recombinants were used as a source of wild- 
type gt11.
(c) Screening of cDNA library with 3 2 P-labelled JA159
The probe used was a 40-mer oligonucleotide synthesised from the 
known internal sequence of the PCR product amplified from P. berghei 
genomic DNA using primers 142 and 143. The oligo was then end labelled
with 32P using T4 polynucleotide kinase.Several attempts were made at 
screening the library with the hot probe. Each time approximately 50,000 
recombinants were screened. While the labelled JA159 was found to 
hybridise strongly to the 200 bp PCR product on southern blots, it failed to 
pick out true positives from the library. Any 'primary positives1 that were 
picked failed to give 'secondary positives’ and were thus assumed to be 
false.
The stringency of the post-hybridisation washing was reduced by 
washing with 6X SSC, 0.02% SDS and by reducing the temperature of the
final wash down to 45°C. These measures however didn’t result in the 
identification of any true positives.
(d) Immunoscreening of cDNA library
Two different antisera were used in the immunoscreening of the 
cDNA library,
(i) Anti-TCS antisera prepared by Susan O’Donovan (S. O’D., PhD. Thesis).
(ii) Anti-C1(+100 kDa) antisera
(i) ANTI - TCS
The anti-TCS antisera was raised against spent media from a P.c. 
chabaudi culture but was nonetheless reactive against a range of P. 
berghei proteins, as can be seen from the immunoprécipitations (Fig. 3.5, 
lane 7).
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Twenty plates with -3000 pfu each were used in the primary 
screening with a 1/500 dilution of preabsorbed anti-TCS. After 2 rounds of 
purification a total of 20 'tertiary positives* were chosen for further 
investigation. Each of the 20 positives were amplified and DNA was 
extracted. The size of the insert in each positive clone was then determined 
by PCR, using the lambda forward and reverse primers (Fig 3.7A).The 
clones were then classified on the basis of this size of the PCR product.
Group 1 PCR product ~1400 bp Clones 4A1, 4A2, 17, 20.2,14.3.
Group 2 PCR product-1300 bp Clones 14.2.
Group 3 PCR product-2000 bp Clones 14.1, 19.1, 19.2, 19.3.
Group 4 PCR product-300 bp Clones 16.1.
The remainder of the 20 ' tertiary positives ‘ didn’t produce a PCR 
product and were disregarded. Clone 20.2 produced 2 PCR fragments, the 
largest of which corresponded to the 1400 bp PCR product of group 1.
Grouping of the clones into 4 classes was confirmed by EcoR1 
digestion of the lambda DNA, followed by gel analysis (Fig. 3.7B). The 
insert size determined by EcoR1 digestion was -100 bp less than the size 
of the corresponding PCR product as was expected. It was probable that 
there wasn’t sufficient DNA from clone 16.1 digested to enable the 200 bp 
insert to be seen. Clone 14.2 had an insert of -1200 bp similar to it’s PCR 
product.The inserts corresponding to the PCR product of 2 Kb (group 3), 
had an internal restriction site for EcoR1, as it produced fragments of -1400 
bp and -600 bp upon digestion (Fig. 3.7B, lanes 21-24). The clones from 
group 1 also contained an insert with an internal restriction site producing 
restriction fragments of -1000 bp and -300 bp (Fig. 3.7B, lanes 4-8). There 
was insufficient DNA from clones 20.2, 4A1 and 4A2 digested to see the 
smaller restriction fragment (Fig. 3.7B lanes 5,7 and 8).After elimination of 
clone 20.2, because of the multiple PCR products, 10 clones remained for 
further investigation.
(ii) ANTI-C1 (+100 kDa)
The anti-C1 antisera was reactive against a range of P. berghei 
proteins as can be seen from its immunoprécipitation of labelled proteins in 
Fig. 3.5 (lane 5).
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The antisera used in this screening was a fraction of the anti-C1 
antisera that had been absorbed to and eluted from C1 proteins >100 kDa 
bound to nitrocellulose. This antisera should preferentially select for 
recombinants whose native protein is >100 kDa.
Twelve plates with -3000 pfu each were screened with a 1/5 dilution 
of the anti-C1 sera fraction prepared as described. Twenty-five 'primary 
positives’ were reduced to 16 positives after 4 rounds of purification. DNA 
was purified from all 16 clones and the insert size determined by PCR 
using the Lambda forward and reverse primers (Fig. 3.8A and 3.8B).
Clones K, Q and U amplified fragments of 1800 bp, 2000 bp and 650 bp 
respectively. All the other clones gave PCR products of between 1300 bp 
and 1500 bp, except O and G which gave no PCR product and were 
discarded. Clone D was the largest of the 1300-1500 bp group followed by 
clones C, H, L, M, N, P, S and V which all appeared to have the same size 
insert. The clone J insert was slightly smaller than this group’s, clone A 
having the smallest insert at approximately 1300 bp. These remaining 14 
clones were further investigated.
DNA from the 10 clones isolated by anti-TCS antisera and the 14 
isolated by the anti-C1(+100 kDa) antisera were used in PCR with primers 
142 and 143. These primers were constructed from the known sequence of 
the 3’ cysteine rich region of the P. falciparum EBA-175. No clone gave any 
PCR product. When DNA was extracted from the total phage library and 
used in this PCR, no fragment was amplified.
Preparation of fusion proteins
The following methods were used to make fusion proteins from the 
phage clones which had been selected from the P. berghei cDNA library by 
immunoscreening,
(a) Preparation of lysogens
Lysogens of many of the immunoselected phage clones and wild- 
type phage were generated in E. coli Y1089 as described. After induction 
of the lytic cycle and fusion protein production, extracts of these lysogens 
were separated by reducing SDS-PAGE, transferred to nitrocellulose and 
probed with anti-B-galactosidase antibody. Fig. 3.9 contains an immunoblot
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of 2 extracts of E. coli infected with wild-type, clone K and clone 14.2 (lanes 
1 &2, 4&5 and 6&7 respectively). The antibodies were reactive with the 6- 
galactosidase band in the extracts of E. coli infected with wild-type phage 
(Fig. 3.9, lane 1 and 2). Many other proteins were also visualised with the 
sera. The sera did not detect any protein in the extracts of E. coli infected 
with recombinant phage that was unique to them i.e. all bands observed 
were also present in the wild-type infected E. coli ex tracts.
(b) Plate Wash Supernatant method
Fig. 3.10 shows a coomassie stained gel of Plate Wash 
Supernatants of several immunoselected clones. The 6-galactosidase 
protein is abundant in wash supernatants of E. coli infected with wild-type 
phage (Fig. 3.10, lanes 2 and 8). The wash supernatants from the 
immunoselected clones did not contain this 6-galactosidase (Fig. 3.10, 
lanes 3-7, 9 and 10). No protein was detected in the wash supernatants of 
E. coli infected with the immunoselected clones that wasn’t present in the 
wash supernatant of the E. coli infected with wild-type phage.Similar results 
were obtained for all the clones selected by anti-TCS or anti-C1(+100 kDa).
Analysis of recombinant clones isolated from P. falciparum  
gametocyte cDNA library
Lambda clones and Rg were selected from a P. falciparum 
gametocyte cDNA library in gt11 by immunoscreening with an antiserum 
fraction that was specifically reactive against P. falciparum sexual stage 
antigens.
(a) DNA analysis
The clones Rt and Rg were first titred and plated on phage 
competent cells at -100 pfu per plate. Single plaque plugs were picked, the 
phage amplified and DNA extracted. The DNA was then used in PCR with 
the lambda forward and reverse primers. The Rg clone amplified multiple 
fragments, the strongest of which were fragments of -290 bp and -600 bp, 
while the Rt clone amplified a fragment of -350 bp (Fig 3.11, lanes 1-3 and 
lane 4 respectively). Multiple fragments were amplified from every phage 
isolate of Rg.
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Attempts to EcoR1 digest the Rt lambda DNA in order to confirm the 
size of the insert proved unsuccessful. One of the EcoR1 sites may have 
been damaged.The Rj DNA was therefore digested with Kpn1 and Sac1 
(Fig. 3.12A). These two enzymes have restriction sites on either side of the 
cloning EcoR1 site, and produce a 2.1 Kb fragment when used on wild-type 
gt11 DNA (Fig. 3.12A, lane 1).This fragment still contains the EcoR1 cloning 
site of gt11. When Rt DNA was restricted with these Kpn1 and Sac1, a 
fragment migrating at 2.4-2.5 Kb was observed, indicating an insert of 300- 
400 bp (Fig. 3.12A, lane 2).The fragment excised with Kpn1 and S ad  from 
both wild type DNA (fragment L) and Rt DNA (fragment U) were cut from the 
gel and PCR amplified with the lambda forward and reverse primers. Rt 
phage DNA and wild-type phage DNA were similarly PCR amplified as a 
positive and negative control.The PCR reactions were analysed by agarose 
gel electrophoresis (Fig. 3.12B). A 350 bp fragment was amplified from 
fragment U and from the Rt phage DNA (Fig. 3.12B, lanes 3 and 5 
respectively).This indicates that the Kpn1/Sac1 restriction fragment of Rt 
DNA contains an insert in the EcoR1 cloning site. No product was amplified 
from the L band or from wild-type phage DNA (Fig. 3.12B, lane 2 and 4 
respectively).
(b) Production of fusion protein
Lysogens of phage R^were generated in E. coli Y1089. Preparation 
of fusion protein from these lysogens proved unsuccessful as the cells 
always ruptured within 20 min of the induction of the lytic cycle. If the culture 
was stopped short of this time the cells ruptured during the first 
centrifugation step no matter what temperature it was carried out at.
The Plate Wash Supernatant method was then used to produce 
fusion protein. When the wash supernatant from both Rt and Rg plates were 
analysed by reducing SDS-PAGE, a large protein not found in the wild-type 
wash supernatant was present in the Rt supernatant. Fig. 3.13 shows an 
immunoblot of plate wash supernatants of Rt , Rg and wild-type probed with 
anti-13-galactosidase (Fig. 3.13, lanes 1, 2 and 3 respectively). A protein 
from clone Rt (Fig. 3.13, lane 1) which was larger (-150 kDa) than wild-type 
(3-galactosidase (Fig. 3.13, lane 3) was reactive with anti-13-galactosidase. 
The antibody did not recognise any proteins in the Rg wash supernatant
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that was unique to it, i.e. all reactive proteins were also present in the wild- 
type wash supernatant (compare lanes 2 and 3).
(c) Purification of Rt recombinant protein.
An anti-B-galactosidase immunoaffinity column was used to prepare 
fusion protein from the Rf and wild-type plate wash supernatants.The wild- 
type plate wash supernatant was passed over the column and the B- 
galactosidase eluted. The column was then reequilibrated and the fusion 
protein purified from the Rf wash supernatant. The elution was performed 
with 3 x 1 ml high-pH (10.2) elution buffer, followed by 1 ml TBS. A sample 
of each of these elution fractions was analysed on reducing SDS-PAGE 
(Fig. 3.14A), transferred to nitrocellulose, and probed with an anti-B- 
galactosidase antibody (Fig. 3.14B). Most of the wild-type B-galactosidase 
and fusion protein was present In their respective second and third eluted 1 
ml fractions (Fig. 3.14B, lanes 2&3 and 8&9 respectively). There appeared 
to be B-galactosidase remaining on the column after the first series of 
elutions which was subsequently eluted with the Rt fusion protein.
Fractions 2 and 3 of the eluted Rt fusion protein were combined and 
their protein concentration calculated as 10 |ig/ml. Fractions 2 and 3 of the 
wild-type B-galactosidase were combined and their protein concentration 
calculated as 20 fig/ml. Five (ig of each preparation was then used in each 
rat immunisation.
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FIG. 3.1. Purification of Plasmodium berghei mature trophozoite-infected 
erythrocytes, in vitro culturing, and reinvasion. Blood from an infected 
Balb/c mouse (A) was layered onto a step-wise Percoll gradient as 
described (METHODS). After centrifugation the erythrocytes infected with 
mature trophozoites banded on the top (B) and were removed, washed and 
maintained in vitro for 6 h (C) before adding to target erythrocytes. 
Reinvasion was assessed by estimating the percentage ring-stage 
parasites in erythrocytes 19 h later (D, arrowed). Panel D shows reinvasion 
into erythrocytes obtained from phenylhydrazine-treated mice.
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FIG. 3.2. Invasion of erythrocytes in vitro by Plasmodium berghei.
Exp. 1, comparison of P. berghei invasion rates into erythrocytes obtained 
from 8-week-old mice, 2-week-old mice, phenylhydrazine-treated 8-week- 
old mice (all Balb/c), rabbit and human.
Exp.2, comparison of invasion rates into erythrocytes of 8-week-old Balb/c 
mice, 2-week-old Balb/c mice and phenylhydrazine treated 8-week-old 
Balb/c and Schofield mice.
Exp. 3, comparison of invasion rates into erythrocytes of normal and 
phenylhydrazine-treated 8-week-old Balb/c, CD-1 and Schofield mice. 
Percentages at the top of columns represent reticulocyte counts of each 
particular target erythrocyte preparation. Shaded columns refer to cell 
preparations from phenylhydrazine-treated mice.
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FIG. 3.3. Binding of the Plasmodium berghGi 130 kDa molecule to 
erythrocytes obtained from various mammals. Binding assays were carried
out by mixing 35S-labelled Hot Pellet Extract of P. berghei (lane 1) and 
erythrocytes from Balb/c mouse (lane 2), rat (lane 3), rabbit (lane 4) and 
guinea pig (lane 5). Molecules that bound to erythrocytes were eluted with 
1.5M NaCI and visualised by reducing SDS-PAGE and fluorography.
FIG. 3.4A. Binding of the Plasmodium berghei and Plasmodium chabaudi
chabaudi 130 kDa molecule to enzyme-treated murine erythrocytes.35S- 
labelled Hot Pellet Extract of P. berghei (lane 1) and P. c. chabaudi (lane 6) 
were mixed with murine erythrocytes (lanes 2-5 and 7-10 respectively). The 
erythrocytes were untreated (lanes 2 and 7), treated with 100 ng/ml 
chymotrypsin (lanes 3 and 8),100 |ig/ml trypsin (lanes 4 and 9) or 100 (ig/ml 
papain (lanes 5 and 10). Molecules bound to erythrocytes were eluted with 
1.5M NaCI and visualised by reducing SDS-PAGE and fluorography.
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FIG. 3.4B. Binding of the Plasmodium berghei 130 kDa molecule to cell 
preparations containing varying amounts of reticulocytes. P. berghei^^S- 
labelled Hot Pellet Extract (lane 1) was used in binding assays with 3 
erythrocyte preparations (A,B and C), which contained 3.8% (lane 2), 23% 
(lane 3) and 46% (lane 4) reticulocytes respectively. Bound molecules were 
eluted with 1.5M NaCI and analysed by reducing SDS-PAGE and 
fluorography.
FIG. 3.5. Immunoprécipitation of 35S-labelled Plasmodium berghei 
proteins. Hot Pellet Extract of P. berghei (lane 1) was used in 
immunoprécipitation reactions with antl-C1 antiserum (lane 5), Balb/c 4.3 
serum (lane 6), and anti-TCS antiserum (lane 7). Precipitation reactions 
using control rabbit, mouse and rat serum were also carried out (lanes 2, 3 
and 4 respectively). The P. berghei 130 kDa erythrocyte binding protein is 
shown in lane 8.
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FIG. 3.6A. Purification of Plasmodium berghei RNA using RNAzol B. Two 
different samples of P. berghei RNA prepared by the RNAzol method were 
analysed on a 0.8% reducing agarose gel (lanes 2 and 3), in parallel with 
E  coli RNA standards (lane 1).
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FIG. 3.6B. Plasmodium berghei cDNA synthesis. A sample of the completed 
second strand cDNA synthesis reaction was analysed on a 2% agarose gel 
(lane 3). 0X174 x Haelll markers and undigested gt11 and were run in 
parallel (lanes 1 and 2 respectively).
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FIG. 3.6C. PCR Amplification of 200 bp sequence using primers 142 and 
143. Samples of PCR reactions using synthesised P. berghei cDNA and P. 
berghei genomic DNA as template were run on a 2% agarose gel (lane 3 
and 5 respectively). Lanes 1, 2 and 4 contained negative controls (no 
template, no dNTP’s and no polymerase respectively) and 0X174 x Haelll 
were run in parallel (lane 6) as markers.
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FIG. 3.7A. PCR Amplification of inserts in gt11 clones (immunoselected by
anti-TCS antiserum) using lambda forward and reverse primers. A sample
of each PCR reaction was analysed on a 2% agarose gel.
lanes 1-6 clones 16.1, 14.3, 14.2, 14.1, 13.1 and 12.2.
lanes 9-13 clones 11.4, 11.3,11.2, 4A2 and 4A1.
lanes 16-19 clone 19.3, negative control, clones 20.2, 19.3.
lanes 22-27  clones 19.2, 19.1, 18.4, 18.3,17 and 16.2.
lanes 7, 14, 15, 20 and 28 x HinDIII
lanes 8 and 21 0X174 x Haelll
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FIG. 3.7B. EcoR1 digestion of DNAfrom gt11 clones immunoselected by 
anti-TCS antiserum. A sample of EcoR1 digested and undigested DNA from 
each clone was run on a 2% agarose gel
Group 1 14.3, 20.2, 17, 4A2, 4A1.
Group 2  14.2.
Group 3 19.3,19.2,19.1,14.1.
Group 4 16.1.
clone 16.2. 
x HinDIII 
0X174 x Haelll
lanes 4-8 cut, lanes 11-15 uncut.
lane 1 cut, lane 2 uncut.
lanes 21-24 cut, lanes 26-29 uncut.
lane 17 cut, lane 19 uncut.
lane 16 cut, lane 18 uncut.
lanes 9,25.
lanes 3, 20.
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FIG, 3.8A. PCR amplification of inserts of gt11 clones immunoselected by 
anti-C1(+100 kDa) antiserum using lambda forward and reverse primers. 
Samples of each PCR reaction were analysed on a 2% agarose gel.
lanes 2-5. 
lanes 7-10. 
lanes 15-18. 
lanes 20-23. 
lane 14
lanes 1, 12, 13, 25.
clones L, K, J, H. 
clones G, D, C, A. 
clones V, U, S, Q. 
clones P, O, N, M. 
PCR negative control, 
x HinDIII.
lanes 6, 11, 19,24. 0X174 x Haelll.
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FIG. 3.8B. PCR amplification of inserts of gt11 clones immunoselected by
anti-C1(+100 kDa) antiserum, using lambda forward and reverse primers.
Samples of PCR reactions were analysed on a 3% agarose gel
lanes 1, 2, 4, 5. clones U, Q, K, C.
lanes 7, 8, 9. clones L, M, A.
lanes 11, 12, 13. clones J, H, D.
lanes 3, 6, 10, 14. 0X174 x Haelll.
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FIG. 3.9. Western blot of cell extracts of lysogens prepared from 
immunoselected phage clones. Cell extracts of wild-type (lanes 1&2), clone 
K (lanes 4&5) and clone 14.2 (lane 6&7). lysogens were separated by 10% 
reducing SDS-PAGE, transferred to nitrocellulose and probed with an anti- 
0-galactosidase antibody. The cell extracts examined were samples of the 
inclusion bodies pellet (lanes 2, 5 and 7), and the TBS-EDTA-TRITON-X 
washes of the inclusion bodies’ pellet (lanes 1, 4 and 6) prepared as 
described in METHODS.
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FIG. 3.10. Production of fusion proteins by Plate Wash Supernatant method. 
Fifty |il of Plate Wash Supernatants from clones immunoselected by anti- 
TCS antiserum or anti-C1(+100 kDa) antiserum were analysed by 10% 
reducing SDS-PAGE.
lane 1 prestained molecular weight markers. 
lanes 2, 8 wild-type.
lanes 3-7 clones 19.3,19.2,16.1,14.3,14.2.
lanes 9,10 clones C, A.
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FIG. 3.11. PCR amplification of Inserts in gt11 clones Rt and Rg using 
lambda forward and reverse primers. Samples of the PCR amplification 
reaction of 3 distinct isolates of clone Rg (lanes 1 -3) and of clone Rt (lane 4) 
were analysed on a 2% agarose gel in parallel with 0X174 x Haelll 
markers (lane 5). The negative control for PCR was a reaction without 
template DNA (lane 7) and gt11 DNA as template was used as a positive 
control (lane 6).
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FIG 3.12A. Digestion of phage DNA from wild-type gt11 and clone Rt using 
Kpnl and Sacl. Five jug of wild-type and Rt DNA was digested with 10 U of 
Kpnl and Sacl each and the reaction products analysed on a 2% agarose 
gel (lanes 1 and 2 respectively). Lane 3 contained x HinDIII markers. 
Bands L and U refer to the Kpnl/Sacl restriction fragment from wild-type and 
Rf DNA which contains the EcoRI restriction site or insert DNA.
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FIG. 3.12B. PCR amplification of inserts from fragments U and L using 
lambda forward and reverse primers. Restriction fragments U and L were 
cut from a gel similar to that in Fig. 3.12A and the DNA separated from the 
agarose by centrifugation through glass wool (10,000 x g, 10s).These DNA 
preparations were then used as template in PCR amplification with lambda 
forward and reverse primers. Samples of the PCR amplification reactions of 
bands L and U were analysed on a 2% agarose gel (lanes 2 and 3 
respectively) alongside gt11 x HinDIII markers (lane 1). The negative 
control for PCR was a reaction without template (lane 4) and the positive 
control used Rt DNA as template (lane 5).
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FIG. 3.13. Analysis of Plate Wash Supernatants of clones Rt and Rg for 
fusion protein. Samples of Rt, Rg and wild-type phage Plate Wash 
Supernatant were analysed by 10% reducing SDS-PAG (lanes 1, 2 and 3 
respectively), in parallel with prestained molecular weight markers. The gel 
was transferred to nitrocellulose and immunoblotted using anti-f3- 
galactosidase antibody.
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FIG. 3.14A. Purification of fusion protein from Plate Wash Supernatants of 
clone Rt and wild-type phage. Ammonium sulphate precipitates of the Plate 
Wash Supernatants of wild-type and Rt phage infected E. co//were applied 
to the immunoaffinity column, and eluted in 1 ml fractions. These fractions 
were analysed by 10% reducing SDS-PAG. Lanes 1-4 contain samples of 
the fractions consecutively eluted from the purification from the wild-type 
batch. Lanes 7-9 contain samples of the fractions eluted from the Rt batch. 
A sample of the ammonium sulphate precipitate of the Rt supernatant (lane 
6) and prestained molecular weight markers (lane 5) were included on the 
gel. The protein band labelled Rt refers to the Rt fusion protein.
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FIG. 3.14B. Immunoblot of fusion proteins purified on immunoaffinity 
column. A gel as shown in Fig. 3.14A was transferred to nitrocellulose, and 
probed with antl-6-galactosidase antibody. Lanes 1-4 contain samples of 
the fractions consecutively eluted from the purification from the wild-type 
batch. Lanes 7-9 contain samples of the fractions eluted from the Rt batch. 
Lane 6 contains a sample of the ammonium sulphate precipitate of the 
plate wash supernatant. The reactive band labelled Rj refers to the Rj fusion 
protein.
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1.Development of erythrocyte invasion assays for Plasmodium 
berghei
Invasion assays have been developed for several Plasmodium 
species, including P. knowlesi, P. falciparum, and P. vivax (Mason et al., 
1977; Miller et al., 1977; and Barnwell et al., 1989 respectively). These 
assays are essential for investigating the molecular intricacies of 
erythrocyte invasion by merozoites either at the ultrastructural level using 
electron microscopy, or at the molecular level using antibodies or other 
reagents which promote or hinder invasion. The invasion assay that we 
have developed for P. berghei is similar to those described for the primate 
species that use schizont infected erythrocytes as a source of merozoites, 
but involves additional steps due to the nature of this particular rodent 
malaria.
The first requirement for the development of a P. berghei invasion 
assay was to find a media that would support the growth of all stages of the 
parasite.The most successful reports of in vitro cultivation of the asexual 
stages of P. berghei were those of Mons et al. (1983) and Janse et al. 
(1984) using a novel suspension system. They achieved continuous 
cultivation of the parasite for up to 90 days, parasitaemias were maintained 
at 7-8% and the average multiplication rate was between 3-3.4 (Janse et 
al., 1984). The length of the schizogonic cycle was similar to that in vivo. 
However they found that continuous agitation of the culture was necessary. 
Furthermore, the culture required the use of rat reticulocytes to maintain 
high invasion rates. RPMI based preparations are the most commonly used 
media for malarial work since the report of continuous cultivation of P. 
falciparum by Trager and Jensen (1976). The media used by Mons etal. 
(1983) was essentially that of Trager and Jensen (1976) except that heat- 
inactivated FCS and neomycin replaced the human serum and gentamycin 
components of Trager and Jensen’s media.
We wished to examine P. bergrfre/'intra-erythrocytic growth in mouse 
erythrocytes using simple static cultures. Initially we assessed the affect of 
various types and concentrations of serum in serum/RPMI based media on 
P. berghei intra-erythrocytic development by setting up short-term low- 
density cultures of parasitised blood. We found that 50% heat-inactivated 
FCS in RPMI supported the development of trophozoites to segmentors.
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Merozoites subsequently ruptured the erythrocytes and invaded fresh 
erythrocytes. In in vivo P. berghei infections, schizont and segmentor forms 
of the parasite sequester in the deep vasculature and are not seen in, nor 
can be obtained from the circulation. Schizonts are a necessary 
requirement for invasion assays, and their development in our media, and 
the production of invasive merozoites was a good indication of its suitability 
for P. berghei.
The high percentage of FCS in our media probably served to supply 
some of the complex nutritional requirements of the parasite, as well as 
buffering the media. Also In our hands, murine erythrocytes, whether 
infected or not, were quite fragile and prone to lysis, and another necessity 
for such a FCS-rich media may have been related to this fragility. FCS 
would have increased the viscosity of the media which may have helped to 
stabilise the extracellular merozoite and the intraerythrocytic parasite. 
Lanners (1992) reports the use of methylcellulose in a media developed for 
the similar malaria P. vivax in order to increase the viscosity of the media 
and increase the stability of the cells.
The schizonts used in invasion assays had also to be highly purified 
and synchronous. Purification of schizont-infected erythrocytes from non­
infected erythrocytes ensures that scored invasions are only as a result of 
invasion into the intended target cells. Synchronisation ensures that scored 
invasions occur within the time-scale of the assay and are not carry-over 
ring-stages from the introduced parasite population. The P. berghei 65-75- 
85 Percoll Step was developed from the procedure and reagents described 
by Wunderlich et al. (1985) and served to both purify and synchronise the 
mature trophozoites from an asynchronous preparation of infected blood. 
This density gradient centrifugation step was rapid and simple to perform 
and the percoll was non-toxic to the parasites. Yields of >95% pure, 
synchronous trophozoite-infected erythrocytes were routinely achieved. 
This proved to be a much simpler method for obtaining synchronous 
parasites to that described by Mons et al. (1985) which involved in vitro 
culturing followed by in vivo passage through rats and which resulted in 
preparations of very low purity.
The invasion assays involve an initial culturing of the pure, 
synchronous trophozoite-infected erythrocytes at a density of 2.5 x
107cells/ml for 5-6h prior to transferring 5 x 106 (0.2 ml) of these cells into
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fresh media (0.8 ml) containing 2 x 107 target erythrocytes. The cell 
concentrations were kept relatively low and the media change was found 
quite necessary as even in our well buffered media (50% FCS and 20mM 
HEPES) the pH dropped to below 7.0 during the preliminary 5h culturing 
period. This pH drop was due to the production of lactic acid as a 
consequence of the exhaustive growth of the parasites in developing to 
schizogony. P. berghei may require a better buffered media than P. 
falciparum as its schizogonic cycle is 24 h compared to 48 h for P. 
falciparum which would suggest a more intensive metabolism for P. 
berghei and hence a more rapid exhaustion of the media.
Centrifugation washes were avoided as schizont-infected 
erythrocytes have a tendency to clump and become difficult to resuspend. 
Because of the fragility of murine erythrocytes and reticulocytes, 
manipulation of these cells was reduced to a minimum and single washes 
with large volumes were used in preference to multiple washes.
The total culturing time for the invasion assay was 24 h. As the assay 
involves development from schizont to visible ring-stage infected- 
erythrocyte, this indicates that parasite development in our system was 
slower than the in vivo development of P. berghei in which the whole 
erythrocytic cycle takes 24 h. Mons etal. (1983) reported a normal 
erythrocytic cycle for P. berghei\n the suspension culture system. It is 
probable also that development in static cultures is slower than 
development in suspension cultures due to the effects of nutrient gradients.
Erythrocyte invasion preferences of P. berghei merozoites in our in 
vitro system correlated well with its known in vivo preferences. Erythrocytes 
of rabbits, guinea pigs and humans were not invaded in vitro while mouse 
erythrocytes preparations were. It is well known that P. berghei merozoites 
preferentially invade reticulocytes (Ramakrishnan & Prakash, 1950; Janse 
et al., 1984,1989; Suhrbier etal., 1987). Using the P. berghei in vitro 
invasion assay, we observed a direct correlation between P. berghei 
merozoite invasion and the presence of reticulocytes. This correlation held 
whether the reticulocytes were 'natural' i.e. obtained from very young mice, 
or 'unnatural’ i.e. obtained from phenylhydrazine-treated mice. Therefore 
phenylhydrazine alone was not the cause of the increased susceptibility of 
such cells to invasion. Greater invasion into reticulocyte-rich preparation 
was also shown by Mons etal. (1985) indicating that the greater invasion
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into reticulocyte rich preparation was not just an artifact of static cultures. 
Invasion rates were similar into erythrocytes from all murine strains tested.
P. berghei invasion assays were carried out using enzyme-treated 
erythrocytes as target cells. To provide statistically significant data, invasion 
into enzyme-treated reticulocyte-rich preparations were examined. 
Treatment of these cell preparations with the enzymes trypsin, chymotrypsin 
or papain reduced the level of merozoite invasion while neuraminidase 
treatment had little significant effect. The effect of the trypsin on invasion 
was so marked (92% reduction in invasion compared to controls) that it is 
reasonable to assume that its action completely destroyed reticulocyte 
ligands for merozoite invasion, while the chymotrypsin and papain may 
have affected both reticulocytes and normocytes less severely.The lack of 
effect of the Vibrio cholera neuraminidase was not surprising as this 
enzyme is known to be relatively inactive against sialic acids on murine 
sialoglycoproteins which are o-aceytlated (Sam-Yellowe & Perkins, 1990).
A clearer understanding of the reticulocyte preference of P. berghei 
merozoites could have been obtained if the relative invasion rates into 
reticulocytes and normocytes could have been calculated. This was not 
possible, however, due to the maturation of the reticulocytes during the 
course of the assay. Reticulocytes in vivo mature to normocytes within 24- 
36h after release from the bone marrow into the circulation. (Gronowicz, 
Swift & Steck, 1984). Reticulocyte maturation in our in vitro system was 
close to the in vivo situation and hence many reticulocytes had matured into 
normocytes during the assay making it impossible to determine whether the 
ring-forms were as a result of newly invaded reticulocytes or normocytes.
The reticulocyte preference of P. berghei is not as marked as that 
observed for P. vivax(a human malaria) or P. cynomolgi (a simian malaria), 
which almost exclusively invade reticulocytes, and are as such, limited in 
their multiplication potential (Kitchen, 1938 and Warren, 1966 respectively). 
P. berghei has the capacity to invade mature erythrocytes, very few 
reticulocytes are seen throughout P. berghei infection in v ivo , possibly due 
to early parasite invasion and subsequent cell destruction. Ott (1968) found 
that if reticulocyte numbers in rats were boosted prior to infection by P. 
berghei, the reticulocytes were parasitised to the near exclusion of mature 
erythrocytes. Whether the basis of the reticulocyte preference of P. berghei 
is due to an increased structural predisposition of reticulocytes to invasion
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or to a specific receptor-ligand interaction is not known. Both these factors 
may contribute to the reticulocyte preference of P. berghei. Reticulocytes are 
known to possess a spectrin based cytoskeletal network that is 
incompletely packed, and therefore would be more pliable or deformable 
and so more susceptible to invasion. Janse et al. (1984) reported that in 
some continuous cultivation experiments he found rat reticulocytes 
containing up to 15 invaded parasites of P. berghei. This could represent a 
reticulocyte sub-population that was particularly susceptible to invasion.
2. E ry th rocy te  b ind ing  assays using m etabo lica lly  labe lled P. 
b e rg h e i p ro te in s
The specificity of merozoite attachment to and invasion of 
erythrocytes is mediated by interactions between surface molecules of the 
erythrocyte and merozoite molecules. In the case of P. falciparum , the 
human-erythrocyte ligand has been shown to be the sialic acid residue of 
glycophorins, and for P. knowlesi and P. vivax, a component of the Duffy 
blood group system was shown to be involved (reviewed by Hadley etal.,
1986). Erythrocyte binding molecules have been discovered for these three 
malarial species and much work has focused on trying to correlate their 
specificities of binding to erythrocytes with the known requirements of the 
particular malarial species for erythrocyte invasion. The P. falciparum 
molecules, EBA-175 and MSP-1 have been shown to bind to susceptible 
erythrocytes in a sialic-acid dependent manner (Camus & Hadley, 1985 
and Perkins & Rocco, 1988 respectively). A similar correlation between the 
binding of a 135 kDa molecule of P. knowlesi, PkDAP-1, or the binding of a 
P. vivax 140 kDa molecule, PvDAP-1, and the availability of components of 
the Duffy blood group system on susceptible cells indicated an important 
role for these erythrocyte binding molecules in erythrocyte invasion 
(Haynes eta l., 1988 and Wertheimer & Barnwell, 1989)
Applying similar methods to those described by Haynes eta l. (1988), 
we succeeded in radiolabelling P. berghei proteins and identifying an 
erythrocyte binding protein of P. berghei. We estimated the molecular 
weight of this protein to be 130 kDa as it migrated slightly faster than the 
PkDAP-1 (135 kDa) on reducing SDS-PAGE (J. Dalton, personal 
communication). This Plasmodium berghei erythrocyte binding protein was
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termed PbEBP-130. When P. bergheitrophozoites were cultured to 
schizogony this erythrocyte binding protein, PbEBP-130 was released into 
the media, and also could be recovered from freeze-thaw extracts of the 
schizonts. This indicates that the PbEBP-130 was probably merozoite 
associated, and was either released into the culture media with the 
merozoites as the erythrocyte ruptured or dissociated from the merozoite as 
the merozoite deteriorated. There was no difference in molecular weight 
between the culture media PbEBP and the extracted PbEBP, and no 
smaller labelled proteins bound to erythrocytes, ruling out the possibility of 
processing of the protein as was observed with the P. falciparum MSP-1 
(Holder and Freeman, 1982,1984).
The binding of the PbEBP-130 could not be correlated with invasion 
specificities of P. berghei. Merozoites of P. berghei invade rat erythrocytes 
both in vivo and in vitro (Janse etal., 1984), however the PbEBP-130 failed 
to bind to rat erythrocytes. Neither did the PbEBP-130 bind to erythrocytes 
from rabbits or guinea pigs which are not invaded in vivo. Enzymatic 
digestion of murine erythrocytes by trypsin, chymotrypsin or papain 
abrogated binding of the PbEBP-130. This correlated with the effect of 
protease treatment on merozoite invasion of erythrocytes . However it 
cannot be concluded that it was solely the loss of the PbEBP-130-specific 
ligand on the erythrocyte that resulted in the reduced invasion.
No correlation was found between the binding of PbEBP-130 and 
the preference of P. berghei merozoites for reticulocytes. The amount of the 
PbEBP-130 binding decreased as the percentage of reticulocytes in the cell 
preparation used in the binding assay increased. This would indicate that 
the molecule we have detected binding to mouse erythrocytes is not the P. 
berghei equivalent of the P. vivax reticulocyte binding proteins PvRBP-1 
and PvRBP-2. These reticulocyte binding proteins (RBP) described by 
Galinski et al. (1992) adhere specifically to reticulocytes of humans and 
other P. vivax susceptible species regardless of their Duffy phenotype.
Since these molecules were localised on the apical pole of merozoites, 
Galinski et al. (1992) postulated that the PvRBPs were responsible for the 
attachment and/or re-orientation of merozoites to reticulocytes. This 
interaction would then provide the signal for junction formation and 
invasion involving the interaction of the released PvDAP-1 and the Duffy 
determinant. If P. vivax invasion took place by trial and error probing, many
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abortive invasion would occur as reticulocytes represent only -1%  of the 
erythrocyte population, therefore the RBP provides the merozoite with a 
means to discriminate between cell types. However Galinski et al. (1992) 
was unable to detect genes homologous to the PvRBPs in P. knowlesi, P. 
falciparum or P. berghei when southern blots of genomic DNA were probed 
with PvRBP sequences, indicating that the reticulocyte preference in other 
malarial species may have a different basis to that of P. vivax. Certainly the 
reticulocyte preference of P. berghei (Ramakrishnan & Prakash, 1950) or P. 
falciparum (Pasvol et al., 1980) is not as pronounced as that of P. vivax 
(Kitchen, 1938) and this may reflect a different basis for reticulocyte 
preference between these plasmodial species.
Galinski eta l. (1992) presents binding assays using metabolically 
labelled P. vivax culture supernatant and Duffy blood group positive 
erythrocytes in which he detects the binding of the 250 kDa RBP-1 and -2 to 
erythrocyte population with elevated reticulocyte populations. It appears 
from the autoradiographs published in this work, that the amount of PvDAP 
that bound to the reticulocyte-rich preparation is less than the amount that 
bound to the normal erythrocyte preparation, even though the number of 
erythrocytes used each time was kept constant. The reduced binding of the 
PvDAP to human reticulocytes is similar to the reduced binding of the 
PbEBP-130 to murine reticulocytes observed in the present study,and may 
indicate a common function for the two molecules.
It is known that P. falciparum invades mouse erythrocytes with low 
efficiency (Klotz et al., 1987). Although ring stage parasites form in the 
mouse erythrocytes, further development does not occur, either due to 
parasite extrusion from the erythrocyte or erythrocyte lysis (Klotz et al.,
1987). Klotz etal. (1987) was able to detect an identical distribution of the 
P. falciparum RESA molecule in invaded mouse erythrocytes as is found in 
invaded human erythrocytes, indicating a similar invasion mechanism. 
Investigations into the binding of P. falciparum molecules to mouse 
erythrocytes were described by Sam-Yellowe & Perkins (1990). They found 
that mouse erythrocytes failed to bind the EBA-175 or MSA-1 molecules 
already identified as having a role in sialic-acid dependent invasion by P. 
falciparum merozoites of human erythrocytes, but did bind a 140/130/110 
kDa complex of proteins that were located to the rhoptries. Trypsin or 
chymotrypsin treatment of murine erythrocytes reduced invasion of mouse
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erythrocytes by merozoites of P. falciparum by up to 80% and also 
abrogated the binding of the 140/130/110 complex. Neuraminidase had 
little effect either on invasion, or on binding of the rhoptry complex to mouse 
erythrocytes. This data compares with the binding of the PbEBP-130 to, and 
the invasion of enzyme-treated murine erythrocytes by P. berghei. When 
Sam-Yellowe & Perkins (1990) investigated the invasion of murine 
erythrocytes by different strains of P. falciparum, they found that the sialic- 
acid independent strain 7G8 invaded mouse cells 3-4 times better than the 
sialic-acid dependent strain FCR-3. Binding of the rhoptry complex of strain 
7G8 was also stronger than that of strain FCR-3 to mouse erythrocytes. This 
may indicate that the mouse erythrocytes are invaded by a process similar 
to the sialic-acid independent invasion process of P. falciparum.
Sam-Yellowe & Perkins (1990) also observed that 50% of the 
murine erythrocytes invaded by either strain of P. falciparum were 
reticulocytes. Anti mouse-glycophorin antibody blocked both the binding of 
the rhoptry complex to mouse erythrocytes and the invasion of erythrocytes, 
but had no effect on the rhoptry complex binding to reticulocytes, or the 
invasion of these cells by merozoites (Sam-Yellowe & Perkins, 1990). The 
preferential invasion of mouse reticulocytes by merozoites of P. falciparum 
could therefore be related to the presence of distinct but antigenically 
related sialoglycoproteins on each erythropoetic stage of the murine 
erythrocyte. Whether the reticulocyte preference of P. falciparum or P. 
berghei in vivo is related to the expression of such sialoglycoproteins is not 
known.
The binding of the rhoptry complex to reticulocyte-rich populations 
rules out the possibility that the PbEBP-130 is related to the P. falciparum 
rhoptry complex, as the PbEBP-130 does not bind to reticulocytes. However 
the invasion of mouse erythrocytes, in particular the preferential invasion of 
reticulocytes by P. falciparum, indicates a possible similarity in the 
molecular interactions involved in invasion between this malaria and P. 
berghei. As it is the sialic-acid independent strains of P. falciparum that 
invade murine erythrocytes most efficiently, the mechanism of murine 
erythrocyte invasion by P. falciparum may be related to the sialic-acid 
independent pathway for invasion.
The precise role played by the PbEBP-130 in invasion of 
erythrocytes by P. berghei is unclear. Because of its binding specificities it
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cannot be regarded as being similar to the reticulocyte binding proteins of 
P. vivax. It is unlikely to belong to the MSP group of proteins first described 
by Holder and Freeman (1982), as it has a smaller molecular size and 
doesn’t appear to be processed to smaller fragments as the MSP-1 of P. 
falciparum.
The PbEBP-130 may be related to a group of erythrocyte binding 
proteins described by Adams etal. (1992). Based on gene structure and 
amino acid homology, Adams etal. (1992) have proposed that the P. vivax 
Duffy binding protein PvDAP-1, the three P. Knowlesi Duffy binding proteins 
and the P. falciparum EBA-175 are members of the same gene family.
These three species of malaria are quite evolutionary diverse and therefore 
it is reasonable to assume that P. berghei would possess a candidate 
molecule in this family.
The PbEBP-130 is interesting in itself; not only was it shown to bind 
to erythrocytes, and hence has a possible role in erythrocyte invasion by P. 
berghei merozoites, but it was also immunoprecipitated from an extract of 
metabolically labelled P. berghei schizonts by serum from a Balb/c mouse 
that had cleared a P. berghei infection. This indicate a possible role for this 
protein in evoking a successful immune response to P. berghei infection.
3. C onstruc tion o f a gt11 cDNA expression lib ra ry  from  
e ry th rocy tic  stages o f P. be rghe i
The cloning and sequencing of many malarial genes has now been 
reported, most of which encode antigens, from the erythrocytic stage. The 
technique used most frequently for cloning antigen genes has been to 
screen cDNA or genomic DNA expression libraries with antibody 
preparations ranging from monoclonals to total human or monkey immune 
serum. A number of different E. coli expression vectors have been used, but 
the phage vector gt11 has been the most popular.
Many malarial proteins show stage specific synthesis, and similarly 
mRNAs have been shown to change drastically in concentration between 
different stages. Deans etal. (1983), examined the stage specific protein 
synthesis by erythrocytic P. falciparum. They detected major changes in the 
type of protein synthesised by the parasite at the onset of schizogony, and 
they concluded that the new proteins synthesised in schizogony were
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involved in the events of nuclear division or were merozoite associated 
proteins (Deans et al. 1983). David et al. (1984) examined the appearance 
of the MSP-1 of P. knowlesi by immunoprecipitation and found that it was 
synthesised late in schizogony. Hyde et al. (1984) were the first to report the 
construction of a cDNA library from the erythrocytic stages of P. falciparum, 
and also performed in vitro translation using mRNA from different stages of 
the erythrocytic parasite, and concluded that a library from schizonts would 
be most suitable for identifying and cloning the P. falciparum MSP-1 gene.
In the metabolic labelling of P. berghei, we cultured mature schizonts, 
and found that the PbEBP-130 was present both in the culture supernatant 
and also in the extracted parasite.The protein that we have identified as 
PbEBP-130 was therefore synthesised during schizogony. We therefore 
used cultured schizonts, prepared in the same manner as for the metabolic 
labelling, for the extraction of mRNA. A cDNA library was constructed from 
this mRNA. This library would be expected to contain gene sequences, 
encoding proteins expressed late in the erythrocytic cycle, such as the 
PbEBP-130.
We wished to construct a cDNA library that could be screened both 
as a expression library with an antibody probe and also with an 
oligonucleotide probe. The phage vector gt11 was considered the most 
suitable for these purposes. A phage vector was chosen for construction of 
the cDNA library, as large numbers of recombinants can be screened 
easily, and phage libraries tend to produce cleaner and less ambiguous 
positives than plasmid libraries (Hyde, 1990). Phage vectors in general 
give more transformants, from a given amount of starting DNA than plasmid 
vectors, as in vitro packaged phage particles enter cells much more 
efficiently than naked pieces of DNA. As we had only very small amount of 
starting mRNA, this was a major consideration in attempting to construct a 
comprehensive library (Hyde, 1990).
gt11 contains an EcoR1 cloning site located within the lacZgene, 
upstream from the G-galactosidase termination codon. If the inserted DNA 
has an open reading frame in register with the remainder of the 13- 
galactosidase gene, a hybrid or fusion protein is expressed when IPTG is 
used to inactivate the repressor (Lac/) of lacZ directed expression. This 
vector also produces a temperature sensitive repressor, c1857, which is
inactive at 42°C, and allows control of the lytic cycle of phage reproduction.
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The vector gt11 is also defective in cell lysis, and when used with a
bacterial strain that is Ion' (protease deficient), can produce large amount of 
recombinant protein.
An essential part of the strategy to isolate a particular clone from an 
expression library is the antibody preparation used to screen the library. 
Screening libraries with a monoclonal antibody is often unsuccessful, as 
the single epitope that it recognises may not be encoded by any of the gene 
fragments expressed or may not be in the correct conformation for detection 
by the monoclonal. Polyclonal antisera are generally more successful as 
they recognise all possible epitopes. One pitfall of screening expression 
libraries with antibodies is that multiple clones containing unrelated DNA 
sequences, but expressing cross-reacting epitopes are often selected. 
Several cross-reacting proteins were selected from a gt11 expression 
library using monoclonal antibodies to the P. falciparum circumsporozoite 
(CS) protein by Dame et al. (1984) before the true CS protein was selected.
Adams et al. (1990) constructed a cDNA expression library in gt11, 
from the mRNA from the late schizont stages of P. knowlesi, and cloned two 
genes of the Duffy receptor family. The sera used to screen the library was a 
fraction of immune rhesus monkey serum eluted from a nitrocellulose strip 
onto which the PvDAP had been transferred.
We were able to identify metabolically labelled PbEBP-130 in culture 
supernatant of P. berghei schizonts and in extracts of cultured schizonts. 
Attempts to purify large amounts of PbEBP-130 antigen from unlabelled 
culture supernatants, by affinity purification from erythrocytes, and 
subsequent immunisation of rats with the eluted proteins proved 
unsuccessful. Attempts were also made to cut the PbEBP-130 band from 
SDS-PAGE gels of total schizont extracts; the acrylamide slice then used in 
immunisations. This approach also failed to induce a polyclonal antisera in 
rats that reacted with the PbEBP-130. The sera that were finally used in the 
library screening were both polyspecific. One was raised against a culture 
supernatant of P. c. chabaudi. The other was reactive against schizont 
extract proteins >100 kDa. Both these sera were considered suitable for 
screening the library in order to clone the PbEBP-130 gene as they both 
immunoprecipitated the labelled PbEBP-130 from labelled extracts of P. 
berghei schizonts.
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Extraction of RNA from the cultured schizonts was performed using 
the commercial preparation RNAzol B. This method of RNA extraction was 
much simpler than the published methods of Comczynski & Sacchi (1987) 
or Hyde et al. (1981), which involved acid guanidinium thiocyanate-phenol- 
chloroform extractions. The manufacturers instructions for use of the 
RNAzol B were followed. Recently Certa (1994) reported use of RNAzol B to 
extract cellular RNA from P. berghei. Certa used 1 ml of infected mouse 
blood with a parasitaemia of 80% and resuspended the washed cells in 
the RNAzol B, followed by a 3 h incubation of this mixture on ice. We used a 
CF11 column, before culturing the cells, to remove leucocytes and 
incubated the RNAzol B/cells mixture on ice for 5 minutes. It is likely that the 
RNA extracted by Certa (1992) contains mouse RNA as leucocytes were 
not removed from the blood preparation, and there would be a large 
population of leucocytes in the blood of a mouse that had a parasitaemia of 
80%.
4. Screening o f cDNA lib ra ry  w ith  an o lig onuc leo tide  probe
The cDNA library was screened with the oligonucleotide probe 
JA159. A schematic representation of the source of oligo JA159 is shown in 
Fig. 4.1, and the nucleotide sequence of JA159 and of primers 142 and 143 
is presented in Fig. 4.2.
Primer 142 and 143 were synthesised from the known DNA 
sequence of a section of the 3’ cysteine-rich region of the gene for the EBA- 
175 of P. falciparum (Sim etal., 1990). Adams et al. (1992) demonstrated 
that the 3’ cysteine rich region of P. falciparum was highly homologous to 
the 3’cysteine rich regions of the Duffy adhesion proteins of P. vivax and P. 
knowlesi and based on the amino acid homology and gene structure of the 
3' cysteine-rich region and other regions placed the EBA-175 gene and the 
DAP genes as part of the same gene family. If a member of the EBA/DAP 
gene family existed in P. berghei, it was likely that it also would possess an 
homologous 3 ’ cysteine-rich region. A 200 bp fragment was PCR amplified 
with primer 142 and 143 when either P. berghei genomic DNA, or the 
prepared cDNA were used as template. The 40-mer oligonucleotide JA159 
was synthesised from the internal sequence of the P. berghei 200 bp PCR
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Fig 4.1
Primer 142 and primer 143 were a 2&-mer and a 29-mer respectively, synthesised 
from the known sequence of the 3’ cysteine rich region (B) of the P  fa/ctparumEBk 
175 gene (A). When Primers 142 and 143 were used in PCR with P. Ajypfey'genomic 
DNA as template, a 200 bp fragment (C) was amplified. The 200 bp PCR product was 
sequenced and a 40-mer oligonucleotide, JA159, was synthesised from the DNA 
sequence.
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A 3' Cysteine-rich Region
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B  Primer 142 3’ GG ATC ATC AAA TTC CCT TTT CGT AC
Primer 143 3’ TGT GAG AAC GAA ATT TCT GTA AAA TAT TG
Oligo 159 5’ AAG GAT CCA ATA ATC TGA TAT TGA GCA GCA TAA TTG TTT C
I I
EcoR1
Fig 4.2.
Panel A. Conserved 3’ cysteine-rich regions of the erythrocyte binding proteins of P. knowlesi^)', P. vivax, 
(V); P. falciparum (F). Conserved cysteine residues are boxed; Xn, the number (n) of intervening residues. 
Protein sequence encoded by the nucleotide sequences of primer 142 (p142) and primer 143 (p143) are 
underlined.
Panel B. Nucleotide sequences of primer 142, primer 143, and probe JA159. An EcoRl restriction site was 
engineered into the 5‘ end of JA159.
product (P. Curley, personal communication).
This 200 bp fragment is slightly larger than the 178 bp fragment PCR 
amplified from genomic DNA from P. falciparum using primers 142 and 143. 
However it does indicate that an homologous gene sequence to that 
encoding the EBA-175 may exist in P. berghei genomic DNA and in the 
cDNA that we prepared.
The Tm (melting temperature) of JA159 was estimated at over 90°C  
even though an EcoR1 site had been engineered into the 5’ end. JA159 
was end-labelled with 32P, and was found to hybridise well to southern 
blots of the P. berghei 200 bp PCR product. We were unable, however, to 
identify any clones from the gt11 cDNA library hybridising to JA159, despite 
using very low stringency hybridising and washing conditions. Any primary 
positives that were identified failed to give secondary positives and were 
thus assumed to be false. When DNA was extracted from the total phage 
library, and used in PCR with primer 142 and 143, no fragment was 
amplified indicating that our gt11 cDNA library did not contain a sequence 
corresponding to the sequence in the EBA/DAP genes encoding the 3’ 
cysteine rich region.
5. Im m unoscreen ing the gt11 cDNA express ion  lib ra ry
Immunoscreening of the gt11 expression library was performed with
two separate sera. The first antisera, termed anti-TCS, had been raised to
culture supernatant of P. c. chabaudi (a rodent malaria). It nevertheless
immunoprecipitated a metabolically labelled P. berghei protein
corresponding in size to the PbEBP-130, and on this basis was used for
immunoscreening. The second antisera, termed anti-C1, used to
immunoscreen the expression library was raised to proteins extracted from
cultured schizonts of P. berghei (termed C1 proteins). It also
immunoprecipitated a metabolically labelled P. berghei protein that
corresponded in size to the PbEBP-130. As the anti-C1 sera
immunoprecipited such a large number of P. berghei proteins, the
immunoscreening was performed with a fraction of the sera that should
react only with recombinants whose native protein is >100 kDa.
The immunoscreening with anti-TCS sera yielded 10 clones, which
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were placed into 4 groups based on the size of the inserts they contained. 
The insert sizes were determined by PCR amplification of the phage DNA 
using primers constructed from sequence on either side of the EcoR1 
cloning site. EcoR1 digestion of the phage DNA confirmed the sizing of the 
inserts and the group classification, each group having identical EcoR1 
restriction fragments. A further indication that 4 groups of similar clones had 
been selected was given by the antibody reactivities of each selected clone 
with the anti-TCS sera; clones in each group reacted similarly with the 
immunoselection sera.
Immunoscreening with the anti-C1 sera fraction resulted in the 
identification of 14 clones, most of which had inserts of 1300-1500 bp as 
determined by PCR amplification using primers from either side of the 
EcoR1 cloning site.
When phage DNA from any of the 24 immunoselected clones was 
used in PCR with primers 142 and 143, no fragment was amplified. This 
indicates that the immunoscreening failed to identify a clone whose insert 
corresponded to that encoding the EBA/DAP 3’ cysteine-rich region. This 
was expected as phage DNA extracted from the total library failed to amplify 
any fragment using primers 142 and 143.
The ability to amplify a 200 bp fragment from P. berghei genomic 
DNA, and from the prepared cDNA using primers 142 and 143, but not from 
total phage library DNA under the same conditions, indicates that the cDNA 
library generated may not have been representative of the cDNA 
synthesised from the schizont-stage mRNA. The transformation efficiency of
the packaging reaction was 105 transformants per |ig packaged DNA. This
is lower than the transformation efficiency of 10^-1 o^ transformants/(ig that 
the manufacturers of the packaging mix indicated should be expected. We 
suspect that the EBA/DAP-like protein would be synthesised in large 
amounts during schizogony, and therefore its particular mRNA should be 
quite abundant, and would be represented in our library despite the low 
transformation efficiency. Dalton et al. (1987) reported the cloning of a 
surface antigen of Schistosoma mansoni from a gt11 cDNA library with a
transformation efficiency of 2.3 x 105 recombinants/(ig packaged DNA.
We did not determine the average insert size of clones in the cDNA 
library. Assuming the insert sizes of the immunoselected clones are
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representative, our library appears to contain inserts of 200-2000 bp. While 
these insert sizes are smaller than the manufacturers indicated should be 
expected, they are in practice, the size range usually found in gt11 
libraries. Although the EBA-175 gene is -4.5 kb, Sim et al. (1990) isolated 
only a 2.5 kb fragment of this gene from their gt11 cDNA library. Similarly, 
the gene encoding the DAP of P. knowlesi is ~4 kb, and only 2.6 kb was 
found in the gt11 expression cDNA expression library of Adams etal. 
(1990). It is possible therefore that only part of the homologous P. berghei 
gene was packaged, and this part of the gene did not contain the sequence 
identifiable by JA159 or amplifiable using primers 142 and 143.
It is also possible that the cDNA synthesis did not result in the 
synthesis of cDNA encoding the EBA/DAP-like protein. This could be due 
either to the lack of the corresponding mRNA molecule in the mRNA 
prepared or to the incomplete synthesis of the first or second cDNA strand.
If the latter was the case then another probe, perhaps to a region of 
homology in the 5 ’ cysteine-rich region may select a clone encoding part of 
the EBA/DAP-like protein. The 200 bp PCR product amplified from the 
cDNA preparation could in fact have been amplified from contaminating 
genomic DNA in the prepared cDNA. Although Hyde etal. (1984) used two 
rounds of oligo-dT affinity chromatography to purify mRNA from total P. 
falciparum RNA for use in preparation of a cDNA library, they found 
contaminating genomic DNA in the fraction eluted from the column. The 
binding of P. falciparum genomic DNA to the column was probably a result 
of the high A+T content of that DNA, a feature shared by the DNA of P. 
berghei (McCutchan etal., 1984).
From the data obtained, it was evident that we would be unable to 
identify a clone containing an homologous region to the EBA/DAP 3’ 
cysteine-rich region. We decided therefore to analyse the immunoselected 
clones and to determine whether any of the inserts in these clones encoded 
part or all of the PbEBP-130. The strategy would be to produce antisera to 
the fusion proteins of these clones, which could then be used in 
immunoprécipitations of metabolically labelled P. berghei proteins. The 
antisera generated could also be used to identify molecules involved in 
merozoite invasion of erythrocytes by their ability to block invasion in in 
vitro invasion assays The fusion proteins could also be tested for their
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ability to elicit a protective immune response against P. berghei in mice. 
However the inability to produce fusion protein either from plate wash 
supernatants of £  coli infected with the immunoselected clones, or from £  
coli lysogens of the immunoselected clones, precluded any of these 
investigations.
No fusion protein seemed to be present in the wash supernatants, 
indicating that the fusion proteins may have been present in an insoluble 
form. When lysogens were generated they proved extremely difficult to 
handle, lysing very soon after the induction of the lytic cycle. Inclusion 
bodies were prepared from some of the lysogens, but they proved very 
difficult to extract. Inclusion bodies are insoluble precipitates within the £  
coli lysogen containing the overproduced fusion protein in a reduced and 
denatured form. They are thought to form because the protein is forced to 
adopt an unnatural pathway of folding when synthesised at high 
concentrations in a foreign environment. The only phage clone that 
produced fusion protein in £  coli lysogens or in infected £  coli plate wash 
supernatants was the wild type phage.
The inability to produce fusion proteins from the immunoselected 
clones could also have been due to damage done to the cloning site during 
ligation of the inserts to the vector arms. Alternatively the cloned cDNA may 
not have been in the correct orientation, or may have been in the incorrect 
codon frame for expression as a fusion protein. Some of the lysogen 
infected £  coli produced 13-galactosidase, indicating that transcription 
initiated from the G-galactosidase start codon was functional, but that it was 
interrupted before transcription of the insert. Alternatively translation could 
have been similarly interrupted. In cloning the circumsporozoite protein of 
P. falciparum, Dame et al. (1984), were unable to produce fusion protein 
from 5 of the 6 clones immunoselected from a gt11 library. They discovered 
that the clones that did not express fusion proteins as £  coli lysogens had 
inserts that were not in frame with the B-galactosidase gene or were in an 
opposite direction to the 13-galactosidase gene (Dame et al., 1984). The 
immunoselection of these clones was made possible probably due to 
transcription from a lambda promoter rather than from the lac promoter. The 
ability to detect antigen produced by £  coli lysogenised clones whose 
coding sequence was out of frame was first observed by Young and Davis
(1983) in their report outlining the construction and use of gt11 as an
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expression vector. Detection of antigen when the insert was orientated 
opposite to that of the 13-galactosidase was also reported by Goto & Wang
(1984).
6. Inves tiga tions on gt11 clones Rt and Rg
Lambda clones Rt and Rg were immunoselected from a P. 
falciparum gametocyte cDNA library in gt11 using an antisera that was 
specifically reactive against P. falciparum sexual stage antigens (J. Dalton, 
personal communication).
We were unable to establish the size of the insert in clone Rg. PCR 
amplification using Rg phage DNA as template and lambda forward and 
reverse primers always resulted in the production of multiple fragments. 
This clone also failed to produce a detectable fusion protein in plate wash 
supernatants of infected E. coli.
DNA from clone Rj PCR amplified a fragment of -350 bp using 
lambda forward and reverse primers. As one of the EcoR1 sites flanking the 
insert appeared to be damaged, the insert size was confirmed by 
Kpn1/Sac1 digestion of phage DNA. A fusion protein of -150 kDa was 
detected in plate wash supernatants of Rt infected E. coli. As R- 
galactosidase is -120 kDa this would imply that the native protein encoded 
for by the insert in clone Rt was -30 kDa. A protein of this size is twice as 
large as could be encoded by an insert of -300 bp. The anomalous 
migration of this fusion protein under reducing conditions may indicate a 
highly charged amino acid content or a repeat amino acid motif in the 
native Rt protein. In cloning the circumsporozoite (CS) protein of P. 
falciparum, from a gt11 expression library, Dame etal. (1984) noted similar 
anomalities in the migration of the native CS protein and a 3- 
galactosidase/CS fusion protein which they believed to be related to the 
repeat regions of the CS protein.
Fusion protein purified from plate wash supernatants of phage Rt 
infected E. coli was used to immunise rats. If the anti-8-galactosidase 
reactivity could be absorbed from the sera, the remaining fraction reactive 
against the native Rt protein could be used in further analysis of the Rt 
protein. Such a sera fraction could be first used to determine the size of the 
native Rt protein by immunoprécipitation of metabolically labelled sexual 
stage proteins, and then used to screen the gt11 cDNA expression library
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again or a genomic expression library in order to isolate the full coding 
sequence of the native protein. The Rf -protein reactive fraction of the sera 
could also be used to localise the native Rt protein in P. falciparum sexual 
stages either by immunofluoresence or immuno-electron microscopy. This 
would provide an indication of the function or activity of the native protein. If 
it were localised on the exterior of the gametocyte, it may function in the 
molecular reaction involved in gametocyte fertilisation. If however it were 
localised in the nucleus of gametocytes, this may indicate a role in the gene 
regulation of gametocytogenesis. Very little is known about regulation of 
malaria genes. The complex life cycle of a malaria parasite is matched by 
an equally intricate system of gene regulation. The genetic switches that 
send merozoites into the developmental pathways leading to rings, 
macrogametocytes or microgametocytes are likely to be as fascinating to 
the developmental biologist as they are to the vaccinologist.
A 200 bp DNA sequence was determined from the 350 bp PCR 
fragment amplified from the Rt phage DNA using lambda forward and 
reverse primers. The determined sequence is shown in Fig. 4.3. The 
sequence was determined for one strand only using the lambda reverse 
primer as the initiation primer for chain elongation. Computer search 
analysis at the DNA and protein level were performed on the 200 bp DNA 
sequence determined. The protein sequence search found greatest 
similarity with the sequence of the Trypanosoma brucei CR4 protein, whose 
mRNA is trans-edited in the kinetoplast of this protozoan (Stuart, 1991). 
Over a stretch of 19 amino acids, there were 9 matches with amino acids 
encoded by one codon frame of the Rt sequence.
The nucleotide sequence search found greatest similarity with a 
mouse mRNA for the NF1-B protein with 63% homology over 71 
nucleotides. The NF1-B (nuclear factor 1-B) protein is a DNA binding 
protein found in mouse brain cells and is necessary for the activation of 
transcription from several promoters, and also found to inactivate 
transcription from other promoters (Inoue et al., 1990). The homology 
between the Rj insert sequence and the sequence of this NF1-B DNA 
binding-protein involved in brain-specific gene regulation is interesting as it 
may indicate a similar role as a DNA binding protein involved in regulation 
of transcription for the native protein encoded (partially) for, by the insert 
sequence in the Redone. No definite conclusion or comparisons can be
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drawn from the 200 bp sequence as it is too short for a definitive protein 
sequence or nucleotide sequence similarity search. Significantly however, 
no similarity was found between the sequence of the insert in the Rf clone 
and any previously published gene sequence of P. falciparum, including 
those of the sexual stage antigens Pfs 25/28, Pfs 48/45 or Pfs 15 (Kaslow 
eta l., 1987; Kochen eta!., 1993; Langsley etal., 1992), indicating that we 
have cloned a novel protein of P. falciparum sexual stages.
Future work on the Rf clone insert should involve confirmation of the 
DNA sequence of the Rt clone insert by sequencing the complementary 
strand. The PCR fragment itself or an oligonucleotide probe could then be 
used to determine the size of the primary transcript of the native Rt protein 
in northern hybridisations with sexual stage mRNA from P. falciparum, and 
in screening a cDNA library or an genomic library if the 300 bp insert in 
clone Rf does not represent the full gene, in order to obtain the full coding 
sequence.
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GAACTAATAGAAGAAGATATACAAAAAGATATAGGAAGAAGATATACAAAAAGATATAGT
ACCAAGATTTACAAAAAGTTATGGTNCAAGATATAGAACAAGATATAGANCAAGATNTAC
AAGATGATGTGCAAGAAGANGATTTACTTGTAGGAACCCCTTTCCACAAAAGGACCTGCC
ACATTTTCTANAACCTCAGC
Fig 4.3.
200 bp DNA sequence of the cloned insert of phage Rj(N = nucleotide at this position not 
determined).
CONCLUSION
We have developed a method for the purification of Plasmodium  
berghei infected erythrocytes, that results in preparations containing greater 
than 95% purified parasites. This purification technique and the 
development of a media that supported in vitro growth of P. berghei allowed 
investigations into the invasion of erythrocytes by merozoites of this 
parasite using in vitro invasion assays and erythrocyte binding assays.
The in vivo erythrocyte invasion specificities of P. berghei merozoites 
were confirmed in vitro in our erythrocyte invasion assays. In particular we 
observed in vitro, the preference of P. berghei merozoites for invasion of 
reticulocytes. Using the erythrocyte binding assay, we identified a 130 kDa 
molecule, termed PbEBP-130, that was synthesised late in the erythrocytic 
cycle by P. berghei and that bound exclusively to murine erythrocytes. Sera 
from a mouse that had cleared P. berghei infection reacted with the PbEBP- 
130 molecule in immunoprécipitations, indicating a role for PbEBP-130 in 
inducing immunity to infection.
Polyclonal antisera were raised to protein preparations of P. 
berghei. These sera immunoprecipitated the PbEBP-130 from labelled 
protein extracts of P. berghei, and were used to screen a cDNA expression 
library that was constructed in gt11. Immunoselected clones failed to 
produce fusion protein. The cDNA library was screened with a labelled 
oligonucleotide probe, synthesised from known DNA sequence of the gene 
for the erythrocyte binding protein of the human malaria, Plasmodium  
falciparum. No clone was selected by the labelled oligonucleotide.
Two gt11 clones, immunoselected from a cDNA library constructed 
from the sexual stages of P. falciparum were investigated. Fusion protein 
was prepared from one of the clones and used to immunise rats, from which 
a polyclonal antisera reactive with P. falciparum sexual stages was 
collected.
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S U M M A R Y
E r y th r o c y te  in v a sio n  assays are d e sc r ib e d  for tw o  sp e c ie s  o f  r o d en t m alaria , n a m ely  P la sm o d iu m  berghei an d  P . c. ch abau d i. 
T h e s e  in v a s io n  assays are s im p le , are ca rr ied  o u t  u s in g  a ca n d le  jar and  a llo w  a n u m b e r  o f  assays to  b e  p er fo rm ed  
s im u lta n e o u s ly . O ur resu lts d e m o n str a te  th a t  b o th  r o d e n t  m alaria  sp e c ie s  sh o w  an in  v i tr o  p re feren ce  for  r e tic u lo c y te s  
a lth o u g h  th e  p referen ce  o f  P . c. ch a b a u d i fo r  th e se  c e lls  is  n o t  as m arked  as tha t o f  P . berghei. T h e  d eta ils  o f  o u r  in v a sio n  
a ssa y s  an d  o u r  resu lts  o b ta in ed  are d isc u s se d .
K e y  w o r d s :  P la sm o d iu m  berghei, P la sm o d iu m  c h a b a u d i ch a b a u d i, m alaria , rod en t, r e t ic u lo c y te s , e r y th r o c y te s , in v a sio n  
a ssa y s.
I N T R O D U C T I O N
E ry th ro c y te  invasion is a process  essen tia l to  the  
surv iva l  o f  m alaria  parasites. A n  u n d e r s ta n d in g  o f  all 
the  m o lecu la r  m echan ism s and  in te rac t io n s  th a t  take 
p lace  d u r in g  the  invasion even t  is im p o r ta n t  since 
in te r ru p t io n  of  any of  these w o u ld  h a l t  th e  p a ra s i te ’s 
asexual cycle and  hence p re v e n t  disease . T h e  
m a jo r i ty  o f  o u r  know ledge on the  m o le cu la r  in te r ­
ac tions  th a t  occur  d u r in g  e ry th ro cy te  invasion  has 
com e f ro m  stud ies  on the  h u m a n  m alar ia ,  P la s­
m odium  fa lc iparum  and  the  m o n k e y  m alar ia ,  P. 
know lesi (H ad ley  et al. 1986). E ry th ro c y te  invasion  
by  b o th  o f  these malarias can be  ex a m in e d  rela tive ly  
easily because  of the  availabili ty  o f  in v itro  invasion  
assays. T h u s  the  req u irem en t  for p a r t ic u la r  e r y th ­
rocy te  ligands,  such  as sialic acid by  ce r ta in  isolates 
o f  P . fa lc ip a ru m  (H adley  et al. 1987) an d  th e  D uffy  
b lo o d  g ro u p  antigen by P . know lesi (M il le r  et al. 
1975), w as clearly d em o n s tra te d .  F u r th e r m o r e ,  these  
assays w ere  essential to  the  iso lation  o f  an t ibod ie s  
capab le  o f  blocking e ry th rocy te  invas ion  by  P. 
know lesi m erozo ites  and  th e  s u b s e q u e n t  c h a ra c ­
te r iza t ion  of  the  ta rge t an t igens  (rev iew ed  by  
H u d s o n ,  W ellem s & M il ler ,  1988). M o r e  recently ,  
invas ion  assays were used to co rre la te  th e  b in d in g  of  
P . know lesi m erozoite  rec ep to r  m o lecu les  to  the  
D u ffy  b lo o d  g ro u p  an tigen  on  p r im a te  e ry th ro cy te s  
w i th  th e  abili ty  o f  m erozo ites  to  in v a d e  these  cells 
(H a y n e s  et al. 1988; D a lton  et al. 1991).
In v a s io n  assays s im ilar to  those  p e r f o rm e d  w ith  P . 
fa lc ip a ru m  an d  P . knowlesi have  n o t  b e e n  deve loped  
for th e  ro d e n t  malarias, such  as P . berghei, P . 
chabaudi an d  P . yoelii. T h i s  is u n f o r tu n a te  since 
th e se  m o d e ls  are m o re  accessible a n d  relatively
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inexpensive co m p ared  to  the p r im a te  m alaria  
m odels .  E ry th rocy te  invasion  assays for  the  ro d e n t  
m alarias  cou ld  p rov ide  easy system s for  the  id e n t i ­
fication o f  m erozo ite  m olecules  suscep tib le  to b lock ­
ing an tibodies .  T h e  hom ologous  m olecu les  could  
th e n  be charac ter ized  in  th e  m ore  im p o r ta n t  h u m a n  
malarias.  In  the  p re se n t  re p o r t  we detail  m e th o d s  for 
invasion assays for tw o ro d e n t  m alarias  nam ely ,  P. 
berghei and  P . chabaudi chabaudi. O u r  p r im a ry  goal is 
to  p rov ide  invasion assays th a t  are s im ple  to use, 
req u ir in g  no  elaborate  e q u ip m e n t  an d  th a t  allow a 
n u m b e r  of  tests  to  b e  carried  out s im ultaneously .
M A T E R I A L S  A N D  M E T H O D S  
P arasites and  animals
T h e  P. berghei (A N K A  strain)  line was m a in ta in ed  
in 6 to  8-w eek-o ld  B a lb /c  mice by  pass ing  b lood 
f rom  one an im al w ith  paras i taem ia  be tw e en  15 and 
20 %  to the  next.  A  c loned  line of  P . c. chabaudi AS 
was m a in ta in ed  in C D - I  m ice and  was passaged 
similarly. T h e se  C D - I  m ice were ad a p te d  to  reversed  
l igh t ing  for 7 days before  infection, the  artificial 
day l igh t  beg in n in g  at 12 m id n ig h t  and  en d ing  at 
12 noon. B a lb /c  and  Schofield mice w ere  b re d  in o u r  
ow n an im al facility in  D u b l in  City U n ivers i ty  and 
C D - I  mice w ere  p u rc h a se d  f rom  Biological L a b o ra ­
tories, Ballina, I re land .
P reparation  o f  target erythrocytes
Blood from  B a lb /c ,  Schofield  and  C D - I  m ice was 
o b ta ined  by  ca rd iac  p u n c tu re  in to  hepa r in ized  
syringes. T e n  m l o f  p h o sp h a te -b u f fe re d  saline (PBS) 
was added  to  1 m l o f  b lood  an d  the  cells w ere  c e n tr i ­
fuged  at 450 g  fo r  5 m in .  T h e  pelleted  cells w ere  then
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re su sp e n d e d  in 0 5  m l of P B S. E ry th ro c y te s  f rom  
g u in e a -p ig s ,  rab b i ts  and h u m a n s  (supp l ied  by 
D u b l in  T ra n s fu s io n  Board )  w ere  p re p a re d  sim ilarly .
In duction  o f reticulocytosis using p h en y lh yd ra zin e
S o lu t io n s  of  0 -4 ° 0 p h en y lh y d ra z in e  w ere  p re p a re d  
in P B S  from  a 97 ° 0 stock so lu t ion  (A ld rich  C h e m i ­
cals, M ilw aukee ,  W I ,  U S A )  im m ed ia te ly  before  use. 
M ic e  w ere  in jected  in t raper i tonea l ly  w i th  1 0 0 /d  of 
th is  s o lu t i o n / 15 g b o d y  w eigh t on  day  1 and  th e n  
ev e ry  a l te rna te  day  u p  to day  9. E ry th ro c y te s  f rom  
these  m ice w ere  used  w h en  the  re t icu locy te  c o u n t  
re a c h e d  above 5 0 ° ó as d e te rm in e d  by  m e th y le n e  
b lu e  s ta in ing .
P la s m o d iu m  berghe i  invasion assay
T h e  assay was p e r fo rm e d  in 4 se q u en tia l  s teps.
(a) P urifica tion  o f  m ature  P. b e rg h e i  trophozoites by 
P ercoll gradien t. P . berghei is an  ‘ a s y n c h ro n o u s  ’ 
m a la r ia  species, all stages of  the  e ry th ro cy t ic  cycle, 
e x c e p t  se q u es te red  sch izonts ,  be in g  p re se n t  in the  
b lo o d  at any  g iven t im e. W e  d eve loped  a s tepw ise  
P e rco l l  g ra d ie n t  m e th o d  for se p a ra t in g  m a tu r e  
t ro p h o z o i te - in fe c te d  e ry th ro cy te s  f ro m  im m a tu r e  
t ro p h o z o i te  and  r in g - in fe c te d  e ry th ro cy tes .  T h e s e  
p u r i f ied  m a tu re  t ro p h o zo i te - in fec ted  e ry th ro cy te s  
w e re  th e n  c u l tu re d  in  v itro  to  allow th e  pa ras ite s  to 
d e v e lo p  to se g m e n to rs  w h ich  w ere  used  in  o u r  
invas ion  assay. A p p ro x im a te ly  1 m l o f  b lood  was 
re m o v e d  f ro m  P . berghei in fec ted  B a lb / c  m ice w ith  
p a ra s i ta em ias  b e tw e e n  15 and  25 %  by ca rd iac  
p u n c t u r e  in to  a h e p a r in iz e d  syringe.  A fte r  pass ing  
o v e r  a 1 m l C F 11  c o lu m n  ( W h a tm a n  In te rn a t io n a l  
L t d ,  K e n t ,  U K )  th e  v o lu m e  was a d ju s te d  to  10 m l 
w i th  P B S  and  th e  cells w ere  c e n tr i fu g ed  at 450 £  for 
5 m in .  T h e  pel le ted  cells w ere  r e s u s p e n d e d  in 0-5 ml 
o f  P B S  and  ca re fu lly  layered  on to  a s te p w ise  Perco ll  
(d e n s i ty  1-13 g/1, S igm a C h e m ic a l  C o m p a n y ,  Poole, 
D o rs e t ,  U K )  g rad ie n t .  T o  p re p a re  th e  s tepw ise  
g r a d ie n t  4 m l of  th e  65 %  Percoll  so lu t ion  was loaded  
in to  a C orex  ( C o rn in g  G lassw ork ,  N Y ,  U S A )  
c e n tr i fu g e  tu b e  first an d  th is  was u n d e r la id  w ith  4 ml 
o f  th e  75° '0 so lu t ion  w h ich  in tu r n  was u n d e r la id  
w i th  2 m l o f  the  85 %  so lu tion .  A fte r  th e  w ash e d  cells 
f ro m  th e  in fec ted  m ice  w ere  layered  on  to p  o f  the 
g r a d ie n t  they  w ere  c e n tr i fu g ed  at 5000 g  for 20  m in  
at ro o m  te m p e r a tu re .  F o l low ing  cen tr i fu g a t io n ,  the  
v e ry  to p  layer o f  cells (show ing  p ig m e n ta t io n ) ,  w h ic h  
d id  n o t  o r  on ly  s l igh tly  p e n e tr a te d  th e  top  P erco ll  
layer ,  was r em o v e d ,  ad d e d  to  10 m l  of  P B S , 
c e n t r i fu g e d  at 450  £  an d  the  p e l le ted  cells re su s ­
p e n d e d  in  0-25 m l o f  P B S . T h i s  p re p a ra t io n  ro u t in e ly  
co n s is te d  of  >  95 %  m a tu r e  p a ra s i te - in fe c te d  e ry ­
th ro c y te s .  T h i s  p re p a ra t io n  we re fe r  to  as s y n ­
c h r o n o u s  m a tu r e  trophozo i tes .
T h e  65 %  P erco ll  was p r e p a re d  by  m ix in g  4-5 m l
of  Percoll , 1-9 ml of so lu tion  A (PB S conta in ing  
2 25 %  m o n o h y d ra te  glucose) and 0 5 ml of so lution 
B (10 x solution  A). T h e  75 % Percoll was p repa red  
by  m ix ing  4-5 ml of  Percoll, 1 0  ml of  so lution A and 
0-5 m l of  so lution B and  the  85 % Percoll by m ix ing  
4-5 ml, 0 29 ml and  0-5 ml of  the  respective solutions.
(b) C ulturing o f purified  m ature trophozoite-in fected  
erythrocytes. S ince P. berghei schizonts canno t be 
o b ta in ed  by b leed ing  infected  mice, because they 
seq u es te r  in the b lood vessels o f  the liver and spleen, 
we o b ta ined  these in vitro  using  cu l tu r ing  m e thods  
s im ila r  to those descr ibed  by M cL e an ,  M acD ougall  
& Phil l ips  (1986). S y n ch ro n o u s  m a tu re  t rophozo ite -  
in fec ted  ery throcytes ,  o b ta ined  as described  above, 
w ere  cu l tu red  in vitro  in 5 0 %  hea t- inac tiva ted  foetal 
ca lf  se ru m  (F C S ,  G ib co  Laboratories ,  Paisley, 
S co tland )  and 5 0 %  R P M I -1 6 4 0  (G ibco  L a b o ra ­
to r ie s :  to w hich  was ad d e d  4 m l  of 1 M  H E P E S ,  
0-5 m g  hypoxan th ine ,  0'2 g glucose, 400 fi\ o f  n e o ­
m yc in ,  1 m l of 200 m M  g lu tam ine  and 2 m l of  a 5 %  
so d iu m  b icarbonate  so lu t io n /1 0 0  ml). T h e se  cells 
w ere  m a in ta ined  at a dens ity  of  2-5 x 107 ce l ls /m l in 
a T 2 5  t is sue-cu l tu re  flask (N u n c ,  K a m s tru p ,  D e n ­
m a rk )  for 5 h at 37 °C in a candle ja r  (T rä g e r  & 
Je nsen ,  1976) in w hich  t im e the parasites had 
deve loped  into schizonts.
(c) Target erythrocytes. T a r g e t  e ry throcytes  were 
p re p a re d  im m edia te ly  before  use  as described  above.
(d) Invasion assay. A tota l o f  2 x 107 ta rge t cells was 
a d d e d  to 0-8 m l of  the  5 0 %  F C S / 5 0 %  R P M I -  
1640 m ed iu m ,  p rep a re d  as above, in wells o f  a 24- 
well t is sue-cu l tu re  plate. T h e  T 2 5  flask contain ing  
the  parasitized  e ry th rocy tes  was rem oved  from  the  
cand le  ja r  (after the  5 h  cu l tu re  period)  and  the  cells 
gen t ly  resuspended . T w o  h u n d re d  fi\ ( 5 x l 0 6 in ­
fected  ery throcytes)  o f  th is  cu l tu re  were then  added  
to  each well con tain ing  ta rge t  cells. T h e  24-well p late 
was th e n  gently ag i ta ted  and  p laced into the  candle 
ja r  w h ich  was th e n  re tu rn e d  to  the  37 °C incubator .  
N in e tee n  hours  later the  con ten ts  o f  each well were 
rem oved, d ispensed in to  a 1 m l cen tr ifuge tu b e  and 
cen tr i fuged  at 450 £  for  5 m in .  T h e  cells were 
re su sp e n d ed  in 50 /A o f  F C S ,  cen tr ifuged  again and 
th e  pellet resuspended  in 20 fi\ o f  F C S .  S m ears  were 
m a d e  on glass slides w h ich  w ere  G iem sa  stained and 
ex am in ed  u nder  a l igh t m icroscope .  T h e  invasion of  
ta rg e t  ery throcy tes  was e s t im a ted  by coun ting  the 
n u m b e r  of  e ry th rocy tes  infec ted  w ith  ring-s tage 
parasites  and  expressing  th is  n u m b e r  as a percentage.
P la sm o d iu m  chabaud i  ch a b a u d i  erythrocyte  
invasion assay
P . c. chabaudi e ry th ro cy te  invasion assays w ere 
ca rr ied  ou t in 4 steps s im ila r  to those  o f  the  P. berghei 
invasion  assay b u t  w ith  som e necessary  differences.
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( a )  P u r i f i c a t io n  o f  p a r a s i t e - in f e c t e d  e r y t h r o c y t e s .  As 
the  in tra -e ry th ro c v t ic  cycle of P. c . c h a b a u d i  is 
sy n c h ro n o u s  th e re  is only a r e q u ir e m e n t  to separate  
in fec ted  f rom  non - in fec ted  e ry th rocy tes .  A single 
74 ° 0 Percoll  so lu tion ,  adapted  from  the  m e th o d  of 
W u n d e r l ic h  e t  a l .  (1985), was p rep a re d  by m ix ing  
9 ml o f  Percoll,  2-17 ml of  so lu tion  A and 1 0  m l of 
so lu t ion  B. Blood (1 ml) taken from  a P. c . c h a b a u d i  
in fec ted  C D - I  m ouse  with  a para s i taem ia  between  
15 a n d  25 ° 0 was passed over  a 1 ml C F -11  co lum n  
an d  th e  v o lu m e  b ro u g h t  to 10 m l w ith  P B S. T h e  
cells w ere  cen tr i fuged  at 450 £  and  re su sp e n d e d  in 
0 5 m l o f  P B S . T h i s  0'5 ml was carefullv  layered on 
1 2 1 7  m l of  the  above Percoll so lu tion  in a Corex 
tu b e  a n d  cen tr i fuged  at 5000 g  for 20 m in  at room  
te m p e r a tu re .  T h e  cells d iv ided  into 2 layers, infected  
e ry th ro c y te s  ( >  95 %  infected) b an d  at the  very  top 
w h ils t  un in fec ted  cells b an d  at the  b o t to m .  T h e  top 
layer  was rem o v e d  and  w ashed  once in  10 m l o f  PBS.
(b) C u ltu ring  o f parasite-in fected  erythrocytes. P a ra ­
s i t ized  cells w ere  th e n  m a in ta ined  in v itro  for 4 h in 
R P M I - 1 6 4 0  (to w hich  was added  2 m l of  1 M 
H E P E S ,  0 5 m g  hypoxan th ine ,  0-2 g g lucose, 200 /<1 
o f  n e o m y c in ,  1 m l of 200 m.vi g lu ta m in e  and  4 2 m l 
o f  5 %  so d iu m  b ica rbona te  s o lu t i o n /100 ml)  co n ­
ta in in g  1 0 %  hea t- inac tiva ted  rat se ru m  ( D C U  
an im a l  ro o m  facility).
(c) T arget erythrocytes. T h e  p re p a ra t io n  of  ta rge t 
e ry th ro c y te s  was as for th e  P. berghei invasion  assay.
(d) Inva sio n  assay. T h e  invasion assay was carried  
o u t  exac t ly  as descr ibed  for P. berghei excep t  th a t  the 
P . c. chabaudi cu l tu re  m e d iu m  was used .
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P. b e rg h e i  invasion assays
T h e  P erco l l  p ro ce d u re  ou tl ined  in th e  M ate r ia ls  and 
M e th o d s  section  can be used for the  efficient 
p u r if ica t io n  of  parasi te - in fec ted  ery th rocy tes .  T h is  
p r o c e d u re  has the  added  advan tage  in th a t  the  
pu r if ied  P . berghei parasites  are p re d o m in a n t ly  
m a tu r e  trophozo i tes  in con tra s t  to the  b lood  o b ta in ed  
f ro m  infec ted  m ice w hich  also con ta ined  r in g -fo rm  
a n d  y o u n g  trophozo i tes  (Fig. 1A and  B). T h e s e  
s y n c h ro n o u s  m a tu re  trophozo i tes  deve loped  to  seg- 
m e n to r s  w ith in  5 h  w h en  m a in ta in ed  in vitro , 
a l th o u g h  a few had  a lready  becom e sch izon ts  and  
o th e r s  h ad  deve loped  fu r th e r  and had  r u p tu r e d  the ir  
h o s t  e ry th ro c y te  (Fig. 1 C). W h e n  se g m en ted  p a ra ­
sites w ere  added  to cu l tu re  wells c o n ta in in g  fresh 
e ry th ro c y te s  they con t in u ed  the ir  dev e lo p m e n t ,  
r u p t u r e d  th e  e ry th rocy te  and released m erozo ites  
th a t  in v a d e d  these  new  ery th rocy tes .  N in e te e n  ho u rs  
a f te r  a d d in g  th e  parasitized  cells to  the  un in fec ted
cells the  percen tage  of  new ly  infected  erythrocytes  
could be es t im a ted  by c o u n t in g  the n u m b e r  of 
e ry th rocy tes  h a rb o u r in g  r ing -s tage  or  young  t r o p h o ­
zoite parasites  (Fig. 1 D). N o  invasion was observed 
into e ry th rocy tes  o f  rab b i ts  o r  hum ans.  In all 
expe r im en ts  e ry th rocy tes  o f  rabb i ts  o r  h u m a n s  acted 
as contro ls  for b ack g ro u n d  invasion. Parasites o b ­
served in these  con tro ls  were  usually  m a tu re  t ro p h o ­
zoites and  w ere  the re fo re  cons idered  as being ring- 
stage parasites  in tro d u c ed  w ith  the  infected m ouse  
e ry throcytes .
U sing  o u r  in vitro  invasion assay we have show n a 
p reference for re t icu locytes  d irec tly ;  Fig. 2 details 
several o f  o u r  ex p e r im en ts .  In  o u r  invasion assay 
using  e ry th rocy tes  o b ta in ed  from  8 to 10-w'eek-old 
mice we rou tine ly  o b se rved  invasion to a level of 
0-5-2 % . R eticu locyte  co u n ts  in  these mice were 
usually  0-5—1 -5 % . O n ly  in one case (Fig. 2, Exp. 1) 
did we observe  a h ig h e r  invasion (2-5% ) using
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F ig . 1. P u r if ica tio n  o f  P la sm o d iu m  berghei m ature  
tr o p h o z o ite - in fe c te d  e r y th r o c y te s , in v i tro  cu ltu r in g  and  
re in v a sio n . B lo o d  fro m  an in fe c te d  B a lb /c  m o u se  (A ) 
w as layered  o n  a s t e p -w is e  P erco ll g ra d ien t as d escr ib ed  
in  th e  M a ter ia ls  an d  M e th o d s  se c tio n . A fter  
cen tr ifu g a tio n  th e  e r y th r o c y te s  in fe c te d  w ith  m atu re  
tr o p h o z o ite s  b a n d ed  on th e  to p  (B ) and w ere rem o v ed , 
w ash ed  an d  m a in ta in e d  in v i tr o  for 5 h (C ) before  
a d d in g  to  ta rg et e r y th r o c y te s . R e in v a s io n  w as a ssessed  
b y  e s tim a tin g  th e  p e r c e n ta g e  r in g -s ta g e  parasites in 
ery th ro cy tes  19 h la ter  ( D ,  a rro w e d ). P anel D  sh o w s  
re in vasion  in to  e r y th r o c y te s  o b ta in e d  from  
p h e n v lh y d r a z in e -tr e a te d  m ice .
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F ig . 2 . In v a s io n  o f  e r y th r o c y te s  in v i tr o  b y  P la sm o d iu m  
berghei. E x p . 1, c o m p a r iso n  o f  P . berghei in v a s io n  rates  
in to  e r y th r o c y te s  o b ta in e d  fro m  2 - \ \e e k - o ld  m ic e ,  
8 -w e e k -o ld  m ic e , p h e n y lh y d r a z in e -tr e a te d  8 -w e e k -o ld  
m ic e  (all B a lb /c ) ,  r a b b it  and h u m a n . E x p . 2 , c o m p a r iso n  
o f  in v a s io n  rates in to  e r y th r o c y te s  o f  2 -w e e k -o ld  B a lb /c  
m ic e , 8 -w e e k -o ld  B a lb /c  m ic e  an d  p h e n y lh y d r a z in e -  
trea ted  8 -w e e k -o ld  B a lb /c  an d  S c h o fie ld  m ic e . E x p . 3, 
c o m p a r iso n  o f  in v a s io n  rates in to  e r y th r o c y te s  o f  n o rm a l 
a n d  p h e n y lh y d r a z in e -tr e a te d  8 -w e e k -o ld  B a lb /c ,  C D - I  
an d  S c h o fie ld  m ic e . P e r c e n ta g e s  at th e  to p  o f  c o lu m n s  
r e p r e se n t  r e t ic u lo c y te  c o u n ts  o f  ea ch  p a r ticu la r  
ta rg e t e r y th r o c y te  p rep a ra tio n . ( □ )  N o r m a l;
(S3) p h e n y lh y d r a z in e  trea ted .
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F ig . 3 . P u r if ica tio n  o f  P la sm o d iu m  c. c h a b a u d i- in fe c te d  
e r y th r o c v te s , in  v i tro  c u ltu r in g  an d  r e in v a s io n . B lo o d  
o b ta in e d  fro m  in fe c ted  C D - I  m ic e  (A ) w a s la y ered  o n to  
a 7 4  ° 0 P e r c o ll gra d ien t p rep a red  as d e sc r ib e d  th e  
M a te r ia ls  an d  M e th o d s  se c tio n . A fte r  c e n tr ifu g a tio n  th e  
p a r a s ite - in fe c te d  e ry th ro cy tes  b a n d e d  at th e  to p  o f  th e  
P e r c o ll (B ) a n d  w ere r e m o v e d , w a sh e d  an d  m a in ta in ed  
in  v i t r o  fo r  4  h  (C ) b efo re  a d d in g  to  ta rg e t e r y th r o c y te s .  
R e in v a s io n  w a s a ssessed  b y  e s t im a tin g  th e  n u m b e r  o f  
r in g -s ta g e  p ara sites  in  e r y th r o c y te s  19 h la ter (D ,  
a r r o w e d ) . (D )  S h o w s r e in v a s io n  in to  er y th r o c y te s  
o b ta in e d  fro m  8 -w e e k -o ld  B a lb /c  m ic e .
e ry th ro c y te s  from  8 to 10-w eek-o ld  m ic e ;  however, 
th e  re t icu locy te  coun t in the  b lood  of  the  an im al used 
in  th is  e x p e r im e n t  was un u su a l ly  h ig h  (11 ° 0). In  an 
a t t e m p t  to  im prove  o u r  invasion  assays we used 
e ry th ro c y te  p repa ra t ions  f ro m  very  you n g  m ice  as 
these  an im als  contain  h ig h e r  re t icu locy te  n u m b e rs  in 
th e i r  b lood .  In  the tw o e x p e r im e n ts  show n (Fig .  2, 
E x p s  1 an d  2) the re t icu locyte  co u n ts  o f  th e  2-week- 
o ld  m ice  u sed  were 29 an d  17-7 %  and  the  respective 
p e rc e n ta g e  invasions w ere  3'9 an d  5-l ; hence  the  
invas ion  of  e ry th rocy tes  by  P . berghei m erozoites  
im p ro v e d .  W e  a t t r ib u te  the  low er  level o f  invasion in 
E xp .  1 as co m p ared  to  E xp .  2 s im p ly  to  varia tion  
b e tw e e n  expe r im en ts .
P h e n y lh y d ra z in e  t r e a tm e n t  is c o m m o n ly  used  to 
in d u c e  re ticulocytosis  in m ice.  U s in g  o u r  p ro toco l of 
100 j«l o f  0 -4 %  p h e n y lh y d ra z in e /1 5 g bo d y  w eigh t 
g iven  o n  days 1, 3, 5, 7 a n d  9 the  re ticu locyte  coun ts  
in t r e a te d  m ice  w ould  be  >  50 %  on  days 6, 8 an d  10.
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F ig . 4. In v a s io n  o f  e r y th r o c y te s  in  v i tr o  b y  P lasm o d iu m  
c. ch a b a u d i.  E x p . 1, c o m p a r iso n  o f  P . c. ch abau d i 
in v a s io n  ra tes in to  e r y th r o c y te s  o b ta in e d  from  2 -w e e k -  
o ld  a n d  8 -w e e k -o ld  B a lb /c  m ic e . E x p  2 , c o m p a r iso n  o f  
in v a s io n  rates in to  e r y th r o c y te s  o b ta in e d  fro m  n o rm a l 
a n d  p h e n y lh y d r a z in e - tr e a te d  8 -w e e k -o ld  B a lb /c  m ice . 
H u m a n , rab b it an d  g u in e a -p ig  e r y th r o c y te s  w ere  a lso  
te s te d . E x p  3, c o m p a r iso n  o f  in v a s io n  rates in to  
e r y th r o c y te s  o f  n o rm a l an d  p h e n y lh y d r a z in e -tr e a te d  
8 -w e e k -o ld  B a lb /c ,  C D - I  an d  S c h o fie ld  m ic e . 
P e r c e n ta g e s  at th e  to p  o f  c o lu m n s  r ep resen t th e  
r e t ic u lo c y te  c o u n ts  in  e a c h  p a r tic u la r  ta rg et ery th r o c y te  
p r e p a r a tio n . ( □ )  N o r m a l;  ( S )  p h e n y lh y d r a z in e  trea ted .
E ry th rocy te  p repa ra t ions  w ith  high reticulocyte 
coun ts  w ere  tested in the invasion assay. Inclusion of 
these cells im p ro v e d  the invasion of P. berghei 
m erozo ites  b e t te r  th a n  7-fold over norm al e ry th ro ­
cytes (F ig .  2, Exps  1, 2 and  3). T h re e  strains of mice 
(B a lb /c ,  C D - I  and  Schofield mice) were similarly 
p h en y lh y d ra z in e  t rea ted  and the ir  e ry th rocy tes  
tested  in invasion assays and  com pared  to no rm al 
e ry th rocy tes  of the  sam e strains. A lthough  in Exp. 3 
invasion in to  B a lb /c  cells was h igher  than  the o the r  
tw o s tra in s  te s ted  we a t t r ib u te  th is  to exper im en ta l  
varia tion ,  because in Exp. 2 the invasion into B a lb /c  
and  Schofield m ice was a lm ost  identical. W e c o n ­
clude the re fo re ,  th a t  P. berghei invades equally  the 
red cells of all m o u se  strains tested  (Fig. 2, Exps 2 
and  3).
P. c. c h a b au d i  invasion assays
W h e n  P. c. chabaudi was m a in ta in ed  in C D - I  mice, 
acclim atized  to artificial day ligh t from  24.00 to 
1 2 .0 0 h ,  seques tra t ion  began  at approx im ate ly  
14.00 h. F o r  the  invasion assays mice were bled  
app rox im ate ly  1 h  before  seques tra t ion  began, 
usually  at 13.00 h. A s im ple  con t inuous  g rad ien t  
Percoll  s tep  was th e n  used to pur ify  parasi te - in fec ted  
e ry th ro cy te s  to a level o f  >  95 ° 0 from  un in fec ted  
e ry th rocy tes  (Fig. 3 A  and  B). W h e n  these infected  
e ry th rocy tes  were c u l tu red  m  vitro  for 4 h the  
parasites  deve loped  into segm ento rs  (Fig. 3 C) 
w hich ,  w h en  ad d e d  to  fresh ery throcytes ,  deve loped  
fu r th e r ,  r u p tu re d  the  red cell and  the  released 
m erozo ites  invaded  ta rge t e ry th rocy tes  (Fig. 3 D).
In  o u r  invasion  assay P. c. chabaudi invaded 
e ry th rocy tes  o b ta in e d  f rom  8 to 10-week-old m ice 
at a level o f  >  4 %  (Fig. 4, E xp  1); no invasion 
o cc u r re d  in to  gu inea-p ig ,  rab b i t  o r  h u m a n  e r y th r o ­
cytes (Fig. 4, Exp . 2). W e  also carried  ou t P. c. 
chabaudi invasion  assays us ing  ery th rocy tes  ob ta ined  
from  2 -w eek-o ld  m ice  and  surp ris ing ly  found  c o n ­
sis tently  h ig h e r  invasion  levels into these e ry th rocy te  
p rep a ra t io n s  (Fig. 4, Exp. 1). W e believed tha t  these  
results  ind ica ted  th a t  P. c. chabaudi p referab ly  
invades you n g  red  cells and  therefore  carried  o u t  
invasion assays using  ery th rocy tes  from  p h e n y l ­
h y d ra z in e - t re a te d  mice. P. c. chabaudi m erozo ites  
cons is ten tly  show ed  an increased invasion into 
e ry th ro cy te  p rep a ra t io n s  ob ta ined  from  p h e n y l ­
h y d ra z in e - t re a te d  mice, w hich  in each case exam ined  
co n ta in e d  a lm ost an  equal ratio of no rm al  e r y th r o ­
cytes to  reticu locytes ,  as co m p ared  to e ry th rocy tes  
f ro m  n o n -p h e n y lh y d ra z in e - t r e a te d  m ice (Fig. 4, 
E xps  2 and  3).
P . c. chabaudi invasion assays w ere p e r fo rm e d  
using  e ry th ro cy te s  ob ta ined  f rom  p h en y lhyd raz ine -  
t rea ted  and  n o n - t re a te d  B a lb /c ,  C D - I  o r  Schofield 
m ice. T h e  results  show ed  tha t  P. c. chabaudi in ­
vades e ry th ro cy te s  o f  d ifferent m ouse  strains at a 
s im ilar  level (Fig. 4, Exp. 3).
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D evelopm ent o f reticulocytes in vitro
E ry th ro c y te s  from  pheny lh y d ra z in e - tre a te d  mice 
w ere  m a in ta in ed  in cu l tu re  for 19 h at a cell dens ity  
and  u n d e r  s im ilar  cu l tu r in g  conditions as in the  
invasion  assays. R e t icu locy te  counts were p e r fo rm e d  
u s in g  m e th y le n e  b lu e  before  and after the  cu l tu re  
per iod .  T h e  re t icu locy te  count, d e te rm in e d  by  
m e th y le n e  b lue  s ta in ing ,  decreased from 56-56 0-0 to 
1 %  d u r in g  th is  t im e  per iod  indicating th a t  the  
re ticu locy tes  were m a tu r in g  into norm ocytes  w ith in  
th e  p e r io d  of  o u r  invas ion  assay (data no t show n).  
B ecause of this re t icu locy te  m a tu ra tion  we w ere  
u n ab le  to  co m pare  th e  relative invasion of  P. berghei, 
o r  P. c. chabaudi in to  reticulocytes and  e ry th rocy tes .
D I S C U S S I O N
In  th e  p re se n t  re p o r t  we detail m e thods  for p e r ­
fo rm in g  e ry th ro cy te  invasion  assays w ith  tw o ro d e n t  
m alar ias ,  P. berghei and  P. c. chabaudi. Several 
ex p e r im e n ts  are also p resen ted ,  which are the  
cu lm in a t io n  of  m a n y  th a t  tested every p a ra m e te r  
invo lved  in these  assays, and  which validate  o u r  
assays as the  resu lts  co rre la te  w ith  p rev iously  
re p o r te d  in vivo  an d  in v itro  reports.
N ecessa ry  r e q u ir e m e n ts  for the d ev e lo p m e n t  o f  
u se fu l  invasion assays inc lude  highly pur if ied  an d  
sy n c h ro n iz ed  para s it ized  erythrocytes .  Purif ication  
is necessary  as sco red  invasions m us t  have o c c u r re d  
in to  th e  in tro d u c ed  ta rg e t  cells only and  s y n c h ro n ­
ization  ensures  th a t  these  invasions h a p p e n e d  d u r in g  
th e  cou rse  of  the  assay. T h e  Percoll cen tr i fuga t ion  
s teps  d esc r ibed  in  th e  p re se n t  s tudy  for the  p u r i ­
f ication of  P. berghei an d  P. c. chabaud i-in fec ted  
e ry th ro cy te s  are r ap id  an d  simple to p e r fo rm  and  
y ie lds  o f  >  95 %  are  rou tine ly  achieved. T h i s  is a 
m u c h  s im p le r  an d  im p ro v e d  m e th o d  for p re p a r in g  
sy n c h ro n o u s  parasites  to th a t  descr ibed  by  M o n s  
et al. (1985) w hich  invo lved  in vitro  c u l tu r in g  and  
in  v ivo  passage th r o u g h  rats and  resu lted  in 
p re p a ra t io n s  of  v e ry  low purity .
T h e  invasion assays inc lude  an initial c u l tu r in g  of  
P. berghei and  P. c. chabaud i-infected e ry th ro cy te s  
a t a dens ity  of  2 - 5 x l 0 7/ m l  for 4 -5  h p r io r  to 
t r a n s fe r r in g  5 x 106 ( 2 0 0 /¿I) o f  these cells in fresh  
m e d iu m  (0-8 ml) c o n ta in in g  the  target e ry th rocy tes .  
W i th in  th is  p e r io d  the  parasites deve lop  in to  
sc h izo n ts  and  will r u p tu r e  w ith in  several h o u r s  of 
the  transfe r .  T h is  s tep  essentially  acts as a m e d iu m  
ch a n g e  an d  reduces  the  a m o u n t  of m a n ip u la t io n  of  
th e  paras ite s  to a m in i m u m .  W e have e l im ina ted  
cen tr i fu g a t io n  w ashes as sch izon t- in fec ted  e r y th r o ­
cy tes  o f  bo th  m a lar ia  species  have a te n d en c y  to  
c lu m p  and  b ecom e difficult to resuspend  (da ta  n o t  
sh o w n ) .  W e  have also obse rved  tha t  m o u se  e r y th r o ­
cy tes  a n d  re t icu locytes  are very  fragile and  h ence  we 
have  r ed u c ed  m a n ip u la t io n  of these cells to  a 
m in i m u m  p re fe r r in g  s ing le  washes w ith  large
v o lu m e s  to m u lt ip le  washes. .McLean et al. (1986) 
also c u l tu re d  P . c. chabaudi-parash ized  e ry throcytes  
for 5—6 h, in R P M I -1 6 4 0  m e d iu m  contain ing  5 -10  ° 0 
F C S  to ob ta in  t ro p h o zo i te s /sch iz o n ts  for im m u n o ­
f luorescence assays. A fter  tes ting  various serum  
types and  co n cen tra t ions  we found  th a t  5 0 %  F C S  
(hea t inactivated)  p ro v id ed  the bes t g row th  rate  for 
P. berghei and 1 0 %  rat se ru m  (heat inactivated) was 
o p t im u m  for P. c. chabaudi.
I t  is well know n  th a t  P. berghei m erozoites 
p re fe ren t ia l ly  invade reticulocytes (R am akr ishnan  & 
P rakash ,  1950; Janse  et al. 1984, 1989; S u h rb ie r  
et al. 1987). U s in g  o u r  in vitro  assays we observed  
a d irec t  co rre la t ion  be tw een  P. berghei m erozoite  
invasion  and the  presence  of  reticulocytes . Invasion 
levels in to  e ry th rocy tes  o b ta ined  from  8 to 10-week- 
o ld -m ic e  w h ich  con ta ined  0-5-1 -0 %  reticulocytes 
w ere  be tw een  0-5 and  2 % .  O n ly  in one case d id  we 
o b se rv e  a h ig h e r  invasion (2 -5% ) into e ry throcytes  
o f  these  m ice an d  th is  co rre la ted  w ith  an  unusually  
h ig h  re t icu locy te  co u n t  (1 1 % ) .  Since reticulocyte 
levels in the  b lood  o f  n ew b o rn s  are h ighe r  than  those 
in m a tu r e  an im als  (R apopor t ,  1986) by using  
e ry th ro cy te s  p rep a ra t io n s  from  2-w eek-o ld  mice 
( re t icu locy te  co u n ts  17-7 and  2 9 % )  we im proved  
invasion  to 5-1 and  3 -9% . Best invasion levels, 
h ow ever ,  w ere  achieved using  ery th rocy tes  from 
p h e n y lh y d ra z in e - t re a te d  m ice as m u c h  h igher  re t i ­
cu locy te  levels ( >  5 0 % )  could  be ob ta ined . Invasion 
levels w ere  rou tine ly  above 4 %  and  o f ten  above 8 %  ; 
in  all ex p e r im en ts  the  invasion into these  cells was 
7-fo ld  g rea ter  th a n  in to  no rm al  e ry throcytes .  T h e  
v a r ia t io n  obse rved  in  these expe r im en ts ,  we believe, 
is d u e  to  th e  difficulty in ob ta in in g  identical 
p rep a ra t io n s  o f  re ticulocytes  in te rm s  of  n u m b e r  ot 
re ticu locytes ,  stage o f  m a tu ra t io n  an d  health , F o r  the 
p u rp o s e  of s tud ies  on e ry th rocy te  invasion, for 
ex a m p le  an t i-m erozo i te  an t ib o d y  b lock ing  studies, 
e ry th ro cy te  p rep a ra t io n s  f rom  2-w eek-o ld  or p h e n y l ­
h y d ra z in e - t re a te d  m ice w ou ld  give acceptable in ­
vas ion rates to ensu re  statistically significant results  
an d  a l th o u g h  the  fo rm er  p rep a ra t io n s  resu lt  in  lower 
invas ion  rates they  m ay be s im pler  to obta in .
E ry th ro c y te  invasion  assays for P . c. chabaudi are 
easier to  p e r fo rm  w’hen  co m p ared  to  those of P. 
berghei because  sy n c h ro n o u s  parasites  are easily 
o b ta in e d  and  the  prov is ion  of  e ry th rocy te  p r e ­
p a ra t io n s  con ta in ing  h igh  levels o f  re t icu locytes  is 
n o t  necessary .  Invas ion  levels o f  5 -6  % w ere  
rou t ine ly  o b ta in ed  us ing  e ry th rocy tes  o f  8 to  10- 
w eek -o ld  mice. A detailed  s tu d y  of  the  course  of 
P. c. chabaudi (AS strain)  pa ra s itaem ias  in  C B A /C a  
m ice  show ed  th a t  th is  paras ite  show s no  p re ference  
for re ticu locytes .  W h e n  the  in v ivo  re t icu locyte  level 
was en h a n c e d  to  equal th a t  of m a tu r e  e ry th rocy tes  
(no rm ocy te s )  by  ph en y lh y d ra z in e  t r e a tm e n t  p r io r  to 
in fec tion  the  invasion f requency  of  P . c. chabaudi 
in to  each  cell type  was s im ila r  ( Jarra  & B row n, 1989). 
T h i s  s tu d y  s u p p o r te d  earlier  in v ivo  s tud ies  (C a r te r
R o d e n t m a la r ia  p a ra s ite s  : in  v i t ro  in v a s io n  a ssa ys 361
& W alliker ,  1975). T h e  results p re se n ted  in th is  
s tu d y  are in te res ting  to co m p are  to the  in v ivo  s tu d y  
of  J a r ra  & B row n (1989) as we show  th a t  w h e n  P. c. 
chabaudi (AS strain)  are p re se n ted  in v itro  w ith  
e ry th ro cy te  p repa ra t ions  w ith  a lm ost  equa l  r e t icu lo ­
cyte and  n o rm o cy te  levels invasion is cons is ten tly  
b e t te r  th a n  into e ry th rocy te  p rep a ra t io n s  w ith  <  1 ° u 
re ticu locytes .  O u r  resu lts  the re fo re  ind ica te  th a t  
P. c. chabaudi does show a p re fe rence  for re t icu lo ­
cytes a l th o u g h  this  p reference  is no t  as m a rk e d  as in 
P. berghei. T h i s  is the  first s tu d y  in w h ich  e r y th r o ­
cyte invasion  by these two m a lar ia  paras i te s  is 
co m p a re d  direc tly  an d  s im u ltaneous ly .  W e  ex a m in e d  
e ry th ro cy te  and  re t icu locyte  p re p a ra t io n s  f ro m  th ree  
m o u se  s t ra in s  and  obse rved  sim ilar  resu lts  ind ica t ing  
th a t  availabili ty o f  e ry th ro cy te  ligands  does n o t  
inf luence the  course  o f  paras i taem ias  in d if fe ren t  
m o u se  s tra ins .  A hos t  genetic  fac to r ,  m e d ia ted  
th ro u g h  the  availabili ty o f  reticu locytes ,  m a y  con tro l  
th e  course  of P. berghei p a ra s i taem ias  in v ivo  (see 
review by  M il le r  & C a rte r ,  1976). T h e  en h a n c e d  
invasion  o f  P. c. chabaudi in to  re t icu locy tes  m ay 
ind ica te  th a t  this species sp o n ta n eo u s ly  a rose  f ro m  a 
line th a t  h ad  a p reference  for re t icu locy tes  s im ila r  to 
P. berghei and  P . yoelii. An ex a m p le  o f  such  a 
sp o n ta n e o u s  d ivergence  a lready  exists for  th e  la tte r  
paras ite  (Yoeli et al. 1975).
A c lea re r  u n d e rs ta n d in g  of P . berghei and  P . c. 
chabaudi m erozo ite  invasion in to  re t icu locy tes  and  
n o rm o cy te s  w ould  have been  o b ta in e d  if co u n ts  o f  
new ly  in v ad ed  parasites  into each  cell ty p e  could  
have b ee n  p er fo rm ed .  Reticu locy tes  in  v ivo  m a tu re  
in to  n o rm o cy tes  w i th in  24—36 h  af te r  release f rom  
the  b o n e -m a r ro w  in to  the  c ircu la t ion  (G ro n o w icz ,  
Sw ift  & Steck, 1984). In  o u r  in  v itro  co n d i t io n s  we 
fo u n d  m a tu ra t io n  to  be  close to the  in v ivo  s i t u a t i o n ; 
h en ce  by th e  end  of  o u r  invasion  assays we o b se rved  
th a t  re ticu locytes  had  m a tu re d ,  losing th e i r  r ib o ­
nucle ic  acid  and  cou ld  no t be v isua lized  w ith  
m e th y le n e  b lue or  o th e r  stains an d  th e re fo re  m ak ing  
it im p o ss ib le  to d e te rm in e  if new ly  in v a d e d  paras i te s  
h ad  invaded  re ticu locytes  o r  n o rm o c y te s .  T h i s  
o b se rv a t io n  was im p o r ta n t  since if re t icu locy te-  
specific l igands for m alar ia  invasion are  also lost in 
such  a sh o r t  t im e p e r io d  it is cruc ia l ,  in o rd e r  to 
o b ta in  h ig h  levels o f  invasion, to  p ro v id e  the  
re t icu locy tes  as close to  the  t im e  o f  P . berghei 
m e ro z o i te  em ergence  as possib le.  T h e r e f o r e ,  the  
c u l tu r in g  o f  P. berghei-infected  e ry th ro c y te s  p r io r  to 
ad d i t io n  to  ta rge t  e ry th rocy tes  fu n c t io n s  n o t  on ly  in 
m a tu r in g  th e  parasites  to  s e g m e n to r s / s c h iz o n ts  b u t  
also synch ron izes  the ir  r u p tu re  be fo re  m u c h  r e t icu lo ­
cyte m a tu r a t io n  can take  place.
In  conc lus ion ,  we have d eve loped  s im p le  assays 
for  th e  s tu d y  of e ry th ro cy te  invas ion  b y  P . berghei 
an d  P . c. chabaudi. As these  ty p e s  o f  assays w ere  
on ly  p rev iously  available for th e  m o n k e y  m alar ia ,  
P . know lesi, and the  h u m a n  m alar ia ,  P . fa lc ip a ru m , 
s tud ies  on  the  m o lecu la r  m e c h a n ism s  o f  invasion
have been  largely confined to these parasites. U n ­
d o u b te d ly ,  the  roden t  m alar ias  can con tr ibu te  im ­
m ense ly  to o u r  know ledge of  e ry th rocy te  invasion, 
and  because  of  their  ease of  m ain tenance  in the 
labo ra to ry  and  the  availabili ty  of the  invasion assays 
deta i led  here ,  fu tu re  in fo rm a tio n  shou ld  be m ore 
easily fo r thcom ing .
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In Vitro Assays for the Study of 
Erythrocyte Invasion by Malarial 
Parasites
JP. Dalton, J. McNally and S.M. O ’Donovan
In v itro  assays for the study o f erythro­
cyte invasion by merozoites are available 
for several primate and rodent malarial 
species. These assays are essential 
means by which potential anti-merozoite 
vaccine candidates are identified. John 
Dalton, John McNally and Susan O ’Dono- 
van describe the various types o f invasion 
assays that are in current use, outline the 
procedures for performing these assays 
and add some pointers on interpretation 
o f data denved from them.
The clinical manifestations o f malaria 
are caused by the asexual erythrocytic 
stages o f the parasite. Invasion o f 
erythrocytes by merozoites involves 
recognition, attachment, re-orientation, 
junction form ation and invagination o f 
the erythrocyte membrane around the 
merozoite. Inhibition o f  any o f  these 
events would prevent disease; hence 
identification and characterization o f 
merozoite molecules involved in all o f 
these events is important, as each rep­
resents a target to  which protective 
humoral immunity could be directed.
Elucidation o f the molecular intricacies 
o f erythrocyte invasion will necessi­
tate the  development o f methods, in 
vitro, tha t allow  examination o f each 
event in the  invasion process. C ur­
rently, tw o  types o f in vitro eiythrocyte- 
invasion assays exist: ( I )  those that 
involve mixing schizont-infected eryth­
rocytes w ith  target erythrocytes; and 
(2) those tha t m ix free merozoites 
w ith  target erythrocytes. In these assays 
the number o f parasites tha t invade the 
target cells is quantified. T o  examine 
reagents fo r  the ir ability to  interfere 
w ith  specific steps in invasion, they are 
added to  these assays and the ir effects 
measured by observing the difference 
in the  number o f successful invasions 
compared to  appropriate controls. 
However, these assays do no t allow us 
to  dissect the  various events o f  inter­
action between the m erozoite and the 
erythrocyte surface as the assays are 
term inated when newly invaded para­
sites have reached a size w ithin the
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target erythrocyte whereby they are 
easily recorded. The rapidity w ith 
which merozoites invade erythrocytes 
makes it difficult fo r  us to  halt the ir 
movements at will. There is only one 
step in the erythrocyte invasion 
process that can be readily impeded, 
tha t is, between junction form ation and 
invagination, by the addition o f  cyto- 
chalasin B to  the assay. In the presence 
o f  cytochalasin B, merozoites w ill re­
orientate and will fo rm  a junction, but 
w ill proceed no fu rth e r1. This ‘freezing' 
o f the invasion process has permitted 
the development o f m erozoite attach­
m ent assays that can be useful in deter­
mining w hether a reagent exerts its 
effect on invasion before o r after junc­
tion  form ation2.
P r im a te  M a la r ia s
Invasion assays tha t use schizont- 
infected erythrocytes are the simplest 
to  perform. These assays are used 
routinely fo r investigating inhibitors o f 
invasion, antibody blocking o f invasion 
and erythrocyte ligands required fo r 
invasion and have been developed fo r 
several Plasmodium species, including P. 
knowlesi2, P. falciparum34 and P. vivax5. 
For these assays it is necessary to  
obtain synchronous schizont-infected 
erythrocytes free o f uninfected eryth­
rocytes. In cases w here erythrocyte lig­
ands required fo r invasion are being 
investigated (eg. by enzyme treatm ent 
o f  target cells), any uninfected cells 
introduced w ith the schizonts to  the 
assays may obscure true  invasion pref­
erences. Infected erythrocytes are 
removed from  the host o r  from  culture 
w hen the parasites have reached 
approximately the six m erozoite- 
infected cell stage, and schizont- 
infected cells are purified by density 
gradient centrifugation2”5. The purified 
parasite-infected cells are added to  24- 
well tissue culture plates, o r m icrotitre 
plate wells, containing the previously 
prepared target erythrocytes. The
plates are placed in a C 0 2 incubator c 
candle jar at 37° C. For P. vivax invasio 
assays, the percentage o f immatur 
erythrocytes in the target cells 
increased by processing cells over pei 
coll o r  Nycodenz cushions5 1. Th 
schizont : target cell ratio is general 
1 :5  o r I : 10 w ith the number c 
target cells typically 2 -5  x 107. A t thes 
ratios, sufficient numbers o f mere 
zoites, tha t allow good statistical anal\ 
sis o f data, will invade. Altemativel 
assays can be performed in Eppendor 
(cheaper microcentrifuge tubes ma 
leach chemicals that are toxic to  para 
sites) which are then gased (6% CO 
3% 0 2, 91% N 2) and placed on a rota; 
ing wheel at 37° C. A fte r allowing tim 
fo r rupture, re-invasion and develop 
ment o f  parasites to  visible nng form 
(usually six hours fo r  P. knowlesi assay-: 
overnight fo r P. falciparum assays, am 
six to  eight hours fo r P. vivax), the eryth 
rocytes are removed from  the wel 
and washed once w ith foetal ca 
serum before preparing smears w hic 
are then Giemsa stained. Invasion c 
erythrocytes is estimated microscop 
cally by calculating the percentage c 
erythrocytes containing one o r m or 
ring-fonm parasites. These percentage 
usually range from  5 to  12%. It is cleat 
therefore, considering the parasitaemi 
at which the assay is initiated, tha 
many merozoites do not successful! 
re-invade. A t which stage o f invasior 
the difficulty fo r merozoites occurs i 
not known; unruptured cells are raref 
seen.
The assays described above are use 
ful fo r testing o r searching fo r erythro 
cyte invasion-blocking antibodies. The 
mechanism by which an antibod', 
blocks invasion can be either a specific 
inhibition o f the activity o f merozoite 
molecules, such as enzymes o r mol 
ecules tha t interact w ith erythrocyte 
ligands, o r by an agglutination o f m ero­
zoites. These tw o  means o f blocking 
can be differentiated by preparing Fab 
fragments. Fab fragments o f antibodies 
tha t block by agglutination will have nc
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blocking activity in these invasion 
assays, whereas those o f specific block­
ing antibodies will. Furthermore, if free 
merozortes can be obtained, aggluti­
nation o f these can be tested directly. 
The level o f blocking o f invasion by 
antibody will obviously depend on its 
concentration, affinity fo r its epitope 
and its isotype. Antibody-blocking 
assays carried out in tissue-culture wells 
and Eppendorfs may render different 
results, as the length o f tim e tha t m ero- 
zoites are exposed to  antibody may 
differ. In tissue-culture wells, since the 
cells are static, merozoites invade the 
erythrocytes immediately surrounding 
the ruptured cell, suggesting tha t the 
distance a merozoite must travel in 
these assays may be the w idth o f a cell 
membrane8.
Caution must be exercised when 
testing certain reagents in invasion 
assays tha t use schizont-infected eryth­
rocytes. Some reagents, such as 
enzyme inhibitors o r polysaccharides9, 
may appear to  affect the invasion 
process but may actually inhibit cell 
rupture. Indeed, reagents dem on­
strated to  inhibit invasion in these 
assays must be shown to  be non-toxic 
to  schizonts. Invasion assays using free 
m erozoites circumvent this problem. 
H owever, o f the pnmate malarias, 
viable free merozoites fo r these assays 
can be obtained only fo r P. know lesi. 
These merozoites are most simply pre­
pared by the syringe-release m ethod2. 
Schizont-infected erythrocytes are 
maintained, in vitro, in the presence o f 
the proteinase inhibitors, leupeptin and 
chymostatin. These inhibitors prevent
the rupture o f the cell and the release 
o f  m erozoites10. The development o f 
the  parasites in vitro is observed by 
removing samples from  the culture at 
hourly intervals and examining them 
microscopically following Giemsa stain­
ing. A fte r approximately three hours, 
when individual merozoites are easily 
discerned, the cells are then removed 
from  the culture and the proteinase 
inhibitors washed out by centrifugation. 
The cells are resuspended in I ml 
medium, 10 i^l anti-rhesus erythrocyte 
serum is added to  agglutinate the cells 
and then the merozoites are released 
by passing (five times) the cells vigor­
ously through a 25-gauge needle 
attached to  a I ml syringe. The suspen­
sion is passed over a 4 x 0.5 cm pro­
tein A-Sepharose column to  remove 
cell debris and unruptured cells. As free 
P. know les i merozoites are viable fo r 
only a short time, aliquots o f the eluant 
containing merozoites are added 
immediately to  prepared target cells in 
Eppendorfs that have been placed in a 
37°C  waterbath. The tubes are gased 
and moved to  a rotating wheel placed 
at 37°C. A fte r a period o f six hours, 
smears are prepared and examined as 
fo r the previously described invasion 
assays. The percentage o f erythrocytes 
containing one o r more newly invaded 
parasites is routinely between 5 and 
10%. Because o f the urgency in com­
bining the free merozoites w ith the tar­
get cells, the exact number o f viable 
merozoites added can not be esti­
mated correctly. However, 2 x I08 
schizont-infected cells should release 
enough merozoites fo r 5 -10  invasion 
assays2. For invasion-blocking exper­
iments, reagents are mixed w ith the 
target cells before the addition o f 
merozoites.
T o  study merozoite attachment, 
cytochalasin B is added to  freed m ero­
zoites to  a final concentration o f 10 
\ ig  ml '. Following addition o f the 
merozoites to  the target cells, the 
tubes are continuously agitated in the 
waterbath at 37°C fo r 10 min, after 
which the cells are fixed by the ad­
dition o f an equal volume o f 4% 
glutaraldehyde in physiological saline. 
A ttached merozoites are counted 
under interference microscopy. Sam­
ples from  each assay are pipetted in 
the triangular space created by placing 
one coverslip partially over another. 
Attached merozoites are scored while 
tapping the microscope slide in order 
to  jounce the fixed erythrocytes so 
tha t all sides are observed and to  
ensure tha t the merozoites are indeed 
attached1.
R o d e n t M a la ria s
The difficulty in maintaining rodent 
malarias, in vitro, has hampered the 
development o f in vitro erythrocyte 
invasion assays fo r these species. Some 
rodent malaria species, such as P 
berghei. are asynchronous, and invade 
only immature erythrocytes. In addition, 
erythrocytes containing mature para­
sites sequester in the deep vasculature.
Recently, erythrocyte-invasion assays 
have been developed fo r rodent 
malaria species P. berghei and P 
chabaudi chabaud iu , These assays are 
similar to  those described fo r the 
primate species using schizont-infected 
erythrocytes. Infected mice are bled 
before parasitaemias reach 25%: at 
higher parasitaemias, multiply infected 
cells appear and parasites within these 
cells do not develop to  schizonts. Mice 
infected w ith  P. c. chabaudi are bled 
before sequestration commences. Para­
site-infected erythrocytes are purifiea 
to  >95% by percoll gradients. In the 
case o f P. berghei these gradients also 
provide preparations o f erythrocytes 
infected w ith  late trophozoite forms 
that are very synchronous. The para­
site-infected erythrocytes are main­
tained, in vitro, at 2 x  107 cells per milli­
litre fo r six hours to  allow the parasites 
to  develop to  schizonts. Tw o hundred 
microlitres o f  cell suspension is then 
removed and added to  the target cells 
in 24-well plates. For P. berghei, imma­
ture erythrocytes are provided. These 
cells are obtained by treating mice w ith 
phenylhydrazine until the reticulocyte 
count is above 50%. It takes 19 hours 
fo r parasites to  rupture from  the cells, 
invade and reach visible ring forms (see 
Fig. I ). The percentage o f erythrocytes 
containing newly invaded parasites is 
routinely between 5 and 12%.
An invasion assay using free P 
berghei merozoites has been described 
by Janse et a l. '2, but has not yet been 
adapted to  establish a merozoite 
attachment assay. Free merozoites are 
isolated from  a culture chamber in 
which parasite-infected erythrocytes 
are maintained, and through which 
medium is continuously passing. The 
exit o f  the chamber is covered w ith a 
polycarbonate filter, which allows the 
passage o f only free merozoites. Rup­
ture is caused by shearing forces o f a 
magnetic bar which is spinning on the 
membrane. Freed merozoites are 
mixed w ith erythrocyte preparations 
containing high reticulocyte counts, 
obtained from  phenylhydrazine-treated 
rats, and cultured fo r 20 hours. A fte r
Fig. I. Photograph o f  Giemsa-stained  
smears on a microscope slide, showing  
newly invaded ring-stage parasites (arrows) 
o f  P lasm od ium  chabaudi chabaudi in ta r­
get (mouse) erythrocytes 19 h a fte r in­
itia tion  o f  the invasion assay, in vitro.
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this tim e period, as many as 13% o f the 
target rodent erythrocytes are invaded.
Recently, Braun Breton et al.13 
described a method fo r performing 
attachment and invasion assays w ith P. 
chabaudi. Leucocyte-free erythrocytes, 
obtained from  infected mice, are incu­
bated in the presence o f the D N A - 
binding bisbenzimidazole dye, Hoechst 
333342. The cells are then maintained, 
in serum-free culture medium, fo r 
6 0 -9 0  minutes, and merozoite release 
fo llow ed by flo w  cytometry. Freed 
merozoites are washed (to  remove 
contaminating cells and cell debris) and 
are then mixed w ith target erythro­
cytes. A fte r  one hour the cells are 
removed, and attached merozoites 
quantified by flow  cytometry. If the 
assay is allowed to  proceed fo r six to  
seven hours, invasion o f erythrocytes 
is quantified by Giemsa staining o f 
smears. Using murine erythrocytes as 
target cells, under the assay conditions 
described, 10-20% erythrocytes bind 
m erozoites and 0.7-2% are invaded. 
T o  tes t reagents fo r the ir ability to
inhibit invasion, freed merozoites are 
incubated w ith  these fo r 10 minutes, 
then washed extensively before adding 
to  target cells.
C o n c lu s io n
In vitro erythrocyte invasion assays 
have contributed greatly to  ou r under­
standing o f  the  interactions between 
m erozoite and erythrocyte at a m ol­
ecular level7. It is clear that there is still 
a requirem ent fo r  assays that permit 
the study o f  each step in the invasion 
process, and it is also obvious th a t fo r 
many malaria species, invasion assays 
are no t yet available. N o  doubt these 
w ill be forthcoming, and w ith  them  will 
come the identification o f  more anti- 
m erozoite vaccine candidates.
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This training manual is in tw o  parts: a 
Learner's Guide intended fo r use by the 
trainees, and a Tutor's Guide to  be used 
by the  course instructor. It is designed fo r 
the  training o f public health workers 
engaged in entomological field w o rk  fo r 
malaria control, and ft can also be in­
corporated into a longer, more compre­
hensive training programme on malaria. 
This is the  second module on malaria 
contro l to  be produced by the W o rld  
Health Organization, as Basic Malaria 
Microscopy was published in 1991 (see 
Ref. I).
The Learner's Guide is divided into 13 
Learning Units, each containing a series o f
objectives. Students are expected to  be 
thoroughly conversant w ith each unit 
before moving on to  the next The training 
activities take place in the classroom, the 
laboratory and the field. The Learning 
Units contain all the essential information 
needed to  apply a variety o f entomological 
techniques, including: the role o f
entomological w o rk  in malaria control, 
recognition o f  anopheline mosquitoes, 
collection o f mosquitoes indoors and 
outdoors (in exit traps and by using bait), 
and collecting larvae and pupae. Tw o  
additional techniques which perhaps could 
have been included are the slide-mounting 
o f  larvae and pupae, and insecticide 
susceptibility testing o f adult mosquitoes. 
The te x t is easy to  understand and is 
complemented w ith  clear, simple line 
drawings. A t the back o f the manual, 
explanations o f  terms used are included. 
The activities are nearly all field-based with 
instructions on equipment required, and 
on methods o f  transport fo r material 
collected. For some activities, students are 
encouraged to  w o rk  in pairs, w ith each 
taking a turn to  comment on the per­
formance o f the other. The import­
ance o f good record-keeping is stressed 
throughout
The Tutor's Guide gives suggestions fo r 
the organization o f the training pro­
gramme and sets out the teaching 
methods tha t are appropriate fo r each o f 
the 13 Learning Units. A  number o f these
contain very useful performance-appraisa 
forms fo r use in assessing students 
progress. Great cane is taken during each 
field activity to  ensure the locai 
community is fully aware o f  the reasons 
why the w ork is being earned out 
Reference is made in the Tutor's Guide tc 
the tw o  techniques which are not coverec 
in the Learner's Guide, ie. the pinning o; 
adult mosquitoes and precipitin testing oT 
bloodmeals. Perhaps details o f these 
methods should have been included. Twc 
useful annexes are to  be found in the 
Tutor's Guide. The first lists various teaching 
methods (such as: brainstorming, buzz- 
groups, case discussion, demonstrations, 
video tapes and role playing) and their 
purposes. These permit variation in the 
way subject m atter is relayed to  the 
students. The second annex is a ques­
tionnaire to  be completed by course 
participants fo r evaluation o f the training, 
included w ith this is a method o f analysing 
the ir responses.
Considerable thought has been 
incorporated in these guides to  ensure 
the style o f  teaching is appropriate to  
situations that exist in those developing 
countries where malaria is endemic.
Reference
I Guy, M .W . ( 1992) Parasitology Today 8, 3 19
Malco lm  G uy
L iverpool School o f  T rop ica l Medicine  
Pembroke Place, L iverpoo l. UK G  5Q A
